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ABSTRACT  
Autoimmune  regulator  (AIRE)  is  the  gene  mutated  in  the  human  polyglandular  
autoimmune   disease   called   Autoimmune   polyendocrinopathy,   candidiasis,  
and   ectodermal   dystrophy   (APECED)   that   belongs   to   the   Finnish   disease  
heritage.  Murine  Aire  has  been  shown  to  be  important  in  the  generation  of  the  
T  cell  central  tolerance  in  the  thymus  by  promoting  the  expression  of  ectopic  
tissue-­specific   antigens   in   the   thymic   medulla.   Aire   is   also   involved   in   the  
thymus   tissue  organization  during  organogenesis.   In  addition   to   the   thymus,  
AIRE/Aire  is  expressed  in  the  secondary  lymphoid  organs.  Accordingly,  a  role  
for  AIRE/Aire  in  the  maintenance  of  peripheral  tolerance  has  been  suggested.  
Peripheral   tolerance   involves  mechanisms   that  suppress   immune  responses  
in   secondary   lymphoid   organs.   Regulatory   T   cells   (Tregs)   are   an   important  
suppressive   T   cell   population  mediating   the   peripheral   tolerance.   Tregs   are  
generated  in  the  thymus  but  also  in  the  peripheral  immune  system  T  cells  can  
acquire  the  Treg-­phenotype.    
   The  aim  of   this   study  was   to   characterize  Tregs   in  APECED  patients  
and  in  the  APECED  mouse  model  (Aire-­deficient  mice).  In  the  mouse  model,  
it   was   possible   to   separate   Aire   expression   in   the   thymus   and   in   the  
secondary  lymphoid  organs.  The  relative  importance  of  thymic  and  peripheral  
Aire  expression  in  the  maintenance  of  immunological  tolerance  was  studied  in  
an   experimental  model   that   was   strongly   biased   towards   autoimmunity,   i.e.  
lymphopenia-­induced   proliferation   (LIP)   of   lymphocytes.   This   experimental  
model  was  also  utilised  to  study  the  behaviour  of  T  cells  with  dual-­specific  T  
cell  receptors  (TCR)  during  the  proliferation.    
The  Treg  phenotype  was  studied  by   flow  cytometry  and   relative  gene  
expression  with   real-­time  polymerase  chain   reaction.  TCR   repertoires  of   the  
Tregs   isolated   from   APECED   patients   and   healthy   controls   were   also  
compared.   The   dual-­specific   TCRs   were   studied   with   the   TCR   repertoire  
analysis  that  was  followed  with  sequencing  of  the  chosen  TCR  genes  in  order  
to  estimate  changes  in  the  dual-­specific  TCR  diversity.  The  Treg  function  was  
tested  with  an  in  vitro  suppression  assay.    
   The  APECED  patients  had  normal  numbers  of  Tregs  but  the  phenotype  
and   suppressive   functions   of   the  Tregs  were   impaired.   In   order   to   separate  
Aire   functions   in   the   thymus   from   its   yet   unknown   role   in   the   secondary  
lymphoid   organs,   the   phenomenon   of   LIP   was   utilised.   In   this   setting,   the  
lymphocytes   that   are   adoptively   transferred   to   a   lymphopenic   recipient  
proliferate  to  stimuli  from  self-­originating  antigens.  This  proliferation  can  result  
in   autoimmunity   if   peripheral   tolerance   is   not   fully   functional.   When  
lymphocytes  that  had  matured  without  Aire  in  the  thymus  were  transferred  to  
lymphopenic  Aire-­sufficient   recipients,  no  clinical  autoimmunity   followed.  The  
Aire-­deficient   donor-­originating   lymphocytes   hyperproliferated,   and   other  
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signs   of   immune   dysregulation   were   also   found   in   the   recipients.   Overt  
autoimmunity,  however,  was  prevented  by  the  Aire-­deficient  donor-­originating  
Tregs  that  hyperproliferated  in  the  recipients.      
   Aire-­deficient  lymphopenic  mice  were  used  to  study  whether  peripheral  
loss  of  Aire  had  an  impact  on  the  maintenance  of  peripheral  tolerance.  When  
normal   lymphocytes   were   transferred   to   these   Aire-­deficient   lymphopenic  
recipients,  the  majority  of  recipients  developed  a  clinically  symptomatic  colitis.  
The   colitis   was   confirmed   also   by   histological   analysis   of   the   colon   tissue  
sections.  In  the  Aire-­deficient  lymphopenic  recipients  Tregs  were  proliferating  
significantly   less   than   in   the   control   group’s   recipients   that   had   normal   Aire  
expression  in  their  secondary  lymphoid  organs.  
   This  study  shows  that  Aire  is  not  only  important  in  the  central  tolerance  
but  is  also  has  a  significant  role  in  the  maintenance  of  the  peripheral  tolerance  
both   in  mice  and  men.  Aire  expressed   in   the  secondary   lymphoid  organs   is  
involved  in  the  functions  of  Tregs  during  an  immune  response.  This  peripheral  
expression  appears   to  be   relatively  more   important   in  some  situations  since  
only  those  lymphopenic  recipients  that  had  lost  peripheral  expression  of  Aire  
developed   a   symptomatic   autoimmune   disease.   This   AIRE-­related   Treg  
defect   could   be   clinically   important   in   understanding   the   pathogenesis   of  
APECED.    
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TIIVISTELMÄ  
Autoimmune   regulator   (AIRE)   -­   geeni   on   mutatoitunut   suomalaisen  
tautiperimän   sairaudessa   autoimmuuni-­polyendokrinopatia,   kandidiaasi   ja  
ektodermaalinen   dystrofia   (APECED).  Hiiren  Aire:n   on   osoitettu   osallistuvan  
kateenkorvassa   T-­solujen   sentraalisen   toleranssin   syntyyn   aiheuttamalla  
transkriptiofaktorina   kateenkorvan   ytimessä   kudosantigeenien   ektooppista  
ilmentymistä.   T-­solujen   kehityksen   aikana   näille   kudosantigeeneille  
reaktiiviset   T-­solut   kuolevat   ennen   kypsymistään,   eivätkä   pääse   elimistöön  
aiheuttamaan   autoimmuunitulehdusta.   Aire   osallistuu   myös  
kateenkorvakudoksen   kehitykseen.   Kateenkorvan   lisäksi   AIRE/Aire   ilmentyy  
sekundaarisissa   immunologisissa   elimissä,   joten   sillä   on   epäilty   olevan  
merkitystä  myös   perifeerisen   toleranssin   ylläpidossa.   Perifeerinen   toleranssi  
tarkoittaa  mekanismeja,   joilla   kypsien   lymfosyyttien   immuunivasteita   hillitään  
kateenkorvan   ulkopuolella.   Säätelijä   T-­solu   (Treg)   on   tärkeä   perifeeristä  
toleranssia   välittävä   solutyyppi,   joka   voi   hillitä   immuunivasteita.   Elimistössä  
Treg-­soluja  syntyy  pääosin  kateenkorvassa,  mutta  myös  muualla  solut  voivat  
hankkia  Treg-­ilmiasun  ja  toimia  Treg-­soluina.  
   Tässä   väitöskirjatyössä   tutkittiin   Treg-­soluja   APECED-­potilaissa   ja  
APECED:n  hiirimallissa,  eli  Aire-­poistogeenisissä  hiirissä.  Hiirimallissa  Aire:n  
ilmentyminen  kateenkorvassa  ja  muualla  elimistössä  voitiin  erottaa  toisistaan.  
Täten   oli   mahdollista   tutkia   Aire:n   suhteellista   merkitystä   sentraalisessa   ja  
perifeerisessä   toleranssissa   tilanteessa,   joka   on   voimakkaasti  
autoimmuniteetille  altistava.  Tähän  tarkoitukseen  soveltuva  tutkimusasetelma  
oli  lymfopeniaa  seuraava  lymfosyyttien  jakautuminen.  Tätä  samaa  asetelmaa  
hyödynnettiin  myös  väitöskirjan  yhdessä  osajulkaisussa,   jossa   tutkittiin  kahta  
eri   T-­solureseptoria   ilmentävien   T-­solujen   menestymistä   lymfopeniaa  
seuraavassa  jakautumisessa.    
Treg-­solujen   ilmiasua   tutkittiin   virtaussytometrialla   ja   eri   geenien  
suhteellista   ilmentymistä   mitattiin   reaaliaikaisella   polymeraasiketjureaktiolla.    
Potilaiden   ja   terveiden   verrokkien   Treg-­solujen   T-­solureseptorien   valikoimaa  
vertailtiin   keskenään.   Kahta   T-­solureseptoria   ilmentävien   T-­solujen   T-­
solureseptorien   valikoimaa   tutkittiin   T-­solureseptorirepertuaarianalyysillä,  
jonka   jälkeen   valitut   T-­solureseptorigeenit   sekvensoitiin.   Tällä   tavoin   oli  
mahdollista   arvioida   kaksois-­T-­solureseptorien   vaihtelevuus   ja   sen   muutos  
solujen  jakautumisen  aikana.  Lisäksi  Treg-­solujen  immuunivastetta  hillitsevää  
toimintaa  mitattiin  soluviljelmissä.  
   Ensimmäisessä   osajulkaisussa   tutkittiin   Treg   soluja   APECED-­
potilaissa,   joissa  Treg-­solujen   ilmiasu  oli  erilainen  kuin   terveillä  verrokeilla   ja  
niiden   toiminta   oli   alentunut.   Aire:n   perifeerisen   ilmentymisen   merkitystä   ei  
vielä   tunneta.  Väitöskirjatyön  kolmas   ja  neljäs  osajulkaisu  keskittyi   tutkimaan  
Aire:n   merkitystä   kateenkorvassa   ja   sen   ulkopuolella.   Kokeellinen  
   10  
lymfopeniaa   seuraava   solunjakautuminen   saatiin   aikaan   siirtämällä   kypsiä  
valkosoluja   geneettisesti   immuunipuutteiseen   hiireen.   Tässä   tilanteessa  
valkosolut   alkavat   voimakkaasti   jakautua   elimistön   omien   rakenteiden  
stimuloimina.   Tämä   jakautuminen   voi   johtaa   autoimmuniteettiin,   mikäli  
perifeerinen   toleranssi   ei   toimi   normaalisti.   Aire-­poistogeenisistä   hiiristä  
normaalisti  Aire:a   elimistössään   ilmentäviin   immuunipuutteisiin   hiiriin   siirretyt  
valkosolut   eivät   aiheuttaneet   autoimmuniteettia.   Nämä   siirretyt   valkosolut  
jakautuivat  runsaasti  ja  muitakin  merkkejä  immuunivasteen  säätelyn  häiriöistä  
havaittiin.   Kuitenkin   voimakkaasti   jakautuneet   Treg-­solut   estivät   oireisen  
autoimmuunitulehduksen  kehittymisen.  
   Muualla   elimistössä   ilmennetyn   Aire:n   vaikutusta   perifeerisen  
toleranssin   säätelyyn   tutkittiin   tätä   tutkimusta   varten   risteytetyissä   Aire-­
poistogeenisissä   immuunipuutteisissa   hiirissä.   Lähes   kaikki   normaaleista  
hiiristä   soluja   saaneet   Aire-­poistogeeniset   immuunipuutteiset   hiiret   kehittivät  
oireisen   autoimmuuni-­paksusuolentulehduksen,   joka   oli   todettavissa   myös  
kudosleikkeissä.  Aire-­poistogeenisissä  immuunipuutteisissa  hiirissä  Treg-­solut  
jakautuivat   huonommin   kuin   kontrolliryhmän   hiirissä,   jotka   ilmensivät  
normaalisti  Aire:a.  
   Tämä   väitöskirjatutkimus   osoittaa,   että   Aire   on   tärkeä   T   solujen  
sentraalisen   toleranssin   muodostumisen   lisäksi   perifeerisen   toleranssin  
ylläpidossa.   Kateenkorvan   ulkopuolinen   Aire   osallistuu   Treg-­solujen  
toimintaan   immuunivasteen   aikana   ja   mikäli   Aire:n   ilmentyminen   puuttuu,  
Treg-­solujen  toiminta  häiriintyy.  Tämä  voi  joissakin  tilanteissa  johtaa  oireiseen  
autoimmuunisairauteen.   Täten   kateenkorvan   ulkopuolella   ilmentyvä   Aire   on  
joissakin   tilanteissa   jopa   tärkeämpi   kuin   kateenkorvassa   ilmentyvä.   Tämä  
löydös  valottaa  APECED-­taudin  kehittymistä   ja   ihmisen   immuunijärjestelmän  
toimintaa  uudella  tavalla.    
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ABBREVIATIONS  
  
AIRE      Autoimmune  regulator  –  gene/protein  (human)  
Aire      Autoimmune  regulator  –  gene/protein  (murine)  
APC      antigen  presenting  cell  
APECED   autoimmune   polyendocrinopathy,   candidiasis   and   ectodermal  
dystrophy  syndrome  
BAFF   B  cell  activating  factor  of  the  TNF  family  
Card11   caspase  recruitment  domain  family,  member  11  
Cbl-­b      Casitas  B-­lineage  lymphoma  ubiquitin  ligase  
CD      cluster  of  differentiation  
CDR      complement  determining  region  
cTEC      cortical  thymic  epithelial  cell  
CTL      cytotoxic  lymphocyte  
CTLA-­4   cytotoxic  T  Lymphocyte  Antigen  4  
DC      DC  
DNA      deoxyribonucleic  acid  
ELISA     Enzyme-­linked  immunosorbent  assay    
FOXP3   forkhead  box  P3  (human)  
FoxP3     forkhead  box  P3  (mouse)  
HIV      human  immunodeficiency  virus  
HLA      human  leukocyte  antigen  
HPRT     Hypoxanthine  phosphoribosyl-­transferase  
IF      immunofluorescence  
IFN-­?      interferon  ?  
Ig      immunoglobulin  
iNKT  cells   invariant  natural  killer  T-­cells    
IL      interleukin  
IPEX      Immunodysregulation  –  polyendocrinopathy  –  enteropathy  –    
X-­linked  
iTreg      induced  regulatory  T  cell  
KO      knockout  mouse  
LIP      lymphopenia-­induced  proliferation  
mAb      monoclonal  antibody  
MHC      major  histocompability  complex  
MLN      mesenteric  lymph  node  
MS      multiple  sclerosis  
mTEC     medullary  thymic  epithelial  cell  
NK  cell   natural  killer  cell  
NOD      non-­obese  diabetic  
nTreg      natural  or  thymic  originating  regulatory  T  cell  
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PBMC     peripheral  blood  mononuclear  cell  
PBS      phosphate-­buffered  saline  
PCR      polymerase  chain  reaction  
RAG      recombination  activating  gene  
mRNA     messenger  ribonucleic  acid  
SAND   human   Sp100,   Aire1,   NucP41/P75,   and   Drosophila   DEAF1  
domain  
SAP      serum  amyloid  P  component  
SCID      severe  combined  immunodeficiency  
SNP      single  nucleotide  polymorphism  
SLE      systemic  lupus  erythematosus  
STAT      signal  transducer  and  activator  of  transcription  protein  
Tbet      T-­box  21  
TCR      T  cell  receptor  
TCR  C   T  cell  receptor  constant  gene  
TCR  D   T  cell  receptor  diversity  gene  
TCR  J     T  cell  receptor  joining  gene  
TCR  V   T  cell  receptor  variable  gene  
Tfh      follicular  T  helper  cell  
TG      transgenic  
TGF-­?     transforming  growth  factor  ?  
Th      T  helper  cell  
TLR      Toll-­like  receptor  
TREC     T  cell  receptor  excision  circle  
Treg      regulatory  T  cell     
TSA      tissue  specific  antigen  
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REVIEW  OF  THE  LITERATURE  
1   T  lymphocytes  and  Their  Functions  
  
T   lymphocytes,   or   T   cells   for   short,   are   a   central   part   of   adaptive   immune  
system.  All  T  cells  express  an  antigen  recognition  receptor,  the  T  cell  receptor  
(TCR).   T   cells   are   divided   into   two   main   categories   according   to   their   co-­
receptor,  the  cluster  of  differentiation  4  or  8  (CD4  or  CD8).    
In  order  to  mediate  their  many  functions  in  the  immune  system,  T  cells  
must  be  activated.  This  process  is  strictly  regulated  and  limited  because  once  
a   T   cell   gets   activated,   it   can   activate   other   cells   of   the   immune   system.  
Uncontrolled   or  wrongly   targeted   T   cell   activation   can   lead   to   severe   tissue  
destruction.  T  cell  tolerance  means  that  T  cells  are  capable  of  recognizing  self  
from  foreign  structures,  and  leaving  host  tissues  unharmed.    
  
1.1   Antigen  Presentation  and  T  Cell  Activation  
1.1.1   T  Cell  Receptors  
T  cells  recognize  their  specific  antigen  with  the  cell-­surface  TCR  that  consists  
of   two   polypeptide   chains,   namely   ?   and   ?,   or   ?   and   ?.   In   the   peripheral  
immune  system,  surface  expression  of  TCR  is   the  best  marker  for  mature  T  
cells394.  Most  effector  T  cells  have  an  ??  receptor.  The  functions  of  ??  T  cells  
are  not  yet  fully  understood.  In  the  following  sections  when  discussing  T  cell  
receptors,  the  focus  will  be  on  ??  receptors,  if  not  otherwise  indicated.  Both  ?  
and   ?   chains   have   three   complement   determining   regions   (CDRs).   CDRs  
code   for   the   parts   of   the   TCR   protein   that   eventually   bind   to   the   peptide   –  
major   histocompability   complex   (pMHC).   CDR   1   and   2   bind   to   the   MHC  
molecules,  and  CDR3,   the  most   variable  part   of   the  chain,  accounts   for   the  
binding  of   the  peptide  antigen.  In  the  complete  receptor  there  are   in  total  six  
peptide  loops  (3  CDRs  from  the  ?  chain  and  3  from  the  ?  chain)  that  bind  to  
the  pMHC394.  
TCR  spans   through   the  cell  membrane  but   its   short   cytoplastic   tail   is  
incapable   of   transferring   the   TCR   signal   to   intracellular   signaling   pathways.  
Thus  the  TCR  is  bound  to  the  cell  membrane  by  the  CD3  molecule  complex.  
This   complex   is   crucial   in   the   initiation  of   the   intracellular   signaling  pathway  
that  transfers  the  receptor  signal  into  the  nucleus.  Without  CD3  the  receptor  is  
unstable  and  cannot  be  transported  to  the  cell  membrane.  The  CD3  complex  
consists   of   several   molecules   that   have   the   specialized   intracellular   motifs  
needed  in  signal  transduction  427.  
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1.1.2   Major  Histocompability  Complexes  and  Professional  Antigen  
Presenting  Cells  
T   cells   can   only   recognize   antigens   that   are   bound   to   the  MHC   protein.   In  
humans  the  MHC  molecules  are  called  the  human  leukocyte  antigens  (HLA).  
The  two  main  categories  of  MHC  molecules  are  called  type  I  and  type  II.  Both  
types  of  molecules  are  highly  unstable  without  a  peptide  antigen  bound  to  the  
protein   so   MHC   molecules   are   always   expressed   in   the   body   as   pMHC  
complexes.   The   general   three-­dimensional   structures   of   both   types   of  MHC  
molecules  are   very   similar.  They  are  heterodimeric  proteins  with  a   cleft   that  
functions  as  an  antigen-­binding  site.  The  antigen-­binding  cleft  determines  the  
type   of   the   peptide   that   can   be   bound   to   the   molecule:   the   MHC   class   II  
antigen-­binding  cleft   is  open  at  both  ends  so   that   it   can  bind   longer  peptide  
antigens,   while   only   short   peptide   chains   fit   into   the   closed   MHC   class   I  
molecules394.   Genetically   MHC   molecules   are   very   polymorphic   with   the  
considerable  variation  in  the  antigen-­binding  site.    
The  CD8+  T  ells  can   recognize   their  antigen  only  when   it   is  bound   to  
the  MHC  type  I  molecule  that  is  expressed  in  all  types  of  nucleated  cells.  The  
antigens  presented  in  the  MHC  class  I  molecule  are  typically  produced  in  the  
cell   itself   whereas   antigens   presented   in   MHC   class   II   molecules   originate  
from   proteolysis   of   extracellular   antigens   in   the   endosomal   compartment.  
MHC   type   II   molecules   are   only   expressed   in   the   professional   antigen  
presenting  cells  (APCs)  and  epithelial  cells  of  the  thymus.    The  CD4+  helper  T  
cells   can   recognize   antigens   when   they   are   expressed   via   MHC   type   II  
molecules394.    
The   only   cells   capable   of   activating   naïve   T   cells   are   called  
professional  APCs.  The  most   important  population  of  APCs  are  the  dendritic  
cells   (DCs)   that   are   found   all   over   the   body   and   especially   on   the   body-­
environment  interfaces,  such  as  the  skin  an  epithelial  tissues.  Other  APCs  are  
B  cells  and  macrophages.  DCs  are  divided  into  two  main  categories,  myeloid  
and  plasmacytoid  DCs282.  These  two  main  populations  both  comprise  several  
subpopulations   with   different   functions   and   anatomical   distributions.   In   the  
following  sections  the  myeloid  DCs  will  be  discussed  briefly.  
DCs  are  star-­like  cells   that  have  many  protrusions,  which  are  used  to  
sample   the   environment   surrounding   the   cell.      DCs   express   various   innate  
pattern   recognition   receptors,   such   as   Toll-­like   receptors   (TLRs),   for  
recognizing  foreign  microbial  structures173.  DCs  can  engulf  foreign  material  by  
macropinocytosis,   phagocytosis,   and   receptor-­mediated   phagocytosis.   DC  
can   process   the   internialized  material   in   endocytoplasmic   vesicles   and   load  
antigenic  peptides  to  an  MHC  class  I  or  II  molecules.  MHC-­antigen  complex  is  
then  transported  to  the  cell  surface.  If  the  surroundings  of  the  DC  have  a  high  
concentration   of   pro-­inflammatory   molecules,   i.e.   danger   signals388,   the   DC  
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becomes  activated.  Activated  DCs  are   fully  maturated  and   they  express   the  
co-­stimulatory  molecules   required   for   naïve   T   cell   activation.   Co-­stimulatory  
molecules   include   CD80   or   CD86,   which   are   collectively   called   the   B7  
molecules.  The  morphology  of   the  DC  changes  upon  activation;;   it   becomes  
rounder  and  more  mobile.   It  starts   to  express  homing   receptors  guiding   it   to  
the  local  lymph  node173.  
The   activated   mature   DCs   produce   large   amounts   of   different  
cytokines.   The   cytokine   profile   they   produce   is   determined   by   the   initial  
signaling   occuring   via   innate   receptors.   Therefore,   DCs   are   important   in  
initiating   the   correct   T   cell   response   to   a   given   microbe84.   DCs   can   also  
secrete   cytokines   that   can   convert   naïve   T   cells   to   suppressing   cells   that  
inhibit   immune  responses.   It   is  not  known  what  are   the  precise  mechanisms  
for  DCs  to  drive  the  pro-­inflammatory  or  suppressive  T  cell  responses  77.    
1.1.3   T  Cell  Activation  
T  cell   activation   is   restricted   in  many  ways.  T   cell   can   recognize   its   specific  
antigen  only  when   the  antigen   is  bound   to  an  MHC  molecule.  For   full  T  cell  
activation  costimulatory  factors  produced  by  interacting  APC  are  needed.  Due  
to   these   restrictions,   T   cell   activation   can   in   practice   take   place   only   in  
secondary   organized   lymphoid   organs,   mainly   in   lymph   nodes   and   the  
spleen323.  
   T  cells  need  four  different  signals  in  order  to  become  activated:  i)  TCR  
binding  its  specific  antigen  bound  to  the  MHC,  ii)  co-­stimulation  from  the  APC,  
iii)  activated  co-­receptor  CD4  or  CD8  signaling,  and  iv)  the  presence  of  T  cell  
stimulating  cytokines  at  the  site  of  activation.  The  first  signal  is  from  the  TCR  
binding   the  pMHC  complex   it   is   specific   for.  The  second  signal   comes   from  
the  T  cell  surface  molecule  CD28  binding  to  the  co-­stimulatory  factors  CD80  
or   CD86   on   the   surface   of   the   activated   professional   APCs.   CD28   is  
constitutively   expressed   on   most   T   cells169.   Only   professional   antigen-­
presenting  cells  can  give  the  co-­stimulation  via  B7  molecules  that  the  T  cells  
need  to  get  fully  activated84.  If  only  the  first  signal  is  present,  the  T  cell  can  go  
into  an  anergic  state,  where  it  is  not  apoptotic  but  not  functional  either68.    
There   are   certain   differences   in   the   T   cell   requirement   of   co-­
stimulation.  For  instance,  in  certain  conditions  CD8+  T  cells  need  less  CD28-­
mediated   co-­stimulation   than   CD4+   cells128,   489.   Meanwhile,   suppressive  
regulatory   T   cells   (Treg)   are   very   dependent   on   CD28-­mediated   co-­
stimulation50.  Recently,   inhibitory  molecules  of  T   cell   activation,   such  as   the  
cytotoxic  T-­lymphocyte-­associated  protein  4  (CTLA-­4)  and  programmed  death  
ligand   1,   have   received   increasing   attention   since   they   are   involved   in  
controlling   the   immune   responses.   Co-­stimulation   is   therefore   not   an   on-­off  
switch,  but  more  like  a  network  of  activating  and  inhibiting  signals128,  427.  
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The  third  signal  for  T  cell  activation  comes  from  the  co-­receptors  CD4  
or  CD8   that  bind  pMHC  class   II  and   I,   respectively.  The  co-­receptor  binding  
stabilizes   the   receptor   complex   so   that   sufficient   signaling   can   take   place.  
This  binding  also  enhances  TCR-­derived  intracellular  signaling.  Thus,  TCR  is  
about  hundredfold  more  sensitive  to  the  MHC-­antigen  complex-­derived  signal  
as  compared  with  the  pMHC  binding  alone141.  
   The  fourth  signal  for  T  cell  activation  comes  from  the  different  cytokines  
which  APC   is   producing.   The   cytokines  will   determine  what   kind   of   effector  
functions  T  cell  will  acquire.  The  local  cytokine  milieu  is  very  important  in  the  
CD4+   T   helper   (Th)   cell   differentiation510   but   it   is   also   important   in   priming  
CD8+   cytotoxic   lymphocytes’   (CTL)   functions489.   Activated   T   cells   are   very  
prone   to  apoptosis  and  need  high  amounts  of  pro-­inflammatory  cytokines   in  
order  to  survive.  They  recognize  antigens  like  naïve  cells,  but  there  is  no  more  
a  strict  need  for  co-­stimulation.  When  the   inflammatory  response  wanes,  the  
cytokine   levels   also   go   down.   Activated   T   cells   die   when   they   do   not   get  
enough   pro-­survival   signaling   through   the   TCR   or   cytokine   receptors.   This  
gretly  limits  lymphocyte-­driven  immune  response  134.  
  
1.2     T   Cell   Effector   Subsets   and   Their   Functions   in   the  
Immune  System  
Different   functions  of  T  cells  are  mediated  by  various  effector  subtypes  of  T  
cells.  The  major  populations  of  T  cells,  the  CD4-­  and  CD8-­positive  T  cells,  are  
defined   by   the   expression   of   either   one   of   the   co-­receptors.   Both  CD4   and  
CD8   positive   T   cells   differentiate   upon   activation   to   effector   cells   that   have  
different   subpopulations.   These   subpopulations   are   characterized   by   certain  
transcription   factors   that   drive   the   expression   of   genes   needed   for   their  
specific  functions,  especially  the  production  of  lineage-­specific  cytokines.    
1.2.1   CD8+  T  Cells:  Cytotoxic  T  Cells  
CD8+   cells   differentiate   upon   encounter   with   their   specific   antigen   to   CTLs.  
The  CTLs  destroy  their  target  cells  by  driving  them  to  apoptosis.  Hence  CD8+  
T   cells   are   the   most   important   cell   type   in   fighting   against   intracellular  
microbes,  for  example  viruses.  CD8+  T  cells  can  be  activated  by  APCs  alone,  
but   usually   the   effective   proliferation   of   CTLs   requires   additional   help   from  
cytokines  produced  by  activated  CD4+  cells.  After  activation  and  proliferation,  
which   usually   takes   place   in   a   lymph   node,   CTLs   migrate   to   the   site   of  
infection  and  kill  infected  cells  that  have  their  specific  antigen  bound  to  a  MHC  
I  molecule  on  the  cell  surface  229,  395.  
CTLs  can  induce  apoptosis  in  targeted  cells  with  different  mechanisms,  
but  all  of  them  require  close  cell-­to-­cell  contact32.  CTLs  can  produce  so  called  
cytotoxic   granules   that   contain   various   cytotoxic   molecules.   The   cytotoxic  
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substances  are  the  primary  effector  molecules  of  CTLs  32,  231.  CTLs  can  also  
induce  apoptosis  in  the  target  cells  via  specific  apoptosis-­inducing  cell-­surface  
molecules   such   as   Fas-­ligand32.   CTLs   produce   various   cytokines   that   e.g.  
activate   other   components   of   the   immune   system,   enhance   antigen  
expression,  or  prevent  viral  replication  in  infected  cells.  
CD8+   cytotoxic   cells   are   important   in   tissue-­specific   autoimmune  
diseases   because   the   chronic   lymphocyte   infiltration   in   inflamed   tissues   is  
often   dominated   by   CTLs135.   Some   autoimmune   diseases   also   have   an  
association  with   the  expression  of  certain  HLA  type   I  molecules   that  present  
antigens   to  CD8+   cells.   However,   since  CTLs   often   require   help   from  CD4-­
positive  helper  T  cells  for  optimal  cytoxicity,  it  is  believed  that  CTLs  alone  are  
not  sufficient  to  break  self  tolerance360.  
1.2.2   CD4+  T  cells:  T  Helper  Cells  
The   majority   of   CD4+   T   cells   differentiate   upon   activation   to   Th   cells.   The  
name  describes  their  action  quite  accurately  since  Th  cells  do  not  act  directly  
on  the  microbe  or  infected  cell  but  instead  enhance  or  “help”  other  cells  of  the  
immune   system   to   manage   the   microbial   invasion   properly.   Many   different  
subsets  of  CD4+  Th  cells  have  been  described  and  new  subsets  still  emerge.  
It   is,   however,   not   certain   that   all   newly-­characterized   subsets   represent  
stable   end-­stage   differentiation   of   Th   cells   or   whether   they   are   merely   at  
different   phases   of   their   differentiation.   There   is   also   a   certain   level   of  
plasticity  in  the  Th  lineages  so  that  under  certain  circumstances  the  cells  can  
change  their  effector  phenotype479.  
Naïve  CD4+  T  cells  have   the  potential   to  differentiate   into   the  effector  
Th-­subsets   depending   on   the   cytokine   signals   they   receive   from   their  
surroundings   upon   activation.   Differentiation   to   a   certain   lineage   often  
requires  more  than  one  cytokine.  Thus,  it  is  actually  the  local  cytokine  miliueu  
in  the  lymph  node,  where  the  cell  gets  activated,  that  eventually  will  determine  
what   kind   of   immune   response   dominates   a   given   infection511.   Different  
subsets   of   Th   cells   are   functionally   characterized   by   their   production   of  
effector  cytokines  that  activate  or  suppress  other  cells  of  the  immune  system.  
Th   cell   populations   can   be   identified   according   to   their   cytokine   production  
and   phenotype.   Each   Th-­subtype   utilises   specific   signal   transducer   and  
activator  of  transcription  (STAT)  proteins,  whose  activity  is  controlled  by  their  
phosphorylation   status510.   Phosphorylated   STAT   proteins   mediate   the  
cytokine  signals   to   the  nucleus,  and  control   the  expression  of  Th  population  
specific   genes.   STATs   are   especially   important   in  Th   differentiation   as   they  
control  the  up-­regulation  of  the  Th  population  specific  transcription  factors350.  
These  master  transcription  factors  further  drive  the  expression  of  Th  subtype-­
specific   genes.  Table  1   summarises   the  main  Th  populations,   the  cytokines  
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and   cells   driving   their   differentiation,   as   well   as   their   major   phenotypic  
characteristics.  
   Originally  Th  differentiation  or  polarization  emerged  between  Th  type  1  
and   Th   type   2   cells   that   are   important   in   the   initiation   and  maintenance   of  
cellular   and   humoral   immune   responses,   respectively177.   ? ?? ??????????? ????
type  response  is  believed  to  be  important  in  autoimmune  diseases  while  Th2  
overreactivity  is  responsible  for  the  generation  of  allergy512.  New  Th-­subtypes  
Th17  and  T   follicular  helper   (Tfh)  cells  are,   if  uncontrolled,  also   important   in  
the   breakdown   of   self   tolerance86,   91.   One   subtype   of   CD4+   T   cells   are  
suppressive   regulatory   T   cells   (Treg)   that   will   be   discussed   in   detail   later.  
They  are  important  in  the  maintenance  of  tolerance.  
  
Table   1:   Summary   of   the  main   non-­suppressive   effector  Th   subpopulations.   IFN  =  
interferon,  IL  =  interleukin,  TGF  =  transforming  growth  factor  
     Th1   Th2   Th17   Tfh  
Cytokines  driving  
differentiation   IFN-­?,  IL-­12  
IL-­4,  IL-­13,  














Tbet   GATA3   ROR?T   Bcl6  
STAT  protein(s)   STAT1,  STAT4   STAT6   STAT3   STAT3  


















1.3   T  Cell  Development    
1.3.1   T  Cell  Development  and  T  Cell  Receptor  Recombination    
T  cells  get   their  name   from   the   thymus,  a   two-­lobed  organ  situated  beneath  
the   sternum,   where   they   develop   from   bone   marrow-­derived   lymphoid  
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progenitors.  The  thymus  is  large  in  childhood  but  it  atrophies  with  age.  Thymic  
involution   reduces  output  of  mature  T  cells,  however,   the  production  will  not  
end  completely.  Histologically  the  thymus  consists  of  multiple  lobules  that  are  
separated   by   connective   tissue   septae.   Each   thymic   lobule   has   two  
histologically   distinct   areas:   the   cortex   and   the   medulla   (see   Figure   1).    
Different  stages  of  T  cell  development   take  place   in  either   the  cortex  or   the  
medulla.   Thus   developing   T   cells,   i.e.   thymocytes,   move   between   different  
areas  in  the  thymus.  Thymic  stromal  cells  strictly  control  this  thymocyte  traffic  




Figure  1:  Hematoxylin  and  eosin  stained  section  and  a  diagram  of  the  structure  of  a  
single   human   thymus   lobule.   Arrows   indicate   the   connective   tissue   septae.                              
C  =  cortex,  M  =  medulla,  *  =  Hassall’s  corpuscle.    
  
The  cortical  and  medullary   thymic  epithelial  cells   (cTECs  and  mTECs  
respectively)   are,   in   addition   to   being   thymocyte   traffic   controllers,   the  most  
important   mediators   of   T   cell   development17.   The   details   of   thymic   stroma  
development   and   function   are   still  mostly   unknown.   Prominent   structures   in  
the  human   thymus  are   keratinized  nodules   in   the   thymic  medulla   called   the  
Hassall’s   corpuscles.   Similar   structures   are   found   in   the   mouse   thymus500,  
even  though  originally  they  were  considered  to  be  very  rare.  The  significance  
of  Hassall’s  corpuscles   is  still  unknown  but  they  have  been  suggested   to  be  
important   in   disposal   of   apoptotic   thymocytes41,   114,   antigen  expression36,   74,  
and  production  of  several  cytokines74,  482.  
The  T  cell  precursors  called   the   thymus  seeding  progenitors  originate  
from  the  bone  marrow-­derived  common  lymphoid  precursoid  cells.  They  enter  
thymus   from   the   bloodstream   through   the   cortico-­medullary   junction   and  
become  the  early  thymic  progenitors.  Commitment  to  the  T  cell  lineage  takes  
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place  at   this  stage  of  development518.  These  very   immature   thymocytes   first  
proliferate  vigorously  in  the  thymic  cortex.  At  first,  thymocytes  do  not  express  
either   CD4   or   CD8   surface   molecules   so   they   are   called   double-­negative  
thymocytes.   After   the   double-­negative   phase   the   earliest   expression   of   the  
CD4  can  be  found.  These  immature  single-­positive  cells  soon  start  to  express  
also   the   CD8   co-­receptor   and   thus   enter   the   double   positive   development  
stage61.    
In   order   to   create   the   vast   antigen   recognition   potential   of  mature   T  
cells,   the  TCR  recombination   is  a  multi-­phased  process.  During  the  process,  
each  genetic   combination   can  be  made   from  a  number   of   options   and   thus  
each   step   increases   the   variation   in   the   resulting   receptor.   Both   chains   are  
recombined   separately   from   multiple   gene   fragments.   The   TCR   ?   locus  
contains  variable   (V),   joining   (J)  and  constant   (C)  genes,  and   in   the  ?  chain  
locus  there  are  also  additional  diversity  (D)  genes.  Gene  segment  joining  sites  
make  up  the  CDR3  region  in  both  chains.  The  gene  segments  are  not  linked  
together   in  a   precise  manner.   Instead  nucleotides   can  be   left   out  or   added,  
which  further  increases  the  CDR3  sequency  variety335.  This  process  is  called  
junctional  diversity,  and   it   is  an   important   factor   in   increasing  T  cell   receptor  
diversity.   Theoretically,   it   has   been   estimated   that   there   are   approximately  
1015  different  potential  TCR  recombinations.  However,  there  are  not  enough  T  
cells  in  the  immune  system  to  express  all  possible  receptor  variants.  Studies  
from  human  peripheral  TCR   repertoire   indicate   that   there  are  approximately  
108  TCRs  in  the  naïve  T  cell  repertoire23,  335.  
TCR   gene   recombination   starts   when   the   recombination   activating  
genes  (RAG1  and  RAG2)  are  expressed  in  double-­negative  thymocytes.  The  
?  chain  is  recombined  first.  When  the  ?  chain  recombination  is  successful,  the  
other  ?   locus  is  shut  down  to  prevent  additional  recombinations  in  a  process  
called   allelic   exclusion53.   It   will   guarantee   that   the   mature   T   cells   almost  
always  express  only  one  recombined  TCR  ?  chain.    
The   remaining   TCR   recombination   is   carried   out   in   double-­positive  
thymocytes61.   The   ?   chain   recombination   is   initiated   by   a   second   wave   of  
RAG   expression.  When   the  ?   chain   is   recombined   and   successfully   paired  
with   the  ?   chain,   the  cell  and   its  newly   recombined  TCR  are   tested.  Thymic  
selections   will   ensure   that   only   functional   and   self-­tolerant   single-­positive   T  
cells  exit  the  thymus  and  enter  the  peripheral  immune  system.    
1.3.1.1   Positive  Selection  of  Developing  T  Cells  
The   thymic   positive   selection   takes   place   in   thymic   cortex   where   cTECs  
present   self-­peptide   –   self   MHC-­complexes   to   thymocytes.   The   developing  
thymocyte  has  to  have  a  functional  TCR  that  binds  with  low  affinity  to  the  self-­
antigen   –   MHC-­complexes.   If   the   receptor   does   not   bind   to   the   MHC  
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molecules   on   cTECs   sufficiently,   the   cell   will   die   by   apoptosis,   the  
programmed  cell   death.  The  exact   self-­peptides   that  drive  positive   selection  
are  not  known  but  the  receptor-­ligand  affinity  needed  for  positive  selection  is  
significantly  lower  than  the  affinity  needed  for  T  cell  activation245.  
In   the   TCR   recombination   process,   the   functionality   and   pairing  
capacity   of   the   ?   chain   with   the   already   recombined   ?   chain   is   tested   by  
positive   selection.  The  cell   can,  however,   continue   to   recombine   the  TCR  ?  
locus   further  or   try   to  pair   the   recombination   from   the  other? ???????????? ???? ?  
chain425.   The   TCR   ?   locus   orientation   allows   multiple   successive  
recombinations  to  occur  so  most  of  the  developing  double  positive  thymocytes  
succeed   in   recombining   at   least   one   functional  ?   chain217.   TCR  ?   chain   is  
considered  to  be  more  important  in  MHC  recognition  than  the  ?  chain433.  The  
V  genes,  that  code  for  the  MHC  binding  CDR1  and  CDR2  loops  in  the  TCR,  
are   inherently   biased   already   in   the   germline   towards   producing   peptide  
chains  that  bind  MHC.  This  has  been  proved  both  in  receptor  crystallization,  in  
vitro  fetal  thymic  organ  cultures,  and  transgenic  mouse  models142,  230.  
Along  with   the   positive   selection   thymocytes   commit   to   the   two  main  
populations  of  mature  T  cells:  CD4+  and  CD8+  T  cells.  The  same  TCR  contact  
and   signaling   that   prevent   apoptosis   in   positive   selection   instruct   the   cell   to  
choose  its  co-­receptor.  After  the  lineage  commitment,  the  thymocytes  express  
only  CD4  or  CD8  and  are  called  single-­positive  thymocytes329.  
1.3.1.2   Negative  Selection  of  Developing  T  Cells  
Positively  selected  single-­positive   thymocytes  migrate   to   the   thymic  medulla.  
At  this  stage,  the  T  cell  receptor  repertoire  has  been  selected  to  be  reactive  to  
at  least  some  extent  to  the  self-­antigen  –  MHC  complexes.  Negative  selection  
is  a  process  where  developing  thymocytes  that  have  a  too  high  affinity  to  self-­
antigens  will  be  selected  out   from  the  T  cell   repertoire  before   they  enter   the  
circulation477.   Negative   selection   is   also   called   central   T   cell   tolerance.   It  
guarantees  that  the  peripheral  T  cell  repertoire  is  overtly  tolerant  towards  self-­
antigens.   Negative   selection   can   take   place   at   any   phase   of   the   thymocyte  
development   once   the   TCR   is   fully   recombined   and   expressed   on   the   cell  
surface.  
The  concept  of  thymic  negative  selection  was  established  using  mouse  
models  that  have  a  transgenic  (TG)  TCR.  The  TG-­TCR  was  reactive  only  with  
an   external   or   endogenous   antigen   whose   tissue   expression   pattern   was  
controllable.   When   the   model   antigen   was   expressed   in   the   peripheral  
immune  system,  it   lead  to  proliferation  and  activation  of  the  TG-­TCR  T  cells.  
When  the  antigen  was  expressed  in  the  thymus,  it  resulted  in  clonal  deletion  
of   developing   thymocytes301.  However,   this   experimentsl  model   for   negative  
selection  has  been  criticized  since  it  does  not  take  into  account  the  negative  
selection  of  the  normal  polyclonal  TCR  repertoire.    
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Negative  selection   in   the   thymus  was   further  established  when   tissue  
specific   antigen   (TSA)   expression   was   discovered   in   the   thymic   medulla.  
mTECs   are   a   specialized   stromal   cell   population   that   has   the   capacity   to  
express   ectopic   TSAs.   This   process   is   also   called   promiscuous   antigen  
expression.   In   the   thymic   medulla   TSAs   such   as   insulin,   are   expressed  
outside  their  normal  functional  location  in  order  to  present  them  to  developing  
thymocytes260,   515.   This   situation   can   be   described   as   an   “immunological  
homunculus”   of   TSAs   created   by   the   mTECs   in   the   thymic   medulla.   How  
these   epithelial   cells   express   such   a   wide   range   of   antigens   is   mostly  
unknown464.  The  only  identified  factor  promoting  this  antigen  expression  is  the  
transcription   factor  Autoimmune   regulator   (AIRE)   and   it  will   be   discussed   in  
depth  later.    
In   addition   to   mTECs,   macrophages   and   DCs   accumulating   from  
circulation  to  the  thymic  medulla  take  actively  part  in  the  TSA  expression  and  
negative   selection377.   mTECs   have   a   high   turnover   rate   and   especially  
medullary  DCs  phagocytose  apoptotic  mTECs.  Thus,  these  DCs  can  acquire  
TSAs  in  their  antigen  processing  machinery244,  245.  A  single  TSA  is  expressed  
at   a   low   level   on   mTECs,   and   thus   the   thymic   DCs   express   TSAs   for   an  
extended  period.  Additionally  DCs  can  express  blood-­borne  antigens,  or  bring  
antigens   with   them   from   peripheral   tissues377.   DCs   can   migrate   to   thymic  
medulla   also   from   the   gut   and   present   antigens   derived   from   the   intestinal  
flora.   This   mechanism   may   be   important   in   the   generation   of   tolerance  
towards  intestinal  commensals99.  
The   thymocytes   that   bind   to   self-­pMHC   complexes   with   a   too   high  
affinity   will   die   by   apoptosis429.   It   is   currently   not   known   what   triggers   the  
apoptosis  in  the  potentially  autoreactive  thymocytes.  There  is  a  view  that  high  
affinity  binding  of  the  TCR  to  a  TSA-­MHC  complex  itself  would  be  sufficient  to  
drive   thymocytes   to   apoptosis358.   This   would   mean   that   there   are   some  
developmentally  determined  TCR  affinity  “windows”  for  different  cell  fates  (see  
Figure  2).   It   is  not  known  how   the  cell  discriminates  between  different  TCR-­
pMHC   affinities.   It   is   also   possible   that   the   TCR’s   binding   interactions   with  
pMHC  in  positive  or  negative  selection  are  qualitatively  different.  The  different  
binding  patterns  could  determine  whether   the  cell  matures  further  or  dies  by  
apoptosis515.   Other   signals   from   co-­stimulatory   molecules   or   co-­receptors  
have  also  an  undetermined  significance  in  the  negative  selection.  
  
   24  
  
  
Figure  2:  A  schematic  representation  of  the  TCR  affinity  model  for  thymic  selections.  
  
1.3.1.3   T  Cells  with  Dual  T  Cell  Receptors  
Allelic   exclusion   in   the  ?   locus  will   guarantee   that  mature  T   cells   have  only  
one  TCR  ?  chain.  However,  this  is  not  the  case  for  the  TCR  ?  chain  loci.  The  
recombination  in  the  two  TCR  ?  alleles  will  stop  only  when  the  cell  is  positive  
selected217.  Thus  it  is  possible  that  a  mature  T  cell  has  two  fully  recombined  ?  
chains   if   the   cell   is   positively   selected   only   after   both   loci   have   been  
recombined.   Approximately   15%   of   mouse   and   human   peripheral   blood   T  
cells  express  two  ?  chains  on  the  cell  surface,  but  the  significance  or  function  
of   these   dual-­specific   T   cells   have   not   yet   been   fully   characterized199,   357.  
Apparently   it   is   quite   common   that   both   ?   loci   are   recombined   in   the   cell  
genome,  but   the  other  one   is  not   translated   to  protein9,   263.  This  could   result  
from  preferential  pairing  of  some  ?  and  ?  chains376.    
It  has  been  speculated  that  T  cells  with  two  antigen  receptors  could  be  
potentially   harmful.   The   second   receptor   can   enable   non-­functional   and  
potentially  autoreactive  receptors  to  bypass  thymic  selection362,  504.  There  are  
conflicting  experimental  data  to  support  this  theory.  In  some  animal  models  of  
autoimmunity,   the   dual-­specific   T   cells   are   important   in   generating   self-­
destructive  inflammation120  but  in  other  models  these  cells  have  been  shown  
to   be   protective   or   have   no   effect   on   autoimmunity85,   120.   Blichfeld   et   al.43  
showed  that  due  to  the  split  TCR  expression  the  dual-­specific  T  cells  received  
less   TCR-­mediated   signaling   per   one   TCR.   This   could   result   in   diminished  
TCR   signaling   and   thus   non-­functional   receptors.   It   has   also   been   claimed  
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that   dual-­specific   T   cell   receptors   expand   the   global   TCR   repertoire   thus  
increasing  the  recognition  potential  against  foreign  antigens198.  
Tuovinen  et   al.462   reported   that   human   regulatory   T   cells   (Tregs)   are  
more   often   dual-­specific   than   non-­suppressive   effector   cells,   indicating   that  
two   different   receptors   could   in   fact   be   necessary   in   Treg   development   or  
function.  Studies  done   in  TG-­TCR  mice  also  suggest   that  Treg  development  
needs  the  second  endogenous  TCR212,   234,   345.  These  results,  however,  were  
not   confirmed   in   another   experimental   setting443,   so   the   true   role   of   dual-­
specific  TCRs  in  autoimmunity  is  still  unknown.    
  
2   T  CELL  TOLERANCE  AND  AUTOIMMUNE  
DISEASES  
  
Immunological   tolerance   as   a   whole  means   the   immune   system’s   ability   to  
separate   the   organism’s   own   structures   from   external   antigens,   and   leave  
them  unharmed.  T  cell  central  tolerance,  i.e.  negative  seletion,  takes  place  in  
the  thymus  during  T  cell  development.  In  the  next  sections,  the  focus  is  on  the  
peripheral   tolerance  and   the  mechanisms   controlling  mature   lymphocytes   in  
secondary  lymphoid  organs  are  described.  The  events  leading  to  autoimmune  
diseases,  i.e.  when  the  tolerance  fails,  are  also  discussed.    
  
2.1   Central  Versus  Peripheral  Tolerance  
Thymic   negative   selection   is   a   very   effective   system   for   selecting   out   TCR  
clones  with  high  affinity  to  self-­antigen  –  MHC  complexes.  However,  data  from  
various   transgenic   and   polyclonal   experimental   models   demonstrate   that  
autoreactive  T  cell  clones  with  low  or  moderate  affinity  to  self  can  be  found  in  
the   peripheral   immune   system  of   also   healthy   individuals.   Even   clones  with  
high  affinity  to  self  can  be  found.  However,  these  cells  comprise  a  very  small  
proportion   of   the   total   T   cell   repertoire48,   139,   499.   Therefore,   it   is   clear   that  
additional  mechanisms  are  needed  in  order  to  maintain  tolerance  after  T  cells  
have   left   thymus.   These   mechanisms   are   generally   called   peripheral  
tolerance,  since  they  are  active  in  the  secondary  lymphoid  organs.  
   The   division   between   central   and   peripheral   tolerance   is   becoming  
more   and   more   difficult   to   determine.   Natural   regulatory   T   cells   (nTregs)  
develop   in   the   thymus  and  are  subjected   to   thymic  selection.  However,   they  
mediate   suppressive   peripheral   tolerance.   Therefore   factors   affecting   the  
negative  selection  in  the  thymus  can  also  affect  the  development  of  Tregs  and  
the  maintenance  of  peripheral  tolerance323.    
It  is  difficult  to  conclude  which  one,  central  or  the  peripheral  tolerance,  
is   more   important   in   preventing   autoimmune   diseases.   Even   in   genetically  
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modified  animal  models,   in  which  all  developing  T  cells  are   reactive  against  
the   self,   the   breakdown   of   tolerance   is   not   automatic,   but   often   requires  
additional   strong   inflammatory   stimuli   such   as   immunization   or   bacterial  
colonization70,  163.  Therefore  mechanisms  of  tolerance  work  in  different  areas  
and   are   complementary   to   each   other.  Central   tolerance  provides   the   basic  
framework  for  tolerance,  but  thymic  positive  selection  also  guarantees  that  all  
T  cells  are  at  least  weakly  reactive  to  self-­pMHC.  That  is  why  many  different  
mechanisms   of   peripheral   tolerance   have   to   exist   so   that   an   organism   can  
respond  and  suppress  autoreactivity  dynamically   in  changing  situations  such  
as   infections.  Only   in   rare  situations  can  a  single  mutation  or   “hit”  break   the  
body’s  multiple  control  mechanisms.  Similarly   to   the  development  of  cancer,  
the   breakdown   of   immunological   tolerance   is   better   described   by   a  multi-­hit  
model  where  several  cumulative  events,  genetic  or  environmental,  result  in  an  
autoimmune  disease254.  
  
2.2   Peripheral  Tolerance  
2.2.1   Restriction   of   Access   to   Tissue   Specific   Antigens   and  
Tissues  
T  cell  activation  is  anatomically  restricted  to  lymph  nodes,  which  is  important  
in   controlling   unwanted   cell   activation.   The   low   concentration   of   TSAs   in  
lymph   nodes   is   generally   not   sufficient   to   activate   the   potential   rare   self-­
reactive  T  cells323.  TSAs  are  abundant  only  in  the  specific  tissues  where  naïve  
T   cells   do   not   normally   circulate.   The   already   activated   T   cells   are   able   to  
reach   the   inflamed   tissues   only   when   pro-­inflammatory   cytokines   and   other  
molecules   up-­regulate   homing   receptors   in   endothelial   cells   and   loose   the  
cellular  junctions323.  
Certain   immune-­privileged  sites   like   the  brain,   eyes,  and   testicles  are  
primarly  beyond  the  reach  of  adaptive  immune  system.  This  is  clearly  evident  
in   tissue   transplantation;;   for   example   the   eye   accepts   non-­identical   cornea  
crafts  at  a  very  high   frequency  when  compared  with  skin  which   rejects  non-­
identical   crafts   very   efficiently.   Immune   privilege   is   an   active   process.   It  
utilises  peripheral   tolerance-­like  mechanisms   together  with  prevention  of   the  
access  of  adaptive  immune  system  into  the  tissue434.  
2.2.2   Regulatory  T  Cells  
Many   identified   populations   of   T   cells   have   regulatory   capabilities.   For  
example   cytokines   produced   by   Th1   type   cells   inhibit   Th2   differentiation.  
These   cell   populations,   however,   are   also   capable   of   activating   immune  
responses.   True   regulatory   cells   are   specialized   in   suppressing   immune  
responses,   and   it   is   their   main   effector   function.   The  most   important   CD4+  
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regulatory   T   cell   population   is   called   Tregs.   This   population   contains   both  
nTregs,   that   have   committed   to   this   lineage   already   in   the   thymus,   and  
induced   Tregs   (iTreg),   that   acquire   the   regulatory   phenotype   after   certain  
peripheral   differentation   signals.   Tregs   constitute   5-­10%   of   the   peripheral   T  
cell  pool400.  These  two  populations  are  discussed  in  detail  in  below.    
The   importance   of   regulatory   T   cells   in   various   diseases   has   been  
established;;  Tregs  have  been   reported   to  play  a   role   in   the  pathogenesis  of  
many   autoimmune   diseases   55,   allergy   and   asthma208,   obesity294   and  
atherosclerosis190.  Tregs  also  control   feto-­maternal   tolerance325  and  mediate  
oral  tolerance  towards  food365.  Their  significance  in  controlling  normal  immune  
responses   towards  microbes  has  gained  a   lot  of  attention   lately34.  However,  
Tregs  can  also  be  harmful  as   they  can  suppress   immune  responses  against  
malignant  cells  and  therefore  aid  the  progression  of  cancer321.    
2.2.2.1   The  Regulatory  T  Cell  Phenotype  
Currently,   it   is  not  possible   to  differentiate  between  CD4+  nTregs  and   iTregs  
according   to   phenotype.   It   is   also   not   possible   to   relialibly   differentiate  
regulatory   T   cells   from   normal   effector   T   cells   since   virtually   all   markers  
associated   with   regulatory   T   cells   are   also   expressed   on   other   T   cell  
populations  (as  summarised  in  Figure  3).  Furthermore,  CD4+  Tregs  comprise  
several   subpopulations   with   distinct   phenotypes   and   functional   properties58.  
However,   some   markers   have   been   more   accurately   described   and   play  
important   functional   roles   in   suppressive   cells.   Most   CD4+   T   regulatory  
populations  express  high  levels  of   interleukin  (IL)  2  receptor  ?-­chain  (CD25).  
Originally   Tregs   were   characterized   only   by   these   two   surface   markers   as  
CD4+CD25high   cells402.   However,   results   from   studies   utilising   only   these  
markers   for   Tregs   were   biased   because   the   CD25high   population   always  
contains   a   subpopulation   of   activated   effector   Th   cells.   Currently   the   best  
marker  for  Tregs  is  an  intracellular  transcription  factor  called  Forkhead  box  P3  
(FOXP3),  which  will  be  further  described  below.    
Tregs   are   highly   dependent   on   IL-­2   signaling   and   will   die   without   it.  
Thus   the   CD25   surface   molecule   is   important   for   the   function   of   Tregs  
because   it   is   the   high-­affinity   IL-­2   receptor   ?-­chain287.   IL-­2   signaling   is  
mediated  into  the  nucleus  of  Tregs  through  the  STAT5-­signaling  pathway,  and  
for   example   the   high   expression   of   FoxP3   required   for   Treg   functions   is  
initiated  by  STAT5  signaling.   IL-­2  or  IL-­2  receptor  knock-­out  (KO)  mice  have  
some   FoxP3+   cells   but   their   FoxP3   expression   level   is   low   and   they   are  
incapable   of   suppressing   immune   responses72.   The   effects   of   IL-­2   in   Treg  
development   and   function   are,   however,   not   restricted   to  mere   survival   but  
high  IL-­2  consumption  of  Tregs  has  even  been  suggested  to  be  a  method  of  
immune  suppression.  
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Other   Treg-­associated   markers   have   functional   significance.   Tregs  
express  constitutively  high  levels  of  both  surface  and  intracellular  CTLA-­4  that  
is   important   in   the   Treg-­mediated   immune   suppression.   It   is   a   negative  
regulator   for   the   co-­stimulatory   molecule   CD28.   Its   role   in   immune  
suppression   is   highlighted   in   the   CTLA-­4-­KO   mice   that   die   of   a   massive  
lymphoproliferative   and   tissue   destructive   inflammatory   disease   within   3-­4  
weeks   after   birth455.   CTLA-­4-­mediated   immune   suppression   is   important  
especially  in  Tregs  since  selective  block  of  CTLA-­4  in  Tregs  caused  a  similar  
lymphoproliferative,  fatal  autoimmune  disease  as  global  CTLA-­4  deficiency490.  
However,  CTLA-­4  is  not  the  only  molecule  used  by  Tregs  for  suppression50.  
Expression  of  different  homing  receptors  is  essential  for  Treg-­mediated  
suppression  since  Tregs  need  intimate  cell-­to-­cell  contact  in  order  to  suppress  
immune   responses58,   127.   A   number   of   different   homing   receptors   are  
associated   with   Treg   functions,   but   no   uniform   Treg-­associated   homing  
receptor  expression  pattern  has  yet  been  established.  Tregs  express  various  
homing  receptors  dynamically   in  response  to  changing   inflammatory  signals.  
The   expression   of   homing   receptors   is   also   different   in   different   anatomical  
locations.      This   highlights   the   functional   and   phenotypical   specialization   of  
different  Treg  subpopulations58.  
  
  
Figure  3:  Transcription  factors,  cytokines,  surface  markers,  and  receptors  associated  
with  the  functional  Treg  phenotype.  Those  highlighted  in  the  text  are  underlined.  
  
2.2.2.2   Forkhead  box  P3  (FOXP3)  Gene  
The   human   syndrome   called   Immunodysregulation   –   polyendocrinopathy   –  
enteropathy   –   X-­linked   (IPEX)   is   a   severe   multi-­organ   syndrome   that   is  
characterized   by   severe   diarrhea,   general   lymphoproliferation,   eczema,   and  
various   endocrinopathies309.   The   patients,   that   are   all   males   due   to   the   X-­
linked   inheritance   of   the   disease,   die   at   a   very   young   age   unless   a   bone  
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marrow   transplant   is   carried   out.   The   gene   defect   behind   the   disease   was  
localized  to  a  gene  called  FOXP3,  and  nowadays  it  is  evident  that  the  product  
of   this  gene  is  actually  an   important  transcription  factor  for  Tregs.  The  many  
different   autoimmune   and   immune   dysregulation   phenomena   seen   in   IPEX  
are  a  result  of  complete  lack  of  functional  Tregs,  even  though  some  cells  with  
a  phenotype  resembling  Tregs  or  other  suppressive  T  cells  are  present  also  in  
IPEX  patients304,   361.  The  mouse  model  for  IPEX,  that   is  called  Scurfy,  has  a  
spontaneous   loss-­of-­function   mutation   the   mouse   FOXP3   homologue  
FoxP3415.  
FOXP3  controls  the  main  suppressive  functions  of  Tregs211,  508  and  it  is  
also  believed  to  be  essential  for  the  development  of  nTregs  in  the  thymus38.  In  
mice,   the   expression  of   FoxP3   is  mainly   restricted   to   suppressive   Tregs.   In  
humans,   however,   it   has   been   shown   that   human   effector   T   cells   can   up-­
regulate  FOXP3  transiently  after  activation  but  these  cells  do  not  acquire  the  
suppressive  capabilities516.  This  transient  FOXP3  expression  makes  it  difficult  
to  differentiate  between  activated  effector  T  cells  and  suppressive  Tregs.  The  
methylation  status  of  the  FOXP3  gene  is  currently  considered  the  best  way  to  
identify  terminally  differentiated  Tregs399.  The  FOXP3  promoter  and  a  certain  
area   in   the   gene   itself   are   almost   completely   demethylated   in   suppressive  
cells  whereas  in  non-­suppressive  T  cells  these  sites  are  methylated265.  There  
is   increasing   evidence   that   the   high   constant   expression   level   of   FOXP3   is  
important   for   Treg   functions.   Thus   the   transient   low   FOXP3   expression   in  
activated  T  cells   is  not  enough   to  give   them   the   full   suppressive  capacity  of  
Tregs516.  
Ectopic  FoxP3  expression  via  a  viral  vector  in  naive  murine  CD4+  cells  
is   sufficient   to   transform   them   into   suppressive   Tregs   and   therefore   FoxP3  
was  long  believed  to  be  the  major  transcription  factor  for  Tregs211.  However,  
when   studies   established   the   full   genetic   Treg   transcription   signature,   it  
became   evident   that   a   significant   proportion   of   the   typical   Treg   gene  
expression   is   actually   independent   of   FoxP3205.   There   are   also   reports   of  
suppressive   Treg-­like   cells   that   do   not   express   FoxP3127.   It   has   been  
postulated  that  FOXP3  is  actually  not  the  transcription  factor  that  initiates  the  
suppressive   actions   in   human   Treg   cells   but   rather   stabilizes   them399.   The  
human   FOXP3   gene   produces   two   different   isoforms517.   Therefore   it   is  
possible   that   the   discrepancies   noted   between   mouse   FoxP3   and   human  
FOXP3   expression   profiles   reflect   the   different   functions   of   these   protein  
variants399.  
FoxP3   can   both   activate   and   repress   various   genes   directly   or  
indirectly,   e.g.   by   affecting   other   transcription   factors507.  However,   the  exact  
functions  of  FoxP3  are  still  partially  unknown.  FoxP3  affects  intracellular  TCR  
signaling   in   many   ways.   The   up-­regulation   of   FoxP3   during   thymic  
development   of   nTregs   is   believed   to   result   from   TCR   signaling38.   FoxP3  
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constantly   promotes   the   expression   of   CD25   and   CTLA-­4,   and   down-­
regulates  CD127  expression.  Therefore   the  main  molecules   of   the   currently  
described  Treg  phenotype  are  FoxP3  dependent400.  
FoxP3  selectively  blocks   the  production  of  pro-­inflammatory  cytokines  
like   IL-­2   and   interferon   ?   (IFN-­?)   346.   Originally   it   was   thought   that   high   and  
stable  FoxP3  expression  blocks  Th  effector  functions  in  Tregs,  and  therefore  
FoxP3+   cells   represent   the   terminal   differentiation   stage   of   Tregs.   A   recent  
report  contrasting  this  finding  showed  that  in  human  tonsils  there  is  a  FOXP3  
positive   population   that   produced   pro-­inflammatory   cytokine   IL-­17478.   In   the  
gut  a  population  that  expresses  Tbet  and  FoxP3  at   the  same  time  has  been  
described78.  Tregs  from  Tbet-­KO  mice  failed  to  suppress  efficiently  Th1  type  
immune   responses249.   Tregs   has   also   been   reported   to   express  GATA3481.  
Tregs  can  also  lose  their  FoxP3  expression  and  become  effector  cells  with  a  
potential   to   cause   pathological   inflammation.   Taken   together,   it   is   apparent  
that   there   is   certain   amount   of   plasticity   between   Treg   and   other   Th  
populations  at  least  in  transcription  factor  expression322.  
2.2.2.3   Regulatory  T  Cell  Development  in  the  Thymus  
Tregs   were   originally   identified   by   Sakaguchi402   in   a   mouse   model   of  
autoimmunity   where   a   multi-­organ   autoimmune   syndrome   is   generated   by  
thymectomizing  a  neonatal  mouse  on   the   third  day  after   the  birth.  Asano  et  
al.24   showed   that   this   autoimmune   attack  was   completely   prevented   by   the  
transfer   of   CD4+CD25high   cells.   This   finding   illustrates   that   the   nTreg  
development  in  mice  is  a  relatively  late  event  since  the  nTregs  are  generated  
only   in   the   latest   part   of   gestation   and   especially   right   after   the   birth.   In  
humans   the   earliest   FOXP3   expression   in   thymocytes   is   noticeable   already  
after  12  weeks  of  gestation  93.  
   It  has  been  well  established  in  mouse  studies,  that  a  certain  proportion  
of   the   single-­positive   CD4+   thymocytes   consistitutively   express   FoxP3   and  
that   these   cells   are   the   progenitors   of  mature   nTregs38.   FoxP3   is   the  most  
important  factor  determining  Treg  development239.  FoxP3  positive  cells  can  be  
found  in  a  small  percentage  in  all  thymocyte  populations.  Thus,  it  is  not  clear  
what  is  the  first  stage  of  T  cell  development  when  FoxP3  is  up-­regulated132.  
TCR   signaling   is   crucial   for   Treg   development   and   possibly   also   for  
FoxP3  up-­regulation368.  In  models  where  TCR  signaling  is  selectively  blocked,  
no   Tregs   are   produced252.   In   a   TCR   transgenic   system  where   endogenous  
TCR  recombination  is  prevented,  Tregs  are  only  generated  when  the  cognate  
antigen  for  the  transgenic  TCR  is  co-­expressed234.  FoxP3  expression  can  be  
used   to   identify   the   earliest   thymic   progenitors   of   Tregs   but   the   factors  
responsible   for   FoxP3   up-­regulation   are   not   known.   Together   with   the   TCR  
signaling,   CD28-­mediated   co-­stimulation   has   at   least   a   partial   role   in   the  
generation  of  thymic  FoxP3+  Tregs493.  The  cytokines  IL-­2  and  TGF-­?  appear  
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to  have  a  synergistic   role   in   thymic  Treg  development.  Mice  deficient   in   IL-­2  
produce  significantly  less  thymic  Tregs,  while  mice  deficient  for  both  IL-­2  and  
TGF-­?   are   completely  devoid  of   thymic  Tregs38.  The  sole  TGF-­?  deficiency,  
however,  did  not  affect  the  amount  of  thymic  Tregs.  
The  data  from  our  own  group  using   the  human  thymus  challenge  this  
TCR-­based   differentiation   model   for   nTregs.   We   have   reported   a   small  
cortical  double-­negative  population   that  expresses  FOXP3  without   functional  
TCR461.  These  cells  were  devoid  of  natural  killer  (NK)  cell  or  ??  T  cell  markers  
so  they  appeared  to  be  the  most  immature  form  of  nTregs.  It  is  thus  possible  
that   the   nTreg   differentiation   actually   precedes   TCR   signaling.   It   is   also  
possible   that   this   population   we   have   described   is   not   connected   with   the  
normal  nTreg  population461.  
FoxP3+   cells   have   been   found   in   all   areas   of   the   thymus38.   Stromal  
cells   are   important   in   Treg   development   and   both   cortical279   and  medullary  
thymic   epithelial   cells25   have   been   reported   to   mediate   Treg   development.  
Most   FoxP3+   cells   are   found   in   the   thymic   medulla38.   DCs   residing   in   the  
thymus  have  an  important  role  in  the  nTreg  lineage  differentiation,  possibly  by  
providing   additional   co-­factors   needed   in   the   expression   of   FoxP3272,   291.  
Hassall’s   corpuscles   have   been   reported   to   be   involved   in   the   nTreg  
development482.  Hassall’s  corpuscles  are  the  only  thymic  structures  producing  
thymic   stromal   lymphopoietin,   which   stimulates   the   DCs   to   induce   Treg  
differentiation187,  482.  
Taken  together,  Treg  development  in  the  thymus  is  a  complex  process  
in  which  TCR  signaling,  co-­signaling,  and  various  cytokines  are  involved.  The  
exact  mechanism  of  how  thymic  Tregs  are  generated  is,  however,  still  mostly  
unknown,  especially  in  humans.       
2.2.2.4   T  Cell  Receptor  Repertoire  and  Antigen  Specificity  of  Regulatory  
T  Cells  
The   TCR   repertoire   of   nTregs   was   long   believed   to   be   self-­reactive.  
This   hypothesis   originated   from   observations   of   Treg   development   in   the  
murine   the   thymus.   In   some   TG-­TCR   settings,   thymic   antigen   expression  
model   resulted   in  an   increase   in   the  proportion  of  Tregs   instead  of  negative  
selection422.  This   lead   to   the   hypothesis   that   there   is  a   specific  TCR  affinity  
window   that   guides   the   developing   thymocyte   to   up-­regulate   FoxP3   and  
thereby   differentiate   towards   the   Treg   lineage278,   343.   This   affinity   window  
guiding  the  Treg  lineage  commitment  is  believed  to  be  more  autoreactive  than  
the  TCR  affinity  needed  for  mere  positive  selection493.  However,   it  should  be  
noted  that  the  data  obtained  from  monoclonal  transgenic  experimental  models  
have   not   been   confirmed   in   a   polyclonal   TCR   repertoire493.   T   cells   bearing  
Treg-­originating   TG-­TCRs   proliferated  more   efficiently   in   lymphopenic   hosts  
than   T   cells   with   effector   cell-­originating   TG-­TCRs215,   216.   This   kind   of  
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proliferation  is  believed  to  be  dependent  on  self-­originating  antigens  and  it   is  
discussed   in   detail   below.   On   the   other   hand,   it   has   been   suggested   that  
these  findings  in  lymphopenic  hosts  could  in  fact  be  a  reflection  of  preferential  
survival  of  Tregs  instead  of  an  increased  TCR-­mediated  Treg  activation469.  
The   view   of   increased   autoreactivity   of   the   Treg   TCR   repertoire   was  
challenged  when  a  larger  number  of  Treg-­derived  TCRs  were  sequenced,  and  
self-­reactive   clones   were   found   to   represent   a   minority   in   the   total  
population355.  These  studies  also  showed  that  there  is  a  significant  overlap  of  
10-­20%  in  the  TCR  repertoires  of  Tregs  and  naïve  T  cells215,  354,  356.  It  should  
be   noted   that   contradicting   results   showing   no   significant   overlapping  
repertoires   of   Tregs   and   effector   T   cells   have   also   been   published255,   284.  
Further,   Tregs   that   have   a   microbial   antigen-­specific   TCR   have   been  
reported,  and  they  seem  to  control  the  immune  response  to  various  infectious  
agents34.  The  current  concept   is   that   the  Tregs  have  a  wide  polyclonal  TCR  
repertoire  that  recognizes  both  self  and  non-­self  antigens354.  
It   is   not   clear   whether   the   Treg-­mediated   suppression   of   immune  
responses   is   antigen   specific   or   non-­specific.   It   is   clear   that   Tregs  must   be  
activated  through  their  antigen  receptor   in  a  similar   fashion  to  that  of  normal  
effector   cells   before   they   can   start   their   suppressive   actions399.   Therefore,  
Treg-­mediated   suppression   of   immune   responses   is   antigen   specific.  
However,  Tregs  can  also  be  indirecty  activated  by  microbial  products  through  
pattern-­expression   molecules   that   they   express442.   It   is   thus   possible   that  
during   immune  response  Tregs  are  activated  also   in  an  antigen  non-­specific  
fashion.    
It  is  not  known  whether  the  effector  T  cells,  i.e.  the  target  of  the  regulation,  
and  the  Treg  need  to  have  the  same  antigen  specificity.  This  scenario   is  not  
supported   by   experimental   evidence   showing   that   suppressive   and   non-­
suppressive  T  cells  have  little  overlap   in  their  TCR  repertoire255,   284.  Antigen-­
specific   Treg   suppression   focusing   on   DCs   initiating   the   immune   response  
could   explain   how   antigen-­specific,   i.e.   TCR   signaling-­dependent,  
suppression  appears   to  be  more  efficient  even   though   their  TCR  repertoires  
are   not   shared77,   498.   Tregs   can   also   suppress   effector   cells   by   producing  
immunosuppressive   cytokines.   This   suppression   is   not   restricted   by   shared  
antigen  specificity  and  it  is  also  called  by-­stander  suppression.  It  is  believed  to  
be  generally  less  efficient  in  the  prevention  of  autoimmune  pathology354.  
2.2.2.5   Induced  FoxP3+  Regulatory  T  Cells    
   After   the  finding  of  nTregs   it  soon  became  evident   that   there  are  also  
suppressive   T   cells   that   acquire   their   phenotype   only   after   activation   in   the  
peripheral  immune  system239.  These  suppressive  cells  can  be  called  adaptive  
Tregs   or   iTregs.   No   population-­specific   markers   for   iTregs   have   yet   been  
found.   Recently   a   transcription   factor   called   Helios   has   been   associated  
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specifically   with   the   nTreg   population150,   454   but   its   value   as   a   tool   to  
differentiate  nTregs  from  iTregs  remains  to  be  confirmed.  CD4+  iTregs  can  be  
defined   by   their   peripherally   acquired   expression   of   FoxP3   while   in   nTregs  
FoxP3  is  up-­regulated  already  during  thymic  development213.  Also  other  iTreg  
phenotypic  markers  are  almost  completely  shared  with  nTregs.    
     It  has  been  shown  especially  in  mouse  models  that  naïve  CD4+  T  cells  
can   acquire   a   Treg   phenotype509.   TGF-­?   and   ?IL-­2   are   the   most   important  
cytokines  in  directing  T  cell  differentiation  to  iTreg  lineage213,  497.  Naïve  CD4+  
cells  require  also  TCR-­mediated  signaling   in  order  to  up-­regulate  FoxP3,  but  
compared   to   the   TCR   signaling   required   for   full   T   cell   effector   activation,  
suboptimal  TCR  signaling  appears  to  be  essential  for  iTreg  conversion.  Thus  
minute  doses  of  antigen  are  more  efficient  in  driving  the  induction  than  large  
ones253.   Similarly   to   the   non-­suppressive   effector   T   cell   activation,   co-­
stimulation   is   required   for   iTreg   conversion213.   iTreg   conversion   is   strongly  
dependent   of   CTLA-­4   signaling   while   the   nTregs   require   CD28   signaling  
during  their  development  in  the  thymus88.  
DCs   are   important   in   directing   the   iTreg   conversion.   Several   cell  
surface  markers  on   the  DCs,   for  example  programmed  death   ligand  1,  have  
been  linked  to  this   induction  together  with  TGF-­?  production133.  A  population  
of  DCs   called   the   tolerogenic  DCs   resides   in   epithelial   tissues,   such  as   the  
lungs   and   the   gut.   These   cells   have   been   shown   to   be   potent   in   iTreg  
induction98.  FoxP3  up-­regulation  can,  however,   take  place  also   in  secondary  
lymphoid  organs  since  iTreg  conversion  occurs  if  the  antigen  is  administered  
systemically213.   iTregs   can   also   develop   during   immune   response   with  
specificity  to  an  infectious  agent213.  It  has  been  speculated  that  the  confusing  
data   about   self-­   or   non-­self   specificity   of   the   Treg   TCR   repertoire  would,   in  
fact,   be   partly   explained   by   contaminating   iTregs126.   The   iTreg   repertoire  
appears   to   be   more   reactive   than   nTregs   to   non-­self   antigens   such   as  
allergens,  commensal  microbiota,  and  alloantigens88.  
iTreg   conversion   has   been   shown   to   occur   in   the   gut-­associated  
lymphoid  tissue88.  This  has  been  explained  by  tolerogenic  DCs  residing  in  the  
lamina  propria  and  gut-­associated  lymphoid  tissue.  The  tolerogenic  DCs  have  
been   characterized  by   surface  expression  of  mucosal   lymphocyte   antigen  1  
(CD103)98.  CD103  is  a  homing  receptor  directing  lymphocytes  into  the  gut  and  
other  epithelial  compartments  of   the  body.  Constitutive  production  of  various  
anti-­inflammatory   cytokines   (IL-­10   and   TGF-­?)   by   the   gut   epithelial   cells   is  
important   in   the   conditioning   of   these   specialized   DCs   to   generate  
tolerance227.   Diet-­derived   retinoic   acid,   i.e.   vitamin   A,   is   very   potent   in  
inducing   FoxP3   expression   and   suppressing   naïve   CD4+   cells338.   It   is  
important   to   note   that   the   gut   has   specialized   ways   of   promoting   antigen  
specific  and  unspecific  tolerance  independently  of  the  thymus  due  to  the  huge  
antigen   load   the  gut  commensal  microbiota  provides.   iTregs  originating   from  
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the  gut  have  indeed  been  reported  to  be  important  in  mediating  oral  tolerance  
towards  dietary  antigens98,  165.  
2.2.2.6   Other   T   cell   Populations   Specialized   in   Suppressing   Immune  
Responses:   IL-­10   Secreting   Tr1   Cells,   Regulatory   CD8+   Cells,  
and  Invariant  NK  T-­cells  
CD4+  regulatory  T  cells  are  currently  the  best  characterized  T  cell  population  
that   can   suppress   immune   responses.   However,   several   other   T   cell  
populations  with  regulatory  functions  have  been  found.  For  example,  invariant  
natural   killer   T   -­   cells   (iNKT   cells)   are   a   specialized   T   cell   population   with  
reported   regulatory   and   suppressive   functions37.   They   express   TCRs   with  
limited  receptor  specificity  together  with  cell  surface  markers  of  both  memory  
T   cells   and   natural   killer   (NK)   cells.   These   cells   appear   to   be   dysfunctional  
especially   in   the  mouse  model  of  autoimmune  diabetes60.  However,   it   is  not  
known  whether   iNKT   cells   are   functionally   important   in   human   autoimmune  
diseases37.  
   Type  1  regulatory  T  (Tr1)  cells  are  a  specialized  population  of  CD4+  T  
cells   that   has   a   capacity   to   produce   large   amounts   of   immunosuppressive  
cytokine  IL-­10389.  Tr1  cells  have  a  role  in  the  generation  of  mucosal  tolerance,  
i.e.   oral   tolerance,   and   they   are   also   induced   if   the   antigen   is   administered  
through  the  nasal  route484.  This  may  explain  why  Tr1  cell  defects  appear  to  be  
important   in   the   generation   of   allergy496.   Tr1   cells   do   not   generally   express  
high   levels   of   FoxP3.  High   IL-­10   production   is   the   hallmark   of   Tr1   cells   but  
they  can  also  produce  other  cytokines389.   IL-­10  has  e.g.   immunosuppressive  
effects   in   the   immune   system,   and   many   types   of   cells   are   capable   of  
producing  it398.  
CD8-­positive  cells  with  regulatory  capacities  were  described  earlier  that  
CD4+   regulatory   T   cells   were   characterized108,   452.   Various   populations   of  
CD8+  regulatory  cells  have  been  found  both  in  humans  and  mice  with  partially  
overlapping  functions.  Some  CD8+  regulatory  cells  also  express  FoxP3108.  
2.2.2.7     Regulatory  T  Cells:  Mechanisms  of  Suppression  
Increasing   evidence   emphasizes   the   importance   of   Tregs   in   the   control   of  
various  immune  responses.  However,   it   is  still  unknown  how  Tregs  suppress  
their   target   cells83.   The   exact   activating   signals   that   initiate   Treg   mediated  
immune  suppression  are  elusive.   It   is  clear   that   for  suppression  Tregs  must  
be   activated   through   their   TCR   and   receive   signaling   from   surrounding  
cytokines   similarly   as   effector   T   cells   do400.   However,   the   antigen   doses  
needed   for   Treg   activation   are   significantly   lower   than   the   ones   needed   for  
activation  of  other  effector  T  cells401.  
Upon   activation,   Tregs   secrete   immunosuppressive   cytokines   that  
inhibit   surrounding   cells   in   an   unselective   way.   Suppression   of   antigen-­
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presenting   cells   will   eventually   affect   the   immune   response   on   a   larger  
scale417.   It   has  been  suggested   that   since  Tregs  are   so   dependent   on   IL-­2,  
even   though   they   do   not   produce   it   themselves,   they   could   regulate   the  
immune  response  by  consuming  IL-­2.  Effector  T  cells  need  high  amounts  of  
IL-­2   in   order   to   survive.   There   is   also   evidence   that   Tregs   can   trigger  
apoptosis   in   effector   T   cells   or   DCs   by   direct   cell-­to-­cell   contact401.   Certain  
surface  molecules  expressed  on  Treg,  for  example  Galectin-­1,  can  arrest  the  
cell  cycle  in  the  proliferating  effector  cells382.  
One  important  suppressive  mechanism  is  the  Treg-­mediated  modulation  of  
DC   functions.   For   example   CTLA-­4   appears   to   have   an   important   role   in  
mediating  Treg  suppression  of  DCs50.  Tregs  expressing  CTLA-­4  can  block  the  
up-­regulation   of   the   co-­stimulatory  molecules   on   DCs   and   thus   prevent   the  
activation   of   antigen   specific   naïve   T   cells.   CTLA-­4   can   also   induce   the  
expression   of   other   immunosuppressive   molecules   on   APCs417.   CTLA-­4  
binding   further   prevents   DCs   from   producing   proinflammatory   molecules457.  
Tregs   can   also   prevent   APC  maturation400.   Anergic   T   cells   and  Tregs   have  
been  postulated  to  be  immunosuppressive  in  a  non-­selective  and  passive  way  
by  blocking   the  access  of  naïve  T  cells   to  DCs.  There   is  some  experimental  
evidence   supporting   this,   especially   for   Tregs,   since   they   accumulate   into  
small  clusters  around  the  DCs417.  Figure  4  summarises  reported  cell-­contact-­







Figure   4:   Summary   of   Treg   cell  
suppression  mechanisms.    
Cell-­contact   independent  
mechanisms:      1)   secretion   of  
immunosuppressive   cytokines  
that   can   silence   both   effector  
and   APC   responses,                                    
2)   consumption   of   IL-­2,   and              
3)   physical   blockage   that  
prevents  effector  cells’  access  to  
DCs.    
Direct   cell-­contact   dependent  
mechanisms:   4)   induction   of  
apoptosis   in   effector   cells,                                  
5)  induction  of  anergy  in  effector  
cells,   6)   prevention   of   DC  
activation   and   maturation,   and    
7)  CTLA-­4-­mediated  inhibition  of  
co-­stimulation  on  DCs.    
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It  appears  that  the  mechanisms  of  suppression  nTregs  and  iTregs  use  are  
somewhat   different.   For   example,   iTregs   have   been   suggested   to   produce  
more   immunosuppressive   cytokines   that   mediate   by-­stander   suppression,  
while   nTregs   utilise   more   cell-­to-­cell   contacts   to   suppress   DCs213.   The  
requirements  for  immune  regulation  in  steady-­state,  chronic  infection,  or  acute  
inflammation  are  very  different  and   thus   the  mechanisms  of   immune  control  
are  versatile88.  In  conclusion,  Tregs  use  various  methods  of  suppression  and  
it  is  currently  unknown  which  of  these  are  functional  in  vivo83,  400.  
  
2.3   Autoimmune  Diseases  in  Humans  
Autoimmune   diseases   are   a   large   group   of   diseases   with   variable   clinical  
pictures  and  outcomes.  Even  though  most  autoimmune  diseases  are  rare,  the  
overall  impact  of  these  diseases  on  health  is  significant.  It  has  been  estimated  
that  approximately  5%  of  the  Western  population  is  affected  with  some  kind  of  
an  autoimmune  manifestation95.  
2.3.1   Classification  of  Autoimmune  Diseases  
Autoimmune  diseases  are  classically  divided  into  organ-­specific  and  systemic  
diseases95.   In   organ-­specific   autoimmune   diseases,   such   as   in   type   1  
diabetes   mellitus,   a   tissue-­specific   antigen   triggers   the   autoimmune  
inflammation,  and  it  can  completely  destroy  the  cells  producing  the  antigen.  In  
a   few   of   these   diseases   the   target   autoantigen   has   been   identified.   One  
example   is   Goodpasture’s   syndrome   where   the   autoantigen   has   been  
recognized  to  be  a  collagen  chain  found  only   in  highly  specialized  basement  
membranes   such   as   in   kidney   glomeruli   and   pulmonary   alveoli366.   The  
syndrome’s   clinical   findings   correlate   with   the   anatomical   distribution   of   the  
autoantigen   expression.   Almost   all   patients   have   autoantibodies   targeted   to  
this   specific   collagen  chain,  and   they   often  have  an   increased  proportion  of  
circulating  T  cells  reactive  for  it366.  
  In   contrast   to   organ-­specific   autoimmunity,   in   the   systemic  
autoimmune  diseases  the  autoantigen(s)  are  expressed  in  many  tissues.  The  
model   for   these   diseases   is   systemic   lupus   erythematosus   (SLE)   where  
autoantibodies  targeted  against  e.g.  DNA  can  often  be  found170.  Even  though  
this   classification   of   organ-­specific   and   systemic   autoimmune   diseases   is  
artificial  and  does  not  necessarily  correspond  to  a  difference  in  causation,  it  is  
clinically   relevant.   Coombs-­Gell   hypersensitivity   classification   can   also   be  
used  to  describe  different  autoimmune  diseases.  It  separates  the  diseases  to  
four   classes   according   to   the  main  mechanisms   of   tissue   damage   that   are  
causing   the   symptoms   and   findings229.   For   example   SLE   can   be   classified  
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according   to   Coombs-­Gell   as   an   immunocomplex   disease   (type   III  
hypersensitivity).  
However,   some   autoimmune   diseases   are   difficult   to   classify   into  
organ-­specific   or   systemic   ones.   In   some  autoimmune  diseases,   such  as   in  
Crohn’s   disease,   a   clear   genetic   defect   in   the   innate   immune   system   has  
been   found416.   The   new   classification   suggested   for   autoimmune-­like  
diseases   is   an   immunological   disease   continuum   that   ranges   from   classical  
autoimmune   diseases,   both   organ-­specific   and   systemic,   to   the   newly  
designated   auto-­inflammatory   diseases302.   Most   common   autoimmune  
diseases,   such   as   rheumatoid   arthritis,   share   features   of   both   auto-­
inflammatory  and  autoimmune  diseases,  and  are  thus  located  in  the  middle  of  
the  continuum302.  
2.3.2   Genetic  Background  of  Autoimmune  Diseases  
Autoimmune   diseases   can   also   be   classified   according   to   their   genetics.  
Monogenetic   autoimmune   diseases   are   caused   by   a   mutation   in   a   single  
gene302.   Monogenetic   autoimmune   disease   can   be   inherited   in   a   dominant  
fashion,   or   be   autosomal   recessive.   Some   monogenetic   autoimmune  
diseases  are  X-­linked,  so  that  only  males  carrying  the  defective  gene  in  their  
X   chromosome   are   affected.   Autoimmune   polyendocrinopathy,   candidiasis,  
and  ectodermal  dystrophy  (APECED)   is  a  monogenetic  autosomal  recessive  
autoimmune   disease   and   it   will   be   described   in   detail   below.   Monogenetic  
autoimmune   diseases   are   rare   but   they   have   been   excellent   models   for  
autoimmune  research483.  
More   common   autoimmune   diseases   such   as   SLE   and   rheumatoid  
arthritis   are   polygenetic.   Their   inheritance   is   not   autosomal   recessive   or  
dominant.   Instead,   in   polygenetic   diseases   gene   polymorphisms   or   alleles  
increase   the   risk   for   the   disease413.   In   the   following   sections   the   most  
common  genetic  risk  factors  for  autoimmune  diseases  are  briefly  described.        
2.3.2.1   Human   Leukocyte   Antigen   Association   with   Autoimmune  
Diseases  
The   most   thoroughly   described   genetic   predisposition   to   autoimmune  
diseases  is  HLA-­association.  It  was  found  that  in  some  autoimmune  diseases  
certain   HLA   alleles   are   significantly   enriched   in   the   diseased   population  
compared  with  the  rest  of  the  population.  The  associations  are  generally  more  
pronounced  in  HLA  class  II  alleles  but  there  are  diseases  that  are  connected  
with  the  class  I  alleles  as  well.  One  of  these  diseases  is  ankylosing  spondylitis  
that   is   strongly   associated   with   the   HLA   class   I   allele   B27.   However,   HLA-­
association  only  increases  the  risk  of  acquiring  a  certain  autoimmune  disease,  
but  it  does  not  predict  accurately  whether  an  individual  will  get  the  disease  or  
not453.   For   instance,   type   1   diabetes   has   a   strong  HLA-­association,   but   the  
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disease  concordance  in  monozygotic  twins,  who  are  genetically  identical,  has  
been  shown  to  be  only  27%  in  Finnish  population223.   It  should  be  noted   that  
there   are   also   HLA-­associations   that   are   protective   for   some   autoimmune  
diseases.    
2.3.2.2   Other  Genetic  Risk  Factors  for  Autoimmunity  
In   many   autoimmune   diseases,   for   example   in   Hashimoto’s   thyroiditis   and  
SLE,  females  are  more  often  affected505.  The  autoimmune  diseases  with  male  
predominance,   like  ankylosing  spondylitis,  are  rare.  Some  diseases,  such  as  
type  I  diabetes,  affect  both  genders  equally.  The  reasons  for  the  gender-­bias  
in  some  autoimmune  diseases  are  mostly  unknown393  but  both  hormonal  and  
X-­chromosomal  factors  are  thought  to  be  involved.    
Research   in   immunogenetics   has   focused   on   revealing   single  
nucleotide   polymorphisms   (SNPs)   that   are   enriched   in   autoimmune  
diseases275,   488.   The  most   often   affected   genes   can   be   roughly   divided   into  
four   functional   categories:   1)   antigen   clearance   and   presentation,   2)   cell  
intrinsic   signaling,   3)   co-­stimulatory   molecules   and   activation,   and   4)  
apoptosis225.  SNPs   in   these   crucial   genes   cause   certain   qualitative   or   slight  
quantitative  changes  in  the  respective  proteins  rather  than  a  complete  loss  of  
function413.  
2.3.3   Environmental  Factors  in  the  Breakdown  of  Tolerance  
Together  with  various  genetic  factors,  environmental   factors  are   important   in  
the   development   of   autoimmune   diseases.   This   is   best   illustrated   by   the  
unequal  geographical  distribution  of   the  autoimmune  disease   incidence95,   229.  
Incidence   of   autoimmune   disease   is   also   growing   in   developed   Western  
countries,   which   could   not   be   explained   by   genetic   factors229.   Enviromental  
factors   can   partly   explain   the   lower-­than-­expected   concordance   of  
autoimmune   diseases   between   identical   twins95,   196,   which   has   not   been  
shown   only   for   type   I   diabetes,   but   also   for   other   polygenetic   autoimmune  
diseases  as  well.  For   example,   if   an   identical   twin   is  affected  with  SLE,   the  
risk   that   the   other   twin   gets   the   disease   is   approximately   24%97.  
Paradoxically,   identical   twins   can   differ   from   each   other   genetically.   For  
example,   the   X-­chromosome   inactivation   in   females   can   lead   to   different  
patterns  of  mosaicism.  Also  TCRs  and  antibodies  are  somatically  recombined  
in  a  stochastic  manner404.  These  intrinsic  epigenetic  factors  are  important  but  
there   are   also   environmental   factors   involved   in   the   generation   of  
autoimmunity.   Factors   such   as   hormonal   variation393,   emotional   stress436,  
toxins,  and  dietary  factors412  have  been  found  to  affect  the  manifestations  and  
outcome  of  human  autoimmune  diseases.    
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2.3.3.1   Microbes  and  Autoimmune  Diseases  
Since  the  immune  system  has  evolved  to  protect  the  body  against  microbes,  it  
can   be   assumed   that   the   microbe–immune   system   interactions   can   also  
influence  the  immunological  tolerance  towards  self28.  An  association  between  
an   infection   and   the   onset   of   an   autoimmune   disease   has   been   shown   for  
many  diseases.  For   example   there   is   a   significant   correlation   of  enterovirus  
infections  with  autoimmune  diabetes   in   individuals  that  are  genetically  at  risk  
of   developing   the   disease501.   Infections   can   predispose   to   autoimmunity  
through  many  mechanisms.  The   target  cells  can  be  chronically   infected  with  
the   microbe   and   polyclonally   activate   lymphocytes,   which   could   eventually  
lead  to  tissue  destruction.  This  mechanism  has  been  proposed  to  play  a  role  
in   the   development   of   type   1   diabetes   since   enteroviruses   can   infect  
pancreatic   insulin-­producing   ?-­cells206.   Inflammation   following   microbial  
evasion   can   also   change   auto-­antigen   structures   to   make   them   more  
immunogenic,  or  reveal  otherwise  hidden  self-­structures28.  Infections  can  also  
generate  conditions  that  favor  autoreactivity,  such  as  lymphopenia,  which  will  
be  described  in  detail  below.  
Processing  of  microbial   antigens  can  also  be  defective  and   lead   to  a  
failure   in   immunetolerance.   For   example,   in   SLE   defective   clearance   of  
apoptotic   cells   and   cellular   debris   is   important   in   the   appearance   of  
autoantibodies  and   following  autoimmunity324.  Molecular  mimicry   is   a   theory  
for   the   development   of   autoimmunity   that   connects   infections   and  
autoimmune   diseases   through   antigen   presentation397.   In  molecular  mimicry  
the  microbial  antigen   is  believed  to  resemble  a  self-­antigen  so  closely   that   it  
can  break  the  tolerance  against  self.  Sometimes  this  could  be  achieved  only  
when  the  antigen  is  presented  in  certain  HLA  molecules137.  A  model  disease  
for   molecular   mimicry   is   rheumatic   fever   where   streptococcal   antigens,  
namely   two   immunodominant   peptides   of   the   bacterial   M5   protein,   display  
cross-­reactivity  with  heart  valvular  proteins  and  cardiac  myosin  peptides175.  It  
has   been   shown   that   CD4+   T   cells   of   the   patients   preferentially   recognize  
these  proteins,  especially  when  the  proteins  are  presented  in  HLA-­DR7  that  is  
the  HLA  allele  associated  with  increased  risk  for  rheumatic  fever175.  
2.3.3.2   Lymphopenia  and  Autoimmunity  
Transient   lymphopenia  often  follows  for  example  viral   infections27.  Persistent  
lymphopenia   usually   results   in   immunodeficiency441.   The   sizes   of   different  
lymphocyte  subpopulations  are  tightly  controlled.  In  a  normal  immune  system,  
the   lymphocytes   quickly   sense   the   “empty   space”   around   them  and   start   to  
divide  in  order  to  reach  their  normal  distribution52.  As  the  individual  ages,  the  
thymic  output  of  naïve  T  lymphocytes  decreases  and  the  constant  numbers  of  
T   cells   is   maintained   by   homeostatic   proliferation   of   existing   naïve   and  
memory   T   cells330.   T   cell   homeostasis   is   remarkably   stable   for   all   different  
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subpopulations   and   is   tightly   controlled   by   cellular   interactions   and  
cytokines14.  
2.3.3.2.1  Lymphopenia-­induced  Proliferation  of  T  Cells  
Lymphopenia-­induced   proliferation   (LIP)   was   discovered   in   mouse   models  
where   mature   T   lymphocytes   were   transferred   to   sublethally   irradiated   or  
genetically   lymphopenic   recipients424.   In   a   lymphopenic   environment,   the  
lymphocytes  proliferated   faster   than   in   steady-­state   lymphoreplete   situations  
and   the   proliferation   resembled   strongly   a   normal   immune   response   to  
external   antigens.   It   also   resulted   in   a   stable  memory-­like   phenotype   in   the  
proliferating  lymphocytes441.  
There   are   many   factors   driving   this   proliferation:   the   self-­antigen–MHC  
complexes,   cytokines,   and   antigens   originating   from   intestinal   flora.   These  
different  factors  are  all  driving  the  LIP  of  T  cells,  but  their  relative  importance  
in   each   experimental   setting   is   dependent   on   the   method   how   the  
lymphopenia   was   generated441.   When   mature   lymphocytes   are   adoptively  
transferred   to   genetically   lymphopenic   animals,   that   are   incapable   of  
producing  functional  lymphocytes  themselves,  the  resulting  LIP  is  very  fast111,  
313.  This  proliferation  in  greatly  reduced  in  animals  that  are  kept  under  germ-­
free  conditions  so  it  appears  that  the  fast  burst  of  cell  division  and  activation  is  
mainly   driven   by   antigens   originating   from   commensal   flora237.   The  
proliferation  is  also  strongly  dependent  of  DCs  and  co-­stimulation111,  503.  When  
transferring   polyclonal   T   cells   to   genetically   lymphopenic   recipients   with  
normal  enteric  flora,  a  small  fraction  of  the  transferred  cells  start  to  proliferate  
vigorously   and   acquires   an   activated   effector   phenotype313,   441.   This  mouse  
model  of  LIP  is  widely  used  in  autoimmune  studies.  
There   is   also   another   form   of   LIP   following   acute   lymphopenia   after  
irradiation   or   lymphocyte   depletion   by   monoclonal   antibodies   (mAbs).   This  
proliferation   is  slow  and   it  usually   takes  several  weeks  before   the  adoptively  
transferred   or   endogenous   cells   have   reached   the   size   of   a   normal  
lymphocyte  pool52.  The  signals  that  drive  the  proliferation  are  the  same  ones  
that   are   needed   for   T   cell   survival   in   a   lymphoreplete   environment,   namely  
contacts   with  MHC-­self-­antigen   complexes148,   157,   238,   and   certain   cytokines,  
especially  IL-­7  and  to  a  lesser  degree  IL-­15313,  441.  During  the  proliferation  the  
dividing   cells   acquire   a   stable   memory-­cell   like   phenotype   and   gene  
expression  profile156  but  they  differ  from  true  memory  cells  in  their  functions75,  
238.   Thus   the   proliferation   does   not   fully   restore   the   normal   proportions   of  
mature  and  naïve  T  cell  populations;;  the  naïve  T  cell  pool  is  only  restored  in  
severe  lymphopenia  by  de  novo  thymopoiesis147.    
Both   types   of   LIP   can   take   place   simultaneously   in   the   same  
lymphopenic  recipient  but  the  kinetics  of  the  proliferation  are  different.  It  is  not  
known  what  explains   the  difference  between  LIP   following   irradiation  and   in  
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genetically  lymphopenic  animals.  Irradiation  disturbs  the  barrier  function  of  the  
enteric  mucosa  so  the  intestinal  bacterial  antigens  should  be  even  more  easily  
available   after   irradiation.   Surh   et   al.   speculated   that   the   lymphopenia  
generated  by  irradiation  is  not  complete  but  some  normal  T  cells  could  remain  
in   the   intestinal   tissue,   and   somehow  prevent   antigen   leakage   from   the   gut  
thus   preventing   the   fast   antigen   specific   proliferation441.   LIP   as   a   model   to  
study  autoreactivity  and  peripheral  tolerance  has  also  been  criticized  because  
of  these  discrepancies  between  different  experimental  conditions424.    
Since  the  resources  and  signals  needed  for  LIP  are  limited,  the  T  cells  
must  compete  for  them.  Such  competition  takes  also  place  during  an  immune  
response134  but  during   lymphopenia   it  becomes  more  pronounced,  and  only  
the   cells   with   the   highest   affinity   towards   self-­   or   gut   microbiota-­originating  
antigens  proliferate441.  A  lymphopenic  environment  can  significantly  lower  the  
activation   threshold   needed   for   T   cells   and   thus   predispose   to  
immunopathology424.   The   resulting   T   cell   repertoire   after   LIP   is   biased  
towards  self-­antigen  recognition.  LIP  can  predispose  lymphopenic  animals  to  
autoimmune  manifestations,  such  as  colitis  that  is  described  in  detail  below.  
2.3.3.2.2    Colitis  Triggered  by  Adoptive  Cell  Transfer  of  Naïve  T  Cells  to  
Lymphopenic  Recipients    
Adoptively   transferred  naïve  CD4+  T  cells  cause  chronic  colitis   in  genetically  
lymphopenic   recipient   animals375.   This   model   is   called   the   T   cell   transfer  
colitis   and   it   is   widely   used   for   studying   human   inflammatory   bowel  
diseases289.  Following   the   transfer  of  naïve  T  cells   the  majority  of   recipients  
develop  a  moderate  to  severe  colitis  in  approximately  five  to  eight  weeks.  The  
animals  show  symptoms  such  as  weight   loss,  hunching,  piloerection,  bloody  
or   watery   diarrhea,   and   rectum   prolapse351.   Histopathological   inspection   of  
distal   colon   obtained   from   mice   with   active   disease   reveals   transmural  
inflammation,  epithelial  cell  hyperplasia,  polymorphonuclear  and  mononuclear  
leukocyte   infiltration,   crypt   abscesses,   and   epithelial   cell   erosions351.  When  
the   transfer   is   done   to   RAG-­KO   recipients,   the   small   bowel   can   also   be  
affected352.  The  genetic  background  of  both  the  donor  and  recipient  can  affect  
the  disease  outcome.  For  example,   recipients   that   received  an  adoptive  cell  
transfer  from  an  IL-­10  deficient  donor,  developed  colitis   faster21.  This   finding  
also   highlights   the   importance   of   IL-­10   in   the   maintenance   of   intestinal  
homeostasis.  
CD4+  Th  cells  are   the  most   important   cell  population   in  mouse  colitis  
since  they  are  the  main  population  infiltrating  colon  tissue  in  all  colitis  models  
examined  so  far.  CD4+  T  cells  are  both   important  as  effector  cells  mediating  
the   inflammation   as  well   as   regulators   suppressing   the   inflammation440.   For  
example,  when  CD4+  T   cells  were   depleted   in   vivo,   the   ongoing   colitis  was  
significantly   reduced344.  T  cell  dominance   in   the   inflammation  has  been  also  
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shown   in   human   inflammatory   bowel   diseases,   both   in   colitis   ulcerosa   and  
Crohn’s  disease33,   47.  When  analyzed  more  closely,  Th1  type  cells  appeared  
to  be  important  in  the  initiation  of  colitis,  since  Tbet-­KO  mice  failed  to  develop  
T   cell   transfer   colitis332.   However,   cytotoxic   CD8+   T   cells   alone   could   also  
induce   colitis   when   transferred   to   lymphopenic   hosts446.   Th17   cells   have  
recently   been   described   to   be   important   effector   cells   both   in   the   T   cell  
transfer  model   of   colitis   and   Crohn’s   disease299.   The   relative   importance   of  
different   T   effector   cell   populations   in   the   disease   initiation   remains   to   be  
shown.    
The   colon  microbiota   is   essential   in   the   generation   of   colitis.  Animals  
that   are   housed   in   a   germ-­free  environment   do  not   develop   colitis   and  pre-­
transfer  antibiotic   treatment  ameliorates   the  disease439.  The  disease  severity  
and  the  time  to  symptom  development  after  cell   transfer  also  depend  on  the  
animal  facility  in  which  the  recipients  are  kept188,  435.  The  T  cell  transfer  colitis  
most   likely   results   from   an   overactive   or   dysregulated   immune   activation  
against   gut-­derived   microbial   antigens424.   There   is   evidence   that   also   the  
human   inflammatory   bowel   diseases   result   from   loss   of   tolerance   to   self  
microbiota,  which  could  follow  from  defective  innate  receptor  signaling26.  
2.3.3.2.3    Regulatory  T  cells  in  Lymphopenia-­induced  Proliferation  
T   cell   transfer   colitis   is   prevented   with   a   co-­transfer   of   CD4+   memory-­
phenotype   cells375.   This   finding   prompted   researchers   to   dissect   the  
population  further  and  soon  it  became  evident  that  one  population  preventing  
colitis   is   Tregs226.   The   colitis   could   be   initiated   also   by   the   depletion   of  
CD25high   cells   from   the   cell   transfer16.   However,   this   depletion   changed   the  
scope  of  autoimmune  manifestations  after   the   transfer.  For  example  gastritis  
became   a   more   dominant   symptom   and   if   colitis   developed,   it   was   mild  
compared   with   the   classic   T   cell   transfer   colitis16.   From   these   initial  
observations   it   was   clear   that   Tregs   have   an   important   role   in   the  
maintenance  of   immune  homeostasis  and  tolerance  during  the  reconstitution  
of  lymphocyte  populations.    
   Tregs  can  partially  suppress  the  fast  burst  of  LIP49,  492.  Treg-­mediated  
suppression  of  the  fast  proliferation  is  dependent  on  the  amount  of  Tregs,  i.e.  
the   Treg   /   T   effector   cell   ratio15.   Treg-­mediated   suppression   in   LIP   is   not  
uniform   but,   instead,   it   has   been   reported   that   Tregs   suppress   the   fastest  
proliferating   clones   more   efficiently,   and   thus   maintain   the   TCR   repertoire  
diversity   during   the   proliferation491,   492.   Timing   the   transfer   of   Tregs   a   week  
before  the  adoptive  transfer  of  naïve  T  cells  seems  to  be  more  potent  than  co-­
transfer   in   the   prevention   of   autoimmune   colitis.   Also   in   vitro   activation   of  
Tregs  prior   to   the  adoptive   transfer  provides  a  more  efficient  protection  from  
colitis94.  Therefore,  it  appears  that  the  Tregs  must  be  pre-­conditioned  or  pre-­
activated   in   order   to   effectively   suppress   the   fast   LIP   and   especially   the  
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proliferating  colitogenic  clones.  The  cytokine  IL-­10  is  important  in  the  efficient  
Treg-­mediated   prevention   of   colitis   both   as   an   immunosuppressive   cytokine  
produced  by  the  Tregs  but  also  in  maintaining  the  stable  Treg  pool326.  Innate  
immune  cells,  for  example  gut  epithelial  macrophages,  produce  IL-­10  and  this  
production   appears   to   be   important   in   maintaining   the   suppressive   Treg  
phenotype326.  
   There  are  also  controversial  reports  showing  that  adoptively  transferred  
FoxP3+  nTregs   lose  their  suppressive  potential  as  well  as  FoxP3  expression  
in   LIP.   These   cells   start   to   express   effector   cell   markers   and   also   produce  
effector  cytokines116,  210.  They  have  been  called  “ex-­Tregs”210  and  have  been  
reported   to  acquire  a  Tfh  phenotype  and  efficiently  promote  germinal  center  
reactions   in   gut-­associated   lymphoid   tissue459.   The   reasons   for   this  
phenomenon   are   still   unclear,   but   Th17   polarizing   cytokines   could   prevent  
FoxP3   expression   and   thus   bias   the   response   towards   a   pro-­inflammatory  
Th17   response.   For   example   IL-­6   has   been   identified   as   an   important   pro-­
inflammatory   cytokine   also   driving   the   LIP446.   Summarising   these   conflicting  
data,  Tregs  are   important   in  controlling  the  LIP,  but   their   full   importance  and  
functions   in   a   complex   situation   like   T   cell   homeostasis   are   still   under  
investigation.    
2.3.3.2.4  Lymphopenia  as  a  Co-­factor  in  Human  Autoimmunity  
Lymphopenia   has   been   associated   with   many   human   autoimmune   or  
autoinflammatory   diseases.   Reduced   numbers   of   lymphocytes   have   been  
reported  in  autoimmune  diabetes,  Crohn’s  disease,  and  celiac  disease94.  The  
reason   for   the   lymphopenia   is   obscure   in   these  diseases.   It   can  both   result  
from  defective  production  of   lymphocytes,  as  well  as   increased  apoptosis,  or  
other  forms  of  increased  loss  of  lymphocytes  in  the  periphery.  
   Primary  immunodeficiencies  are  rare  genetic  syndromes  that  are  often  
complicated  with  autoimmune  manifestations  together  with  varying  degree  of  
lymphopenia164.  For  example  Omenn’s  syndrome   is  caused  by  hypomorphic  
mutations   in   the   RAG   gene   that   results   in   severe   defects   in   lymphocyte  
development290.   The   patients   are   lymphopenic   but   also   have   many  
autoimmune  manifestations  such  as  erythrodermia,  lymphadenopathy,  colitis,  
and  alopecia.  Patients  also  suffer  from  recurrent   infections,  chronic  diarrhea,  
and  failure  to  thrive,  which  are  classical  symptoms  of  immunodeficiency.  The  
TCR   repertoire   of   these   patients   is   strongly   biased   with   oligoclonal  
expansions  of  autoreactive  T  cells   that  also   infiltrate   into   target  organs290.  A  
similar  combination  of  immunodeficiency  and  autoimmunity  has  been  reported  
in   the   combined   variable   immunodeficiency–syndrome,   severe   combined  
immunodeficiency  (SCID),  Bruton  agammaglobulinemia,  hyper  IgM  syndrome,  
leukocyte   adhesion   deficiency,   Wiskott-­Aldrich   syndrome,   and   chronic  
granulomatous   disease164.   As   the   defects   behind   primary   immunodeficiency  
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syndromes   can   also   fundamentally   affect   the   development   of   immune  
tolerance,   it   is   not   known   if   lymphopenia   per   se   causes   the   autoimmune  
manifestations   in   these   diseases.   However,   e.g.   the   animal   models   of  
Omenn’s   and   Wiskott-­Aldrich   syndrome   have   suggested   that   dysregulated  
homeostatic  proliferation  would  be  important  in  the  breakdown  of  tolerance164,  
290.  
   Some  patients   suffering   from  cancer   or   severe   autoimmune  diseases  
have   lymphopenia   following   different   treatments   such   as   irradiation,  
chemotherapy,   or   monoclonal   antibody   therapy.   For   some   solid   organ  
transplants,  e.g.  the  heart,  patients  must  be  depleted  of  lymphocytes  in  order  
to   avoid   rejection426.   The   immunosuppressive   therapy   following   the  
transplantation  can  also  cause   lymphopenia.  These  patients   can  sometimes  
suffer  from  autoimmune  manifestations  during  the  immune  reconstitution.    
Patients   infected   with   the   human   immunodeficiency   virus   (HIV)   often  
acquire  various  disease  manifestations  that  can  be  viewed  as  autoimmune  or  
autoinflammatory386.  For  example  diffuse   infiltrative   lymphocytosis   syndrome  
is  a  HIV–specific  disease  that  in  many  ways  resembles  Sjögren’s  syndrome,  a  
systemic   autoimmune   disease.   This   infiltrative   lymphocytosis   affects  
approximately   7%   of   HIV   patients   and   it   is   associated   with   the   HLA-­DRBI  
alleles   (most   usually   HLA-­DRB1*1102,   DRB1*1301,   and   DRB1*1302)386.  
Another   HIV-­specific   auto-­inflammatory   manifestation   is   the   immune  
reconstitution   inflammatory  syndrome  that  manifests  after   the   initiation  of   the  
highly   active   anti-­retroviral   therapy.   This   therapy   results   in   a   dramatic   and  
rapid  increase  in  CD4+  T  cell  counts.  The  immune  reconstitution  inflammatory  
syndrome  is  constituted  of  acute  worsening  of  inflammatory  symptoms  of  pre-­
existing   autoimmune   disease  or   infections174.  Dead   or   dying  microbes,   self-­
structures,  or  commensal  flora  initiate  the  exaggerated  inflammation.  Immune  
reconstitution  syndrome  is  not  a  failure  to  control  infection.  The  clinical  picture  
is   very   variable   and   it   depends   on   the   individual’s   previous   history   of  
opportunistic  infections105,  254.  
Altogether,   it   appears   that   in   humans   lymphopenia   alone   is   not  
sufficient   to   break   tolerance   but   it   can   be   a   co-­factor   in   the   progression  
towards  autoimmunity.  
2.3.4   Regulatory  T  cells  in  Human  Autoimmune  Diseases  
Since   the   convincing   discovery   of   human   Tregs29,   30,   several   reports   of  
dysfunctional   or   reduced   Tregs   in   human   autoimmune   diseases   have   been  
published.  Tregs  can  be  dysfunctional  in  humans  in  several  ways:  1)  defects  
in   thymic   production   of   nTregs   or   peripheral   conversion   of   iTregs   results   in  
inadequate  numbers  of  Tregs,  2)   impaired  activation  or  suppressive  function  
of   Tregs,   and   3)   non-­suppressive   effector   T   cells   can   be   resistant   to   Treg  
mediated  suppression55.  
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2.3.4.1   Methodological   Challenges   in   Studying   Human   Regulatory   T  
Cells    
Several   research   groups   have   published   findings   of   reduced   numbers   of  
Tregs   in   different   autoimmune   diseases.   However,   older   studies   used   non-­
specific   Treg   markers   such   as   CD4+CD25high   and   thus   the   reported   Treg  
population  was  significantly  contaminated  with  activated  effector  T  cells256,  399,  
502.   The   lack   of   established   clinical   reference   values   for   Treg   numbers   has  
made  comparison  between  different  studies  difficult.  The  finding  of  the  FOXP3  
as   a   lineage   specific  marker   solved   the   problem   at   least   to   some   extent55.  
However,  when  it  was  found  that  the  activated  non-­suppressive  effector  cells  
could   transiently   up-­regulate   FOXP3   without   gaining   the   full   suppressive  
phenotype,  the  role  of  FOXP3  as  the  only  marker  for  human  Tregs  had  to  be  
reconsidered.   The   laborious   analysis   of   the  methylation   status   of   the   Treg-­
specific  demethylated  region  is  currently  the  best  way  to  differentiate  between  
transient   FOXP3   up-­regulation,   and   stable   suppressive   high   expression   of  
FOXP3   in   thymus-­originating   nTregs265.   However,   the   methylation   status   is  
impossible  to  measure  in  viable  cells.  
   It   is   not   know   how   well   the   amount   of   Tregs   in   circulating   blood  
correlates   with   the   number   of   Tregs   in   the   inflamed   tissue55.   It   is   also  
challenging  to  select  the  correct  controls  for  studying  Tregs  in  inflammation.  In  
non-­inflamed  tissues  there  are  in  general  very  low  number  of  lymphocytes  so  
the  increase  of  Tregs  in  the  inflamed  tissue  might  be  secondary  to  the  general  
increase   in   lymphocyte  numbers458.  Therefore   the  control   sample  should  be  
equally   inflamed  as   the  studied  material,  but   the   inflammation  should  not  be  
autoreactive.   For   example  osteoarthritis   is   used  as  a   control   for   rheumatoid  
arthritis55.   Studying   Tregs   in   human   autoimmune   diseases   is   challenging  
because   many   diseases   become   symptomatic   only   after   significant   tissue  
destruction   has   taken   place.  This   is   often   a   late   event   considering   the   long  
path  from  the  original  brake  in  immune  tolerance  leading  to  symptoms458  
FOXP3   is   expressed   intracellularly,   and   cells   need   to   be   fixed   and  
permeabilized   before   the   analysis.   Thus   it   is   difficult   to   get   viable   FOXP3+  
cells   for   functional   analysis   from   human   patients399.   When   low   CD127  
expression  was   identified   to  be  a  Treg-­specific  marker283   together  with  other  
surface   markers,   viable   Treg   isolation   became   more   efficient90.   However,  
since  we  do  not  know  the  exact  mechanisms  how  Tregs  mediate  suppression  
in   vivo,   their   function   is  difficult   to  measure,  and  all   the  suppression  assays  
used  in  vitro  are  still  unprecise399.  
   Most  of  these  methodological  problems  faced  in  humans  can  be  solved  
in  mice  by  using  a  green  fluorescent  protein  marker  genetically   linked  to   the  
FoxP3  expression131,   132.  With   this   genetic   construct   it   is   possible   to   closely  
follow   the   fate   of   Foxp3   expressing   cells   in   vivo   and   also   to   isolate   viable  
suppressive  cells.  Since  this  is  a  powerful  tool,  a  significant  proportion  of  data  
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on  Treg  development  and  functions  has  been  gained  from  these  mice400.  Also  
the  importance  of  Tregs  in  the  prevention  of  autoimmunity  is  mostly  based  on  
findings   in  mouse  models   of   autoimmunity.   However,   it   must   be   noted   that  
mouse  models  of  autoimmunity  differ  in  many  ways  from  the  human  diseases  
and  represent  simplified  versions  of  the  clinically  diverse  human  conditions307,  
319.   There   are   several   differences   in   the   human   Tregs   compared   to   their  
mouse  counterparts399.    
2.3.4.2   Regulatory  T  Cells  in  Human  Autoimmune  Diseases  
Tregs   have   been   extensively   studied   in   multiple   sclerosis   (MS)   that   is   a  
relapsing   and   remitting   tissue   specific   autoimmune   disease   affecting   the  
central  nervous  system.  No   reduction   in   the   total  number  of  circulating  Treg  
has  been  reported55,  but  when  Treg  subpopulations  were  analyzed,  the  naïve  
Treg   population   was   decreased   in   MS   patients   as   compared   to   healthy  
controls179,   474.   Tregs   in   MS   patients   also   failed   to   suppress   auto-­antigen  
driven   antigen-­specific   proliferation   as   well   as   polyclonal   proliferation180,   475,  
476.  The  percentage  of  Tregs  among  T  cells   in   the  cerebrospinal   fluid  of  MS  
patients  is  comparable  to  the  proportion  seen  in  blood180  but  still  the  sclerotic  
plaques   in   brain   tissue   contained   very   few   FOXP3+   cells136.   Tregs   isolated  
from  MS   patients   also   showed   increased   sensitivity   towards   apoptosis   and  
dysregulated   homeostasis473.   In   this   organ-­specific   autoimmune   disease  
various   defects   in   the   functions   and   subpopulations   of   Tregs   have   been  
found,  even  though  the  overt  Treg  numbers  originally  appeared  to  be  normal.  
In   rheumatoid   arthritis339   and   type   1   diabetes458   the   amount   of   Tregs   in  
circulation   is   also   generally   reported   to   be   normal,   but   their   suppressive  
function  is  impaired.    
Mouse  studies  have  indicated  that  the  accumulation  of  Tregs  at  the  site  
of   inflammation   is   required   for   effective   suppression.   The   findings   in   MS  
support  this  cellular  contact-­dependent  suppression  mechanism  in  humans  as  
well136.  Conflicting  reports  of   increased  amounts  of  Tregs  in  the  target  tissue  
during   active   inflammation   have   been   published   for   synovial   fluid   in  
rheumatoid  arthritis320,  skin  biopsies  of  psoriatic  lesions  51,  and  gut  biopsies  in  
inflammatory  bowel  diseases  207,   298.   It  should  be  noted   that   these  diseases,  
especially  inflammatory  bowel  diseases,  all  share  many  features  of  the  newly  
designated  autoinflammatory  diseases.  For  example,  in  Crohn’s  disease  Treg  
function  has  been  found  to  be  normal  and  the  amount  of  Tregs  in  circulation  
to  be  increased107,  405.  It  is  possible  that  the  role  of  Tregs  is  different  in  these  
diseases  compared  with  their  role  in  autoimmune  diseases416.  
Non-­suppressive   T   cells   isolated   from   type   1   diabetes   patients   show  
resistance  to   the  Treg-­mediated  suppression268,   409.   It   is  not  yet  known   if   the  
Tregs  are  functionally  defective   in  SLE  because  the  published  data  are  very  
conflicting   (reviewed   by   Gerli149).   However,   in   SLE   the   responder   T   cell  
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resistance  to  Treg-­mediated  suppression  appears  to  be  important470,  472.  The  
responder  cell  resistance  as  a  mechanism  of  tolerance  breakdown  in  humans  
is  supported  also  by  in  vitro  findings  with  Tregs  from  healthy  volunteers29,  30  
   The   pathogenetic   role   of   human   Tregs   in   autoimmune   and  
autoinflammatory   diseases   is   still   largely   unknown.   The   Treg   defects   found  
are   mostly   qualitative   rather   than   quantitative,   and   factors   other   than   the  
Tregs  themselves,  such  as  responder  T  cell  resistance,  have  to  be  taken  into  
consideration.    
  
3   AUTOIMMUNE  REGULATOR  –  GENE    
  
3.1   Autoimmune  Polyendocrinopathy,  Ectodermal  Dystrophy,  
and  Candidiasis  (APECED)  
APECED  is  an  abbreviation  for  autoimmune  polyendocrinopathy,  candidiasis,  
and  ectodermal  dystrophy.  The  other  name  for  the  syndrome  is  autoimmune  
polyendocrine  syndrome  1  (APS-­1)483.  The  clinical  phenotype  of   the  disease  
was   first  described  by  M.F.  Leonard   in  1946273.  Finland  has  a  high   reported  
prevalence  of  the  syndrome  (1:  25  000)  in  the  world228,  and  only  Iranian  Jews  
(1:  9000)519  and  Sardinians  (1:  14  500)390  have  a  higher  prevalence.  Also  the  
Norwegians   have   a   high   prevalence   of   the   disease   (1:   90   000)495   and  
numerous  cases  around  the  world  have  been  reported  (Ireland  prevalence  1:  
130   000112   and   Poland   1:   129   000437).   The   Finnish   patients   are   the   best  
described   ones   with   90   diagnosed   cases   with   follow-­up   data   for   up   to   60  
years  of  age.  APECED  belongs  to  the  Finnish  Disease  Heritage7.  
   APECED   is   caused   by   loss-­of-­function   mutations   in   the   gene  
autoimmune   regulator   (AIRE)129,   328.   In   the   Finnish   patients,   82  %  have   the  
same  mutation  called  the  Finn  major  R257X  indicating  a  founder  effect  in  an  
isolated   population.   Over   60   other   mutations   of   the  AIRE   gene   have   been  
described65.   There   are   also   patients   that   fulfill   the   clinical   diagnostic   criteria  
but  do  not  carry  the  presently  identified  mutations203.  The  Finn  major  mutation  
R257X  is  the  most  common  identified  mutation  also  outside  Finland.  The  vast  
number  of  other  mutations  makes  genetic  diagnostics  difficult65,  121,  410.    
APECED   is   inherited  mainly   in   an   autosomal   recessive  manner   with  
homozygous  carriers  of  the  mutations  affected  with  symptomatic  disease7,  65.  
There   is   one   family   with   a   dominant   mutation   in   Italy.   The   syndrome   is  
generally  the  same  as   in  the  autosomal  form  but  this  mutation   increases  the  
incidence   of   autoimmune   thyroiditis66.   The   dominant   mutation   inhibits  
selectively  the  function  of  the  other  AIRE  allele  that  could  explain  the  different  
inheritage   pattern224.   The   heterozygous   carriers   of   the   recessive   mutations  
appear  to  be  generally  healthy  of  the  clinical  manifestations  of  APECED,  even  
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though   the   issue   has   not   been   extensively   studied.   There   are   conflicting  
results   of   the   potentially   increased   risk   for   autoimmunity   in   the   APECED  
patients’   siblings   but   these   studies  have  been  done  with   a   small   number  of  
patients  and  thus  need  confirming57,  64,  411.    
3.1.1   Clinical  Phenotype  of  APECED  
In   monogenetic   diseases   the   clinical   phenotype   is   generally   relatively  
constant.  This,  however,   is  not  the  case  for  APECED.  The  syndrome  can  be  
different   even  between   siblings   bearing   the   same  mutation   and   living   in   the  
same  environment.  Symptoms  manifest  on  average  at  the  age  of  five,  but  the  
variation   is   from  0.2   to  18  years363.  The  first  disease  component   is  normally  
oral   candidiasis  and   it   is  also   the  most  common  disease  component  among  
Finnish   patients.   The   majority   of   patients   have   different   mucosal   or   skin  
Candida  infections  at  least  periodically.  The  Finn  major  mutation  is  associated  
with   a   high   incidence   of   candidiasis183   while   in   the   Iranian   patient   cohort  
candidiasis   is   relatively   rare519.   Even   though   the   patients   have   an  
immunodeficiency   against   Candida   spp.   they   do   not   present   general  
susceptibility   towards   other   fungal,   bacterial,   or   viral   pathogens363.   Candida  
infections  are  generally   limited   to  the  epithelial  surfaces  of   the  body,  namely  
gastrointestinal  tract,  skin,  nails,  and  mucosal  surfaces  of  the  genitalia.  Deep  
invasive   Candida   infections,   or   other   severe   infections,   are   reported   only  
rarely   and   they   generally   are   associated  with   immunosuppressive   treatment  
for  autoimmune  components  of  the  syndrome378.  
It   is   generally   accepted   that   two   of   the   most   common   disease  
components  are  required  for  the  APECED  diagnosis.  Chronic  mucocutaneous  
candidiasis   is   almost   always   present   at   the   time   of   diagnosis,   while  
hypoparathyroidism   and   Addison’s   disease   are   the   most   common  
endocrinopathies.   However,   the   accuracy   of   clinical   diagnosis   has   been  
questioned,  because  very  mild  or  atypical  phenotypes   in   individuals  with   the  
disease   causing  genotype  have  been   reported371.  Currently,   since   the   gene  
test  is  available,  the  diagnosis  is  confirmed  with  identification  of  the  mutation.  
The  mean   diagnostic   delay   in   Italian   patients   was   10.2   years   from   the   first  
symptoms   to   genetically   confirmed   APECED   diagnosis300.   It   has   also   been  
suggested   that   the   presence   of   auto-­antibodies   against   type   I   interferons  
could  be  used  for  diagnosis  instead  of  laborious  genotyping306.    
The   other   common   endocrine   components   in   the   syndrome   include  
gonadal   failure,  hypothyroidism,  and  type  1  diabetes363.  Patients  often  suffer  
from   different   gastrointestinal   symptoms   such   as   chronic   diarrhea   or  
constipation.   Gastrointestinal   manifestations   are   believed   to   be   a   result   of  
autoimmunity   towards   the  neuroendocrine   cells   of   the   gut.  Another   possible  
explanation   is   chronic   exocrine   pancreatitis   and   following   malabsorption228.  
Other   autoimmune  manifestations   found   in   APECED   are   hepatitis,   gastritis,  
   49  
pernicious  anemia,  and  most  recently  autoimmune  lung  disease  with  varying  
symptoms12,  96.  
Ectodermal   dystrophy   is   seen   in   patients   as   enamel   hypoplasia,   nail  
dystrophy,   alopecia,   and   vitiligo241.   Keratopathy   can   result   in   blindness.  
Enamel   dysplasia   combined   with   the   choric   candidiasis   in   the   mouth   often  
results   in   poor   oral   health.   Collins   et   al.79   suggested   that   the   classical  
ectodermal   dystrophy   components   (nail   and   enamel   dystrophy)   found   in  
APECED  could  in  fact  result  from  chronic  infections.  Alopecia  and  vitiligo  can  
be  classified  also  as  autoimmune  manifestations  of  the  skin  and  hair  follicles.  
Inflammation   appears   to   have   a   role   in   the   disease   progression   since  
immunosuppressive  medication   is  often  effective   in   the  APECED-­associated  
keratinopathy.   Thus   Collins   et   al.   have   questioned   whether   APECED  
syndrome  actually  has  an  ectodermal  dystrophy  component  at  all79.    
The   incidence   of   oral   carcinoma   is   significantly   higher   in   APECED  
patients385.  Apparently  oral  cancer  is  the  result  of  chronic  inflammation  of  the  
mucosa   due   to   the  Candida   infection   and   is   not   associated   with   the   AIRE  
deficiency   itself44,   466.   The   incidence   of   other   cancers   appears   to   be   normal  
amongst   APECED   patients   except   for   anecdotal   reports   of   hematological  
malignancies106,  204.  
Virtually   all   patients   have   more   than   two   disease   components,   and  
cases   of   up   to   ten   different   endocrine   or   ectodermal   components   in   one  
individual  have  been  reported.  On  an  average  the  patients  have  four  disease  
components5.  Patients  can  acquire  new  disease  components  throughout  their  
life,  which   is  once  again  an   indicator  of   the  high  variability  of   the  syndrome.  
The  disease  components  of  AEPCED  are  summarised  in  Table  2  on  page  50.  
3.1.2   Autoantibodies  in  APECED  
APECED   patients   have   multiple   different   autoantibodies428.   Their  
pathogenetic   role   in   the   development   of   the   syndrome   is   largely   unknown.  
Most  tissue-­specific  autoantibodies  are  targeted  against  intracellular  enzymes  
such   as   cytochrome   P450   enzymes   of   the   liver428.   A   parathyroid   antigen  
called  NALP5  was  identified  to  be  the  target  of  common  autoantibodies  found  
in  APECED  patients:  49%  of  patients  with  APECED  and  hypoparathyroidism  
were   positive   for   autoantibodies   targeted   to   NALP513.   Other   APECED-­
associated  autoantibodies  and  their  known  antigens  are  summarised  in  Table  
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The  diagnostic  value  of  autoantibodies   in  APECED  varies  a   lot.  Most  
autoantibodies  are  common   in  other  autoimmune  diseases  as  well  and   thus  
their   diagnostic   sensitivity   for   APECED   is   low.   Autoantibodies   can   often   be  
found  before  the  onset  of  clinical  symptoms  and  therefore  they  can  be  used  to  
predict   disease   progression   for   gonadal   failure   or   Addison’s   disease6.  
However,  the  predictive  value  of  autoantibodies  is  quite  low  for  diabetes247.  
Neutralizing   autoantibodies   targeted   against   type   I   interferons   (IFN),  
especially   IFN-­? ? ????? ??? ??? ??? ?????????? ?????? ?????? ??????????????? ????
found  at  an  exceptionally  high   rate.  100%  APECED  patients  are  positive   for  
autoantibodies  targeted  to  IFN-­?,  -­?8,  or  -­?2305.  Anti-­IFN  antibodies  are  even  
present  before  diagnosis   in  high   titers241.   In  addition   to  APECED,   type   I   IFN  
auto-­antibodies   have   been   found   only   in   patients   that   have   thymomas,   but  
with  lower  prevalence  and  titers64,  243,  305.  IFN  antibodies  may  also  have  a  role  
in  the  pathogenesis  of  APECED.  Kisand  et  al.243  reported  that  patient-­derived  
IFN-­?   targeted   autoantibodies   caused   a   down-­regulation   of   multiple   IFN-­
regulated  genes  in  immature  DCs  isolated  from  APECED  patients.  The  effect  
was   reversed   when   the   cells   were   futher   cultured   without   the  
autoantibodies243.  
Recently,   two   independent   groups   showed   that   the   majority   of  
APECED   patients   have   neutralizing   autoantibodies   against   Th17-­type  
cytokines  IL-­22  and  IL-­17242,  380.  The  patients  also  have  less  IL-­22  producing  
cells.  Th17  cells  are   important   in  the  protection  against  Candida   infections81,  
so   the   autoantibodies   could   be   associated   with   the   Candida-­specific  
immunodeficiency  seen  in  APECED  patients.  Indeed,  the  autoantibodies  were  
found   in   APECED   patients   that   had   chronic   mucocutaneous   candidiasis.  
Similar   autoantibodies   were   also   found   in   patients   suffering   from   chronic  
mucocutaneous   candidiasis   without   APECED380.   IL-­22   and   IL-­17   cytokine  
antibodies  were  associated  with   the  Finn  major  mutation242.  Puel  et  al.  were  
able  to  identify  autosomal  recessive  and  dominant  mutations  in  the  IL-­17  gene  
in  patients  with  chronic  mucocutaneous  candidiasis  disease  that   is  not  AIRE  
associated379.  This  finding  further  consolidates  the  importance  of  IL-­17  in  the  
protection   against  Candida.   Thus   neutralizing   auto-­antibodies   against   IL-­17  
could  explain  at  least  partially  the  specific  immunodeficiency  towards  Candida  
spp.  found  in  APECED241.    
It   is  not  known  why  candidiasis  in  APECED  is  only  limited  to  skin  and  
mucosal   surfaces   even   though   the   autoantibodies   are   found   systemically.  
Ahlgren  et  al.  recently  showed  that  peripheral  blood  monocytes  isolated  from  
APECED  patients  produce  more   IL-­17A  than  healthy  controls   in  response  to  
Candida   stimulation4.  However,  Kisand  et     al.   reported   that  peripheral  blood  
mononuclear  cells  (PBMC)  of  APECED  patients  produce  significantly  less  IL-­
17F,   and   one   patient   also   showed   reduced   IL-­17A   production   in   a   similar  
setting242.   IL-­17A   production   varies   also   in   healthy   controls   in   response   to  
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Candida-­stimulation   so   the   variance   in   results   could   reflect   methodological  
differencies241.   Both   groups   agreed   that   IL-­22   production   was   significantly  
lower   in   patients   with   chronic   mucocutaneous   candidiasis   with   or   without  
APECED   as   compared   to   healthy   controls4,   241.   IL-­22   producing   cells   are  
preferentially   found   in   the   skin   and   mucosal   surfaces506.   IL-­22   therefore  
appears   to   be   more   important   in   the   epithelial   immune   response   towards  
Candida  in  APECED.  
  
Table  3:  Autoantibodies  in  APECED  





21-­OH   adrenal  cortex   Addison's  disease   66   428  
17a-­OH   adrenal  cortex,  
gonads  
Addison's  disease   44   428  




52   428  
AADC   liver   hepatitis   51   428  
TPH   Intestinal  serotonin  
producing  cells  
gastrointestinal  dysfunction   48   118  
HDC   gut   gastrointestinal  dysfunction   37   241  
TG   thyroid   hypothyroidism   36   241  
TPO   thyroid   hypothyroidism   36   241  
TDRD6   pituary  gland      49   241  
TH   hair  follicles   alopecia   44   201  
GAD65   endocrine  pancreas   diabetes   32   247  
CYP1A2   liver   hepatitis   8   428  
TSGA10   testis      8   241  
IA-­2   endocrine  pancreas   autoimmune  diabetes   7   428  
CaSR   parathyroid   hypoparathyroidism   50-­86   144  
SOX9   melanocytes   vitiligo   15   200  
SOX10   melanocytes   vitiligo   22   200  
NALP5   parathyroid   hypoparathyroidism   49   13  
KCNRG   bronchial  epithelium   autoimmune  lung  disease   7   12  
type  I  IFNs   soluble      100   305  
IL-­22   soluble   candidiasis   91   242  
IL-­17   soluble   candidiasis   75   242  
  
3.1.3   Other  Genetic  Factors  Affecting  APECED  Phenotype  
HLA-­association  analyses  with  the  disease  components  have  shown  that  the  
incidence  of  type  1  diabetes,  Addison’s  disease,  and  alopecia  are  associated  
with  the  same  HLA  type  II  molecules  as   in  non-­APECED  patients  with  these  
diseases183.   No   HLA   class   II   association   could   be   found   for  
hypoparathyroidism  in  Italian  patients64.  The  small  number  of  patients  makes  
large-­scale  HLA-­association   studies   very   hard.   In   the   Finnish   patient   cohort  
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no   clear   HLA   profile   for   other   disease   components   or   component  
combinations  could  be  found183  
Associations  between  different  APECED  causing  mutations  and  certain  
phenotypical   patterns   have   been   difficult   to   find.   There   is   a   high   number   of  
different   APECED-­causing   mutations   and   a   small   number   of   patients   with  
each  mutation.  However,   the  Finn  major  mutation  R257X   in   the  AIRE   gene  
has   an   association   with   a   higher   incidence   of   chronic   mucocutaneous  
candidiasis183,   242.   On   the   other   hand,   in   the   unique   Sicilian   family   with   a  
dominant-­negative   p.G228W   substitution   in   AIRE,   the   patients   have   a   low  
incidence  of   candidiasis   but   an   exceptionally   high   incidence   of   autoimmune  
thyroiditis.   This   mutation   is   inherited   in   dominant   fashion   with   a   lower  
penetrance  of  the  full  APECED  phenotype66,  306.  Another  AIRE  mutation,  that  
is  common  in  the  Italian  APECED  patients,  was  associated  with  a  later  onset  
of  Addison’s  disease65.  
Gender  is  an  important  risk  factor  in  autoimmune  diseases  as  generally  
females   are  more   often   affected.   In  APECED  males   have   been   reported   to  
manifest   a  milder   APECED   phenotype   characterized  with   later   onset   and   a  
lower   incidence   of   hypoparathyroidism178,   437.   Men   also   suffer   less   from  
hypogonadism428   than   females   but   this   finding   could   also   result   from   the  
immuno-­privileged  status  of  testicles.    
3.1.4   Other  Human  Diseases  that  Have  Association  with  Reduced  
AIRE  Expression,  AIRE  Mutations,  or  Polymorphisms  in  AIRE  
Since   the   discovery   of   AIRE   and   the   understanding   of   its   vital   role   in  
maintaining   immunological   tolerance  many  autoimmune  diseases  have  been  
analyzed   for   different   AIRE-­haplotypes   that   might   increase   or   decrease  
disease   susceptibility.   Associations   of   the   increased   risk   for   disease   and  
SNPs   in   AIRE   have   been   found   for   systemic   sclerosis   associated   with  
autoimmune   thyroiditis125.   Recently,   Terao   et   al.   reported   also   a   strong  
association  with   two  SNPs   in  AIRE  and  rheumatoid  arthritis   in   the  Japanese  
patients451.  These  polymorphisms   in   the  Japanese  population  affected  AIRE  
expression  level  which  could  be  the  mechanism  explaining  the  association451.    
For   melanoma,   three   protective   SNPs   in   AIRE   were   identified   in   healthy  
controls80.  
Contradictory  reports  on  SNPs  in  AIRE  have  been  published  for  vitiligo233,  
448,  alopecia367,  449,  485,  and  childhood  autoimmune  hepatitis  type  1110,  266.  The  
importance  of  AIRE  polymorphisms  remains   to  be  shown   in   these  diseases.  
No   association   with   AIRE   mutations   or   polymorphisms   has   been   found   in  
autoimmune  polyendocrine  syndrome  type  2,  isolated  autoimmune  Addison’s  
disease45,  467,  type  1  diabetes463,  sporadic  idiopathic  hypoparathyroidism160,  or  
polyglandular  autoimmunity109.  In  all,  AIRE  polymorphisms  are  not  associated  
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with   common  autoimmune   single   endocrinopathies   even   though  all   of   these  
diseases  are  components  of  the  APECED  syndrome.  
  Hypomorphic  mutations  in  the  RAG  genes  in  humans  cause  the  Omenn’s  
syndrome   that   is   composed   of   both   immunodeficiency   and   severe  
autoimmune  manifestations290.  Cavadini  et  al.   reported  that  AIRE  expression  
was  significantly   reduced   in   two  patients  with  Omenn’s   syndrome63.   Loss  of  
AIRE  expression  could  explain  some  of  the  autoimmune  manifestations  in  this  
syndrome  even   though   the  clinical  pictures  of   these   two  diseases,  Omenn’s  
syndrome  and  APECED,  are  not  overlapping290.  
   Thymoma   is   a   rare   neoplasmic   tumor   of   the   thymus.   Thymomas   are  
often   complicated   by   various   paraneoplastic   autoimmune  manifestations,   of  
which  myasthenia  gravis   is   the  most  common  one.  Up   to  95%  of   thymomas  
do  not  express  AIRE,   or   the  expression   is  greatly   reduced407,   445.  Thymoma  
patients  are  thus  chimeric  for  AIRE  expression  because  their  remnant  thymus  
tissue  and  secondary  lymphoid  organs  maintain  the  normal  AIRE  expression.  
However,   they   do   not   generally   develop   APECED-­like   symptoms438,   expect  
for  one   reported  case73,  even   though   the   IFN  auto-­antibodies  are  commonly  
found  in  both  diseases241.  Myasthenia  gravis  per  se  is  not  associated  with  the  
loss  of  AIRE  expression  in  thymoma293.  
  
3.2   Mouse  Models  of  APECED  
3.2.1   Aire-­deficient  Mouse  Models  
When   human   AIRE   was   found,   the   mouse   homologue   Aire   was   quickly  
identified42,   480   and   KO   mouse   models   were   created.   The   two   first   strains  
reported,   Peltonen’s384   and   Mathis’20   mice,   are   both   in   the   C57BL/6  
background.  Aire-­deficient  mice  in  B6  and  B10  backgrounds  have  a  relatively  
mild  autoimmune  phenotype,  which  is  consistent  with  the  reported  resistance  
to  autoimmune  diseases  in  these  inbred  strains450.  Aire-­/-­  animals  in  BALB/c  or  
SJL   background   have   generally   more   pronounced   autoimmune  
manifestations.  Gastritis  is  typical  for  the  BALB/c  strain146.  It  is  evident  that  the  
background   strain   has   a   significant   impact   on   the   scope   and   severity   of  
autoimmunity   in   Aire-­deficient   mice232.   The   most   common   autoimmune  
manifestations   are   reduced   fertility,   autoimmunity   against   retina,   gastritis,  
salivary   gland   inflammation,   and   exocrine   pancreatitis.   Aging   increases   the  
frequency  of  the  autoimmune  manifestations195.  
Aire-­deficient   mice   do   not   develop   similar   autoantibodies   as   the  
APECED  patients220,   374.  Ahlgren  et  al.4   reported   that  Aire-­deficient  mice  are  
more   susceptible   to   Candida   albicans   infection   in   the   gastric   mucosa.  
However,  mice  with   the  same  genetic  deletion   in  a  different  background  are  
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not  susceptible  to  Candida220.  Increased  Candida  susceptibility  has  not  been  
found  in  any  other  Aire-­deficient  strain.  
So   far   four   different   Aire-­KO   strains   have   been   described   and   their  
phenotypes  are  summarised  in  Table  4  on  pages  56-­57.  
3.2.2   Aire  deficiency  in  Autoimmunity-­prone  Background  Strains  
Both  Mathis’   mice   and  Matsumoto’s   Aire-­deficient   mice   have   been   crossed  
with   the  autoimmune  diabetes  prone  NOD  strain232,   334.   In  both   cases,  Aire-­
deficient   mice   in   NOD   background   developed   a   very   severe   autoimmune  
syndrome  characterized  by  weight  loss  and  increased  mortality.  Jiang  et  al.232  
reported   that   generalized   pneumonitis  was   the  major   reason   for   lethality.   In  
Niki’s   mice,   the   main   autoimmune   manifestation   was   a   severe   exocrine  
pancreatitis334  that  was  also  evident  in  Jiang’s  mice.  Interestingly,  even  in  the  
NOD   background,   both   Aire-­/-­NOD   mice   strains   were   completely   protected  
from   diabetes.   Given   the   complex   background   of   autoimmunity   in   NOD  
mice18,   it   is   hard   to   estimate   why   the   loss   of   Aire   has   such   contradicting  
effects   on   the   NOD   phenotype,   namely   protection   from   diabetes   but  
acceleration  of  the  other  disease  components.    
   Chen   et   al.71   crossed   the   Mathis’   Aire-­/-­   mice   with   Scurfy   (FoxP3sf)  
mice.  Scurfy  have  a  spontaneous  mutation  in  FoxP3  gene  and  these  mice  do  
not   have   functional   Tregs.   Aire-­/-­FoxP3sf   mice   developed   an   autoimmune  
syndrome   that   was   more   severe   than   in   either   one   of   the   parental   strains  
alone.  All  Aire-­/-­FoxP3sf  mice  had  to  be  euthanized  before  the  age  of  28  days.  
The   lethal   autoimmune   manifestations   in   these   double-­deficient   mice   were  
lung   inflammation   and   necrotizing   hepatitis71.   The   animals   did   not   produce  
significant   levels   of   autoantibodies.   Also   many   organs   affected   in   the   Aire-­
deficient   mice   in   the   B6   background   were   almost   completely   devoid   of  
infiltrates.   This,   however,   could   result   from   the   young   age   of   the   studied  
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FoxP3  deficiency  combined  with  Aire  deficiency  thus  resulted  in  severe  
autoimmunity.   This   finding   could   indicate   that   peripheral   tolerance   and  
especially  Tregs  are  important  in  suppressing  autoreactive  T  cell  clones.  Teh  
et  al.   studied   the   importance  of  peripheral   tolerance  with   the   loss  of  Aire  by  
crossing  Aire-­/-­  mice   in   the  B10  background  with   four  different  mouse  strains  
with   known   defects   in   peripheral   tolerance450.   Defects   in   activation-­induced  
cell   death   of  mature   T   cells,   or   inhibition   of   inducible   T   cell   co-­stimulator   –  
mediated  co-­stimulation  and   loss  of  Tfh  cells  did  not  affect   the  phenotype  of  
Aire-­/-­  mice449.  The  resulting  double-­deficient  mice  had  comparable  symptoms  
with   their  single-­deficient  counterparts.  The  authors  also  crossed  Aire-­/-­  mice  
with  a  strain  that  has  a  point-­mutation  in  caspase  recruitment  domain  family,  
member  11  (Card11)   that   is  a  critical  scaffold  protein  needed  for  example   in  
the   TCR   signaling.   These   Card11-­/-­   mice   have   been   reported   to   have  
defective   TCR   and   CD28   signaling   that   results   in   a   decreased   amount   of  
FoxP3+   Tregs.   Contrary   to   the   results   seen   in   Aire-­/-­FoxP3sf   mice,   these  
double-­deficient  animals  stayed  overtly  healthy  with  no  findings  exceeding  the  
phenotype  of  the  parental  strains450.  
   Casitas   B-­lineage   lymphoma   ubiquitin   ligase   (Cblb)   is   an   important  
molecule  in  the  generation  of  T  cell  anergy218.  It  is  up-­regulated  in  mature  and  
anergic   T   cells   where   it   inhibits   co-­stimulatory   signaling   and   T   cell  
proliferation,  i.e.  it  is  a  negative  controller  of  T  cell  activation  like  CTLA-­4218.  In  
mice  that  have  a  KO  mutation  in  this  molecule,  T  cells  are  released  from  the  
strict   need   for   co-­stimulation   through   CD28.   These   mice   do   not   show   any  
signs  of  overt  autoimmunity  or  T  cell  hyperproliferation.  However,  when  Teh  et  
al.450   crossed   these  mice  with   Aire-­deficient  mice,   the   resulting   double-­KOs  
developed   a   severe   autoimmune   exocrine   pancreatitis   that   necessitated  
euthanaziation  of  animals  on  at  the  age  of  25  days  an  average.  The  animals  
also  had  sialoadenitis  and  mild  gastritis,  together  with  autoantibodies  targeted  
to   exocrine   parts   of   pancreas   and   salivary   glands.   All   symptoms   were  
transferable   with   total   splenocytes   from   double-­deficient   animals   to  
lymphopenic  healthy  recipients  indicating  that  the  disease  was  likely  mediated  
by   lymphocytes.   Both  CD4+   and  CD8+   T   cells   were   required   to   transfer   the  
disease450.  Since  Cblb  has  multiple  functions  in  the  adaptive  immune  system,  
it  is  difficult  to  estimate  how  the  double-­deficiency  of  Aire  and  Cblb  resulted  in  
synergistic  development  of  autoimmunity.    
3.2.3   Experimental   Induction   of   Autoimmunity   in   Aire-­deficient  
Mice  
Considering   the   variable   phenotypes   and   impact   of   aging   in   Aire-­deficient  
mice,   environmental   factors   are   potentially   important   in   the   breakdown   of  
tolerance.   Gray   et   al.168   tested   if   treatments   with   various   innate   immunity  
stimuli  would  have  an  effect  on  the  autoimmunity  in  Aire-­/-­  mice  B6  and  NOD  
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backgrounds   (Mathis’   mice).   Innate   immune   system   signaling   did   not   have  
any  significant  impact  on  the  severity  or  onset  of  autoimmune  manifestations.  
Also  animals  kept  in  a  germ-­free  conditions  developed  similar  disease  as  their  
counterparts  kept   in  normal  animal  facility.  Microbial  colonization  is  therefore  
not  needed  for  the  development  of  autoimmunity  in  Aire-­/-­  mice.  
   Aire-­deficient   mice   showed   increased   susceptibility   to   chemically  
induced  autoimmune  diabetes194.  Surprisingly,  the  mice  heterozygous  for  Aire  
had  the  highest  frequency  of  diabetes  after  the  chemically  induced  pancreatic  
beta  cell  destruction.    
   Aire-­deficient   mice   in   the   C57BL/6   background   showed   increased  
susceptibility   to   experimental   autoimmune   myasthenia   gravis,   where  
autoimmunity   to   the   acetylcholine   receptor   is   induced   by   immunization   with  
the   autoantigen22.   The   disease   susceptibility   was   not   uniform,   but   younger  
Aire-­deficient  mice  were   partially   protected   from   the  disease   compared  with  
wild-­type   controls.  On   the   contrary,   aged  Aire-­deficient  mice   showed   higher  
disease   scores.   In   an   experimental   autoimmune   encephalomyelitis   model  
Aire-­deficient  mice  became  symptomatic  significantly  earlier  than  the  wild-­type  
mice,  but   the  disease  severity  was  not  affected248.   In  an  experimental  model  
for   rheumatoid  arthritis,   the  collagen-­induced  arthritis,   the  Aire-­deficient  mice  
became   symptomatic   faster   and   had   a   more   severe   disease   after  
immunization59.   In   all   these   immunization   models   of   autoimmunity,   the  
autoantigens  used  are  expressed  under  the  control  of  Aire  in  the  thymus  but  
Aire-­deficient   animals   do   not   show   signs   of   autoimmunity   targeted   to   these  
autoantigens  spontaneously.  The  tolerance  is  broken  only  after  immunization  
with  an  adjuvant.  Thus   the  breaking  of   tolerance   in  Aire-­deficient  animals   is  
often  dependent  on  environmental   factors,  such  as  strong   inflammation   that  
the  adjuvant  initiates.    
  
3.3   Autoimmune  Regulator  (AIRE)  Gene    
3.3.1   The   structure   of   AIRE   and   Structural   Implications   for   Its  
Function    
AIRE  gene  is  located  in  the  q22  region  of  chromosome  21129.  Its  product  AIRE  
is   a   nuclear   protein   545   amino   acids   long.   AIRE   has   several   functional  
domains  that  indicate  its  function  as  a  transcriptional  regulator  and  chromatin-­
binding   protein:   caspase-­recruitment   domain,   two   plant   homeodomain   zinc  
fingers,   four  nuclear-­receptor-­binding  motifs,  and  a  proline-­rich   region   that   is  
common   with   transcription-­associated   proteins295   (see   Figure   5).   However,  
AIRE   is   not   a   typical   transcription   factor   because   it   can   promote   the  
expression   of   thousands   of   genes   and   the   transcriptional   start   sites   can   be  
different  from  those  required  for  the  genes’  expression  outside  the  thymus295.  
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AIRE   influences  a   large  number  of  genes  when   introduced   into  different  cell  
lines,   but   the   spectrum   of   genes   affected   is   different   from   one   cell   type   to  
another172,  248.  The  genetic  distribution  of  genes  affected  by  AIRE  is  clustered,  
but  the  same  cluster  can  contain  AIRE-­dependent  and  -­independent  genes101  
further   arguing   against   AIRE   functioning   as   a   classical   sequence-­specific  
transcription  factor.    
   In   the   cell,  AIRE   is   found  mainly   in   the   nucleus   but   it   has   also   been  
found  in  fibrillar  structures  in  the  cytoplasm39.  In  the  nucleus,  it  is  concentrated  
in  nuclear  bodies  that  are  located  in  close  proximity  of  nuclear  speckles,  but  it  
is  also  found  in  the  nucleoplasm40.  This  kind  of  nuclear  distribution   is  well   in  
line  with  the  functional  domains  indicating  a  role  of  AIRE  in  the  transcriptional  
regulation184.  
The   precise   manner   of   how   AIRE   regulates   gene   expression   is   still  
elusive.   The   identified   AIRE   mutations   in   APECED   patients   have   provided  
some  insight  into  the  functions  of  the  AIRE  protein182.  The  regions  in  the  gene  
associated  with  nuclear  and  cytoplasmic  localization  and  zinc-­finger  domains  
are  rather  conserved  between  the  murine  and  human  homologues  of  AIRE42,  
480  but  especially  the  proline-­rich  region  and  the  DNA-­binding  “human  Sp100,  
Aire1,   NucP41/P75,   and   Drosophila   DEAF1   domain”   (SAND)   domain   show  
little   overlap   between   mammalian   species403.   Most   APECED  mutations   are  
found  in  evolutionally  conserved  regions  of  the  AIRE  gene403.    
The  SAND  domain  seems  to  be  needed  for  the  nuclear  localization  of  
AIRE,   and   it   possesses   a   regulatory   function   in   the   homomultimerization   of  
AIRE182,   224,   384.  Two  different  SNPs   located   in  SAND  have  been  associated  
with  decreased  AIRE  expression450.  Mutation  in  the  SAND  domain  of  AIRE  is  
the   only   APECED   mutation   inherited   in   a   dominant   fashion.   Autoimmune  
thyreoditis   is   especially   common   in   the   clinical   phenotype   following   this  
mutation66,   224.   The   mechanism   behind   this   different   inheritance   pattern  
appears   to   be   caused   by   an   inhibition   of   the   normal   allele   by   the  mutated  
protein224.  The  same  mutation  also  affected  HLA  class  II  expression  in  thymic  
epithelial  cells456.  
   In  vitro  experiments  indicate  that  AIRE  has  a  preferential  DNA  binding  
capacity  both  by   the  SAND  domain  and   the  zinc   fingers257.  Considering   the  
large  pool  of  genes  under  AIRE  control,  it  seems  unlikely  that  AIRE  functions  
only  as  a  direct  DNA  binding   transcription  factor.  As  a  proof  of  AIRE’s  more  
general   involvement   in   transcription   regulation,   many   proteins   that   work   in  
concert   with   AIRE   have   been   identified2.   AIRE   is   found   in   large   molecular  
weight  complexes182.  Recently  45  molecular  partners  of  AIRE  were  reported2.  
They   could   be   categorized   to   four   different   functional   groups:   nuclear  
transport,   chromatin   binding   /   structure,   transcription,   and   messenger  
ribonucleic  acid   (mRNA)  processing.  AIRE  was   found   to   have   the   strongest  
impact  on  pre-­mRNA  splicing2  and  this  could  explain  how  TSA  expression  is  
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more  efficient   in  MECs  expressing  AIRE.  The  correctly  spliced  RNA  is  more  
stable  and  the  translation  can  be  carried  out  longer.    
AIRE   has   a   preferential   binding   capacity   for   unmethylated   histones  
through   the   first  plant  homeodomain   -­   type  zinc   finger348.  This   indicates   that  
AIRE   has   potentially   a   wider   epigenetic   control   over   the   inactive   parts   of  
chromatin,  and  thus  it  promotes  the  expression  of  otherwise  silent  antigens251,  
347.   However,   binding   to   the   unmethylated   histones   does   not   completely  
explain   the   transcriptional   activity   of   Aire.   In   a   mouse   model   with   targeted  
mutation  to  the  histone  binding  element  in  Aire,  the  mutation  affected  most  but  
not  all  of  the  genes  that  the  Aire-­null  mutation  affected250.  AIRE  has  also  been  
connected,   together  with  other  molecules,  with   the  activation  of   stalled  non-­





Figure   5:   A   schematic   presentation   of  AIRE  protein   domain   structure.   Locations  of  
the  APECED  causing  mutations  are  indicated  by  arrows.  CARD,  caspase-­recruitment  
domain;;   PHD,   plant   homeodomain   zinc   finger;;   LXXLL   sequence,   nuclear-­receptor  
binding  motif;;  PRR,  proline  rich  region.  
  
3.3.2  AIRE  expression  
3.3.2.1     Aire  Expression  in  the  Thymus  
The   highest   level   of   AIRE   expression   can   be   found   in   the   thymus   in   the  
mTECs40,   129,   328.  However,   only  a   fraction  of  all  mTECs  express  Aire100,   154.  
Suzuki   et   al.   found   AIRE   expression   in   human   double-­positive   thymocytes  
and  thymic  B  lymphocytes444.  Also  human  thymic  DCs  express  AIRE161.    
In  the  mouse,  Aire  expression  in  the  thymus  is  restricted  almost  entirely  
to  mTECs   and   these   cells   are   enriched   in   the   cortico-­medullary   junction521.  
Murine  thymic  DCs  show  only  very   low  expression  of  Aire521.     Aricha  et  al.22  
studied   thymic   Aire  mRNA   expression   in   different  mouse   strains   and   found  
that   the   C57BL/6   mice   have   spontaneously   the   lowest   Aire   expression   as  
compared  to  SJL  and  BALB/c  mice.    
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3.3.2.2     Aire  Expression  Outside  the  Thymus  
The   expression   of   AIRE   outside   of   the   thymus   has   been   long   debated.   At  
mRNA  level,  Aire  and  AIRE  transcripts  were  found  from  multiple  solid  tissues  
but   the   protein   expression   was   more   difficult   to   determine119.   This   is   most  
likely  the  result  of  different  splice  variants,  and  the  varying  affinity  of  the  used  
poly-­   and   monoclonal   antibodies119,   221.   In   human   and   mouse   extra-­thymic  
tissues   AIRE   and   Aire   expression   has   been   confirmed   both   at   mRNA   and  
protein  level  in  the  spleen  and  lymph  nodes3,  184,  202,  203,  372.  A  few  groups  have  
been  able  to  show  AIRE  expression  in  PBMCs184,  373,  444.  It  can  be  concluded  
that  AIRE  and  Aire  are  expressed  in  secondary  lymphoid  tissues  outside  the  
thymus  but   its  expression  in  other  tissues  remains  to  be  confirmed.  Different  
methods  used  have  given  confusing  reports  especially  in  mouse  solid  tissues.  
The   reported   positive   and   negative   AIRE   protein   expression   in   human   and  
mouse  tissues  are  summarised  in  Tables  5  (page  63)  and  6  (page  64).    
   Lee   et   al.271   found   that   murine   lymph   node   stroma   contains   Aire-­
expressing   cells.  Gardner  et   al.   studied   this   population   further   in   transgenic  
mice  using  a  green  fluorescent  protein  marker143.  The  authors  described  Aire  
expression   in   mouse   stroma-­originating   non-­DCs   in   lymph   nodes   and   the  
spleen   that   they   called   extrathymic   Aire-­expressing   cells143.   These   cells  
resembled   DCs   in   their   gene   expression   profiles   and   they   also   expressed  
MHC  class  II  molecules,  but  no  co-­stimulatory  factors  (CD80  or  CD86),  or  the  
DC   marker   protein   CD11c.   Interestingly,   extrathymic   Aire   expressing   cells  
also   expressed   a   variety   of   tissue   specific   antigens   like  mTECs   do   but   the  
expression  profiles  in  these  cells  were  different143.  These  Aire+  cells  were  able  
to  delete  autoreactive  T  lymphocytes  from  peripheral  T  cell  pool,  even  though  
the  study  did  not  confirm  the  role  of  Aire  in  the  peripheral  deletion.  
3.3.2.3     Aire  Expression  in  Embryos,  Fetuses,  and  Neonates  
There   are   conflicting   reports   on   Aire   expression   during   mouse  
embryogenesis.   First,   the   expression   was   found   to   be   associated   with   the  
initiation   of   the   thymic   organogenesis   on   the   embryonic   day   14521.   Another  
study   did   not   detect   Aire-­expressing   mTECs   before   embryonic   day   16487.  
However,  recently  it  was  shown  that  significant  Aire  expression  can  be  found  
already   on   embryonic   day   6.5336.   This   Aire   expression   starts   just   before  
gastrulation   that   is   the   division   of   the   three   primary   tissue   layers,   namely  
ectoderm,   mesoderm,   and   endoderm.      The   authors   speculated   that   if   the  
expression  pattern  of  human  AIRE  is  similar  to  tht  in  mouse,  the  lack  of  early  
AIRE  expression  might  explain  the  ectodermal  dystrophy  in  APECED336.    
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Table  5:  Reported  positive  AIRE  and  Aire  protein  expression  in  tissues.  
Tissue   Human   Mouse   References  
thymus   X   X   3,  184,  202,  203,  221,  372,  384,  408  
spleen   X   X   3,  184,  203,  271  
lymph  node   X   X   3,  184,  203,  271,  372  
tonsils   X      372  
gonads      X   3,  408  
kidney      X   3  
lung      X   3  
PBMC   X   X   184,  444  
fetal  liver   X   X   3,  203  
liver      X   384  
bone  marrow      X   184  
brain      X   3,  384  
gut  (goblet  cells)      X   3  
fallopian  tubes      X   3  
gut  associated  lymphoid  
tissue  
X      372  
     
One  mouse  model  of  conditional  Aire  expression  has  been  developed  
in   NOD   background171.   Aire   expression   was   conditionally   turned   off   in   the  
thymus   epithelium   at   different   time   points,   namely   during   organogenesis,  
neonatally,   or   in   adult   animals.   In   this   model,   the   mice   developed   a   full  
autoimmune   syndrome  only   if  Aire   expression  was   turned  off   in   the   thymus  
during  embryogenesis  and  the  neonatal  period.  If  thymic  Aire  expression  was  
turned   on   after   weaning   of   the   mice,   all   mice   were   protected   from   the   full  
autoimmune  syndrome171.  In  mice,  Aire  expression  in  the  thymus  before  birth  
might  therefore  be  more  important  than  in  later  life.  Adamson  et  al.3  found  that  
there  are  dynamic  changes  in  Aire  expression  in  mice  during  the  fetal  period  
and  Aire  expression  decreased  towards  delivery.  In  human  fetal  tissue,  AIRE  
expression  has  been  seen  only  in  the  thymus  and  liver203,  372.  The  expression  
level  of  AIRE  in  relation  to  gestation  time  has  not  been  studied.      
   64  
Table  6:  Reported  negative  AIRE  and  Aire  protein  expression  in  tissues.  
Reported  contradicting  results  are  indicated  with  an  asterisk.  
  
Tissue   Human   Mouse   References  
spleen   X   X*   202,  221,  372  
lymph  node      X*   202,  221  
gonads   X   X*   202,  203,  372  
kidney   X   X*   202,  203,  372  
lung   X   X*   202,  203,  372  
PBMC     X*      203,  372  
liver   X   X*   3,  203  
brain   X      372  
bone  marrow   X      372  
bowel   X      372  
heart   X   X   3,  203,  372  
pancreas   X      203,  372  
skin   X      203  
skeletal  muscle   X   X   203,  372  
adrenal  gland   X   X   3,  184,  202,  203,  372  
thyroid  gland   X      203,  372  
eye   X      372  
mammary  gland   X      372  
salivary  gland   X      372  
*  Contradictive  results     
     
3.3.2.4     Factors  Controlling  Aire  Expression  
Aire   up-­regulation   in   immature  mTECs   appears   to   be   controlled   by   specific  
signals,   such   as   Receptor   Activator   of   Nuclear   Factor   ?   B   and   CD40  
signaling8,  391,  487,  but  the  exact  molecular  network  controlling  Aire  expression  
is   still   unknown.  The   three-­dimensional   structure   of   the  mTECs   is   important  
for  Aire-­expressing  cells,  since  the  expression  of  Aire  is  decreased  when  the  
thymic  structure  is  disturbed176.  Mature  thymocytes,  however,  are  not  needed  
for  Aire  expression486  supporting  the  view  that  Aire-­expressing  mTECs  are  a  
specialized  population   that  diverge   from  other   thymic  epithelial   cells  already  
during  thymic  organogenesis185,  297.  
In  several  mouse  models  the  expression  of  Aire  has  been  found  to  be  
defective   or   lacking.   From   these   models   it   has   been   possible   to   identify  
   65  
signaling   pathways   and  molecules   that   are   involved   in   Aire   expression:   the  
lymphotoxin   pathway76,   RelB   transcription   factor   274,   adaptor   molecule  
TRAF68,  and  NF?B130,  513.  In  these  models  the  thymic  architecture  is  disturbed  
and  mTEC  numbers  are   low.  Therefore   it   is  hard  to  differentiate  whether  the  
loss  of  Aire   is  secondary   to   the   loss  of  mTECs   in  general.  For  example,   the  
importance  of   the   lymphotoxin  pathway   for   the  expression  of  Aire  has  been  
widely  questioned292,  391,  471.  
  
3.3.3  The  Functions  of  AIRE  
Table  8  on  page  73  briefly  summarises  the  suggested  functions  of  Aire  in  the  
thymus   and   peripheral   immune   system.   In   the   following   sections,   these  
functions  are  described  in  more  detail.  
3.3.3.1     Aire  in  the  Thymus  Development  and  Tissue  Organization  
Originally   the   thymus   architecture   in   Aire-­deficient   mice   was   considered  
normal20,   384   and   research   focused  mainly   on   the   transcriptional   aspects   of  
Aire  driving   the  expression  of  TSAs   in  mTECs.  Gillard  et  al.154  carried  out  a  
more  detailed  analysis  of  the  thymic  cellular  departments  and  noticed  several  
differences   in   the   thymic  morphology   in  Aire-­deficient  animals.  For  example,  
Aire-­deficient  animals   lacked  a  mTEC  population  staining  clearly  positive   for  
Ulex  europaeus  agglutinin  1,  a  marker  generally  used  for  the  thymic  epithelial  
cells154.  This  could  indicate  that  Aire-­deficient  mTECs  are  not  fully  maturated  
or  functional  since  they  do  not  express  mature  mTEC-­associated  markers311.  
In   Aire-­deficient   thymus,   the   morphology   and   distribution   of   mTECs   is  
concentrated   in   the  medulla,   instead  of  cortico-­medullary   junction  as   in  wild-­
type  normal  thymus500.  In  the  same  study,  the  authors  reported  that  Hassall’s  
corpuscle-­like   structures   are   almost   completely   absent   in   Aire-­deficient  
thymuses.   Therefore   the   loss   of   Aire   significantly   affects   the   thymus  
morphology,   which   indicates   that   Aire   is   necessary   for   normal   thymus  
development.  
Thymic   epithelial   cells,   both   cortical   and   medullary,   originate   from  
common   bipotent   progenitors.   Aire-­expressing   cells   have   been   generally  
considered   to   represent   the   terminally  differentiated  population  of  mTECs297  
Recently,  however,   it  has  been  shown   that  Aire  expression  stops  before   the  
terminal   differentiation   of   mTECs336.   Hamazaki   et   al.185   found   that   tight  
junction   components   claudin-­3   and   claudin-­4   are   preferentially   expressed   in  
Aire-­expressing  mTECs  but  their  expression  is  not  dependent  on  Aire.  During  
the   thymic   organogenesis   claudin-­3   and   claudin-­4   positive   cells   were  
identified   as   progenitors   for   Aire-­expressing   cells.   This   finding   suggests   a  
specific  differentiation  program  for  Aire  expressing  cells185.    
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Supporting   the   view   that   Aire   is   essential   for   thymic   organogenesis,  
Gillard  et  al.154   found   that  Aire   controls   the  expression  of  Nanog,  Oct4,  and  
Sox2,  which  are  transcription  factors  critical  in  maintaining  the  multipotentiality  
in   progenitor   cells154.   In   addition   to   these   genes,   Aire   also   controls   the  
expression   of   different   transcription   factors,   for   example   a   number   of   bone  
morphogenetic   proteins   that   are   involved   in   many   important   immunological  
processes   such   as   cytokine   production,   lymphocyte   homeostasis,   and  
activation   392.   Aire   has   been   associated   with   the   expression   of   various  
chemokines19   and   cytokines406   in   the   thymus,   and   it   takes   part   in   the  
intrathymic  migration  of  developing  thymocytes262.  The  precise  role  of  Aire  in  
thymic  development  and  thumus  function  remains  to  be  clarified.  
3.3.3.2   Aire,  Peripheral  Tissue  Antigen  Expression   in   the  Thymus,   and  
Central  Tolerance  
Aire’s   best-­described   function   is   in   promoting   the   ectopic   expression   of  
peripheral  TSAs  in  mTECs.  TSAs  are  vital  in  the  negative  selection  and  clonal  
deletion   of   the   autoreactive   developing   thymocytes   as   discussed  
previously477.  The  data   supporting   this   view  come  mainly   from  Aire-­deficient  
mice   models.   mTECs   from   Aire-­/-­   and   wild-­type   mice   were   isolated   and  
genome-­wide  micro-­array  analysis  showed  that  the  expression  of  large  part  of  
TSAs,  such  as   insulin,     was  Aire-­dependent20.  Many  of   these  antigens  have  
later  been  shown   to  be   the   targets   for  autoimmune  attacks   reported   in  Aire-­
deficient   mice   but   there   are   also   autoimmune   manifestations   targeted   to  
antigens   whose   expression   in   the   thymus   was   unaffected   by   the   loss   of  
Aire259,   334,   392.   Table   7   summarises   the   auto-­antigens   that   are   targets   of  
autoimmunity  in  Aire-­deficient  mice  and  their  expression  in  thymus.  
Negative  selection  involves,  in  addition  to  ectopic  TSA  expression,  the  
clonal   deletion   of   thymocytes   reactive   to   them.  The  association   of  Aire  with  
clonal  deletion  was  established  in  transgenic  mouse  systems.  Liston  et  al.281  
utilised   a   neo-­self-­antigen   hen   egg-­lysozyme   that   was   placed   under   Aire-­
dependent   tissue   specific   transcription   promoter   (rat   insulin   promoter).   The  
model-­antigen   transgenic   mice   had   also   their   TCR   loci   replaced   with   a  
monogenic   TCR   specific   for   the   neo-­self   antigen,   so   that   all   developing   T  
lymphocytes   were   specific   for   it.   With   normal   Aire   expression,   the   model  
antigen   was   expressed   in   the   thymus   and   all   developing   TCR-­transgenic  
thymocytes  were   deleted,   i.e.   the   animals  were   tolerized.  When   these  mice  
were   crossed   with   Aire-­deficient   mice,   the   model-­antigen   reactive   TG-­TCR  
expressing   mature   T   cells   escaped   to   periphery   and   autoimmune   diabetes  
developed   because   the   insulin   promoter   also   drove   the   expression   of   the  
model  antigen  in  pancreatic  ?-­cells281.  
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Table  7:  The  role  of  Aire  in  the  expression  of  autoantigens  in  the  murine  thymus.  
Autoantigen   Disease  association  
Thymic  expression    
in  Aire-­/-­mice   Ref.  
Interphotoreceptor  retinoid-­
binding  protein  
retinitis   reduced   102  
Mucin  6   gastritis   reduced   146  
Seminal  vesicle  secretory  
protein  2  
prostatitis   reduced   214  
Type  II  collagen  
collagen-­induced  
arthritis  






reduced   248  
Acetylcholine  receptor    
experimental  
myasthenia  gravis  
reduced   22  
?-­fodrin   Sjögren's  syndrome  like  exocrine  inflammation   unaltered   259  
Odorant  binding  protein  1a  
keratoconjunctivitis  
sicca  
reduced   103  
Pancreatic  protein  disulfide  
isomerase  
exocrine  pancreatitis   unaltered   334  
Experimental  autoimmune  
prostatitis  antigen  2  
experimental  
autoimmune  prostatitis  
unaltered   392  
Vomeromodulin   interstitial  lung  disease   reduced   419  
RIP-­OVA  (transgenic)   insulitis   unaltered   19  
RIP-­HEL  (transgenic)   insulitis   reduced   281  
  
Anderson  et  al.19  used  a  similar  genetic  construct  as  Liston  et  al.,   i.e.  
the   rat   insulin   promoter,   but   used   ovalbumin   as   the   model   antigen.  
Surprisingly,  ovalbumin  expression  levels  were  unaffected  by  the  loss  of  Aire  
expression.   Even   though   the   model   antigen   expression   in   the   thymus   was  
independent   of   Aire,   the   loss   of   Aire   resulted   in   the   escape   of   pancreatic  
ovalbumin-­specific   T   cell   clones   to   periphery   where   they   caused   a   lethal  
autoimmune  diabetes19.  Anderson  et  al.  concluded  that  Aire  has  an  important  
role   in   clonal   T   cell   depletion,   and   it   is   not   necessarily   limited   solely   to   the  
ectopic   TSA   expression19.   Indeed,   they   showed   that   the   loss   of   Aire  
influenced  an  array  of  other  genes  as  well,  especially  many  genes  associated  
with  antigen  processing  and  homing   (for  example  chemokines).  Aire  did  not  
only   up-­regulate   these   genes,   but   in   some   cases   the   gene   was   down-­
regulated  in  an  Aire-­dependent  manner19.  
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In   models   where   different   antigens   were   abundantly   expressed,   for  
example   the  male  antigen  model,   the   loss  of  Aire  had  no  effect  on  negative  
selection19.   Also   in   transgenic   systems   using   systemic   promoters   the   neo-­
antigen-­specific   T   cells   were   not   deleted280.   Using   another   TG-­TCR   and  
model  antigen  combination,  Liston  et  al.  were  able  to  demonstrate  the  role  of  
Aire   is   negative   T   cell   selection   also   in  mice   heterozygous   for   the   Aire-­KO  
mutation280.  This  dose-­dependent  effect  of  Aire  on  negative  selection  has  not  
been   reported   in  other  mouse  models.  On   the  other  hand,  using  a  promoter  
that   was   specific   for   the   thyroid   tissue,   autoreactive   T   cells   escaped   to  
periphery,   but   did   not   cause   a   disease280.   Therefore,   in   transgenic   models  
Aire   is   involved   in   the   thymic  expression  of   tissue  specific  antigens,  but  not  
that  of  systemic  antigens.  However,  the  impact  of  Aire  on  TSA  expression  in  
the   thymus   is   not   always   predictable,   as   is   highlighted   by   two   different   rat-­
insulin  promoter  constructs  with  contrasting  results19,  281.  
In  transgenic  models  Aire  is  clearly  involved  in  negative  selection  of  T  
cells.   Whether   or   not   this   is   linked   to   Aire-­driven   TSA   expression   can   be  
questioned.   Current   published   data   linking   the   loss   of   Aire   expression   to  
defective   clonal   deletion   and   following   autoimmunity   are   all   derived   from  
transgenic  models.  Spontaneous  autoimmunity  against  endogenous  antigens,  
whose  expression  in  the  thymus  is  controlled  by  Aire  in  the  thymus,  has  been  
reported102,  103,  146,  214,  419.  These  findings,  however,  are  not  sufficient  to  prove  
that   the   autoimmune   inflammation   results   from   defective   negative   selection  
per  se.  Aire  deficiency  and   loss  of  TSA  expression   in   the   thymus  could  also  
affect  the  maintenance  of  peripheral  tolerance.  However,  autoimmune  attacks  
in  Aire-­deficient  animals  are  also  targeted  to  antigens  whose  expression  in  the  
thymus   is  unaltered  by   the   loss  of  Aire259,   334,   392.  This  discrepancy  could  be  
explained  by  the  role  of  Aire  in  antigen  expression  on  a  more  general  level  for  
example  through  decreased  HLA  expression19,  456.    
A  relatively  small  population  of  mTECs  expresses  Aire,  and  on  a  single  
cell  level  it  has  been  shown  that  a  given  mTEC  expresses  only  a  limited  array  
of   TSAs100.   The   thymus   must   express   a   huge   array   of   TSAs   to   maintain  
effective  central   tolerance.  Thus,  Aire  cannot  be   the  only   transcription   factor  
involved   in   TSA   expression.   It   is   not   known   how   the   constant   wide   pool   of  
TSAs  is  maintained  in  the  thymic  medulla,  and  what  is  the  role  of  Aire  in  this  
phenomenon.   Aire+   mTECs   are   rapidly   proliferating   and   they   have   a   very  
short  lifespan113,  124,  167.  This  has  been  suggested  to  facilitate  TSA  expression  
since  the  thymic  DCs,  that  surround  the  mTECs,  phagocytose  apoptotic  cells  
and   can   then   cross-­present   the   TSAs   they   acquire   during   this   process140.  
Recently,   Hubert   et   al.   showed   that   Aire   drives   the   antigen   transfer   from  
mTECs   to   thymic   DCs219.   Aire   has   also   been   suggested   to   drive   the  
accumulation  of  DC  to  the  thymus  medulla272.  Thymic  DCs  have  been  shown  
to   be   important   in   the   negative   selection99.   The  mechanisms   they   utilise   to  
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mediate  deletional   tolerance  are  still  unknown.  Approximately  50%  of  thymic  
DCs   migrate   from   the   circulation   to   the   thymus   and   therefore   can   carry  
antigens   from   other   parts   of   the   body,   including   non-­self   antigens99.   Aire-­
dependent  antigen  transfer  to  thymic  DCs  expands  the  role  of  Aire   in  thymic  
negative  selection  even  further  and  may  explain  some  of  the  earlier  conflicting  
results.  
In   the  human   system,   there   have  been  a   few   reports   linking  AIRE   to    
TSA  expression  in  the  thymus155,  447.  Giraud  et  al.155  showed  that  AIRE  affects  
the  thymic  expression  of  CHRNA1,  a  gene  that  encodes  for   the  ?-­subunit  of  
muscle   acetylcholine   receptor,   which   is   the  main   target   of   the   pathogenetic  
autoantibodies  in  autoimmune  myasthenia  gravis.  Aricha  et  al.22  showed  that  
acetylcholine   receptor   expression   is   also   reduced   in   the   thymuses   of   Aire-­
deficient  mice.    
3.3.3.3     Aire  and  Cell  Populations  Developing  in  the  Thymus    
Li  et   al.274   found   that   there   is   a   developmental   arrest   of   thymocytes   at   late  
thymic   developmental   stages   in   the   Aire-­deficient   mice.   This   finding   was  
repeated  by  Hubert  et  al.219.  The  peripheral  major  T  cell  populations,  however,  
have   been   reported   to   be   normal   in   Aire-­deficient   mice20,   220,   369,   384.   Aire  
deficiency   apparently   does   not   have   any   impact   on   the   non-­self   antigen  
recognizing   TCR   repertoire235   even   though   some   small   alterations   in   the  
general  peripheral  TCR  repertoire  of  the  Aire-­/-­  mice  have  been  found220,  384.  In  
the   peripheral   T   cell   pool,   Aire-­/-­   mice   have   more   T   cells   with   activated   or  
memory   phenotype   but   this   is   most   likely   the   result   of   an   inflammatory  
process  seen   in  these  mice20,   220.  Therefore,   it  seems  that  Aire  has  a  role   in  
the   thymic  T  cell  development,  which   is  a  highly  selective  process  and  does  
not  lead  to  overt  imbalance  in  the  peripheral  T  cell  populations.    
There   are   other   cell   populations   than   ??   T   cells   that   originate   and  
develop  in  the  thymus.  T  cells  with  the  ??-­TCR  develop  normally  without  Aire  
460.   Thymic  metallophilic  macrophages,  which   have   been   reported   to   act   as  
APCs,  also  develop  normally   in  Aire-­deficient  mice310.  Thymus-­derived   iNKT  
cells   were   first   believed   to   develop   normally   in   Aire-­deficient   mice,   even  
though   reduced   numbers   were   noticed   in   the   spleen369.   Recently   Lindh   et  
al.276  reported  a  detailed  analysis  of  the  iNKT  cells  in  both  Aire-­deficient  mice  
and  APECED  patients.  The  number  of   iNKT  cells  was   reduced   in  both  mice  
and   human   patients,   and   iNKT   cells   were   dysfunctional   in  mice.   They   also  
found   that   thymus-­originating   NK   cells   developed   normally   without   Aire,   as  
well   as   conventional  NK   cells   developing   in   the   bone  marrow276.   The   lower  
frequency  of   iNKT  cells   in  APECED  patients  was   later   confirmed   in  another  
study333  
Motivated   by   the   additive   effect   of   FoxP3   deficiency   in   Aire-­deficient  
mice,   many   groups   have   studied   Aire’s   influence   on   nTreg   development.  
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Originally  the  Treg  population  was  reported  to  be  normal  both  in  numbers  and  
function  in  Aire-­deficient  mice19,  20.  A  more  detailed  analysis  showed  that  the  
TCR  repertoires  of  Tregs  were  unaltered  in  Aire-­deficient  animals92.  Hubert  et  
al.220   summarised   their   own   results   and   the   data   published   by   others   and  
claimed  that   in  Aire-­/-­  animals  there   is  a  trend  of  decreased  Treg  numbers   in  
the   periphery.   Hubert’s   own   data,   however,   did   not   reach   statistical  
significance.  Aricha  et  al.22   found  a  clear   reduction  of  FoxP3+  Tregs   in  Aire-­
deficient   thymuses.   The   percentage   of   Tregs   was   not   affected   in   the  
peripheral  immune  system  in  young  mice,  but  it  reduced  when  the  mice  aged.  
Also   FoxP3  mRNA   expression   level   was   lower   in   aged   Aire-­/-­   mice   than   in  
their  wild-­type  controls.  This  finding  could  explain  the  earlier  negative  results  
since  the  previous  studies  have  generally  been  done  in  younger  animals.  
Aschenbrenner  et  al.25  were  able  to  target  model  antigen  expression  to  
Aire+  mTECs  by   inserting  their  TG-­antigen  sequence  under  the  control  of  an  
Aire   promoter.   When   mice   that   had   only   these   model   antigen-­expressing  
mTECs  were  crossed  with  the  model  antigen-­specific  TG-­TCR  mouse  strain,  
the   thymuses   of   these   mice   produced   an   increased   proportion   of   FoxP3+  
nTregs25.  Thus   is   is  possible   to   speculate   that  Aire+  mTECs  are   involved   in  
the   generation   of   nTregs.   It   should   be   noted,   however,   that   the   setting  
Aschenbrenner   used   was   highly   modified   and   was   far   from   a   normal  
polyclonal  nTreg  development.    
A  recent  study  by  Lei  et  al.272  linked  XCL-­1  chemokine  produced  solely  
by   Aire-­expressing   mTECs   to   the   correct   homing   of   thymic   DCs   that   drive  
nTreg  development.  Without  Aire,  the  chemokine  was  not  produced  in  thymic  
medulla,   no   DCs   accumulated   in   the   medulla,   and   a   reduced   number   of  
nTregs   was   produced.   They   also   found   that   lymphocytes   adoptively  
transferred  to  lymphopenic  recipients  from  mice  deficient  in  XCL-­1  developed  
autoimmune  dacryoadenitis  similarly  to  Aire-­deficient  mice272.  
3.3.3.4   The   Functions   of   Aire   in   Dendritic   Cells   and   on   Other  
Components  of  the  Innate  Immune  System  
Aire  is  expressed  also  in  DCs  both  in  mice  and  humans,  and  many  functional  
disturbances   in   the   Aire-­deficient   DCs   have   been   found.   APECED   patients  
have  a  higher  proportion  of  circulating  monocytes,  i.e.  the  precursors  of  tissue  
DCs,   than   healthy   individuals209.   The   populations   of   monocytes   and   both  
CD11b+  and  CD11c+  DCs  are  increased  in  Aire-­/-­  mice  in  the  body  cavity  and  
in  the  circulation383.  DCs  from  Aire-­deficient  mice  also  express  high   levels  of  
the   vascular   adhesion  molecule  VCAM-­1   indicating   a   potential   defect   in  DC  
homing383.  AIRE  over-­expression  in  a  transfection  study  using  a  monocyte  cell  
line  up-­regulated  several  molecules  involved  in  cell  adhesion,  chemokine  and  
cytokine   signaling   indicating   that  AIRE-­expression   could   be   required   for  DC  
trafficking421.  
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In  Aire-­deficient  mice  less  monocyte  precursors  were  found  in  the  bone  
marrow  than  in  wild-­type  mice195.  These  few  precursors  proliferated  at  a  high  
rate195.  Therefore  there  appears  to  be  a  maturation  defect  in  Aire-­/-­  mice,  and  
also  a  premature  exit  of  Aire-­/-­  monocytes  from  the  bone  marrow,  which  could  
explain  the  increase  in  the  monocyte  counts  in  the  circulation195.  This  finding  
should   be   considered  with   caution,   as   it   is   not   generally   accepted   that   Aire  
would   be  expressed   in   the  bone  marrow  or   in  monocytes.  Halonen  et  al.184  
found   murine   Aire   expression   in   the   bone   marrow   but   this   finding   has   not  
been  repeated.  Poliani372  reported  that  human  bone  marrow  was  negative  for  
AIRE  expression.      
DCs  from  patients  or  Aire-­deficient  mice  activate  T  cell  hybridomas   in  
vitro  more   than   normal  DCs383.  Consistent  with   this,   a   study   by  Ryan  et   al.  
showed   that  monocyte-­derived  DCs   from  APECED   patients   produced  more  
tumor   necrosis   factor   ?   and   expressed   more   co-­stimulatory   factor   CD86  
without  any  stimulation  in  comparison  with  healthy  controls396.  Another  study,  
however,  described  that  DCs  from  APECED  patients  produced  less  cytokines  
as   a   response   to  microbial   stimulus373   indicating   that  DCs  do  not   reach   the  
fully  mature  state  without  AIRE421.  
  The   immunodeficiency   in   APECED   towards  Candida   spp.   has   been  
hypothesised  to  result  from  defects  in  AIRE-­dependent  signaling  pathways  in  
DCs54.  For  example,  the  initiation  of  a  proper  Th17  response  towards  Candida  
is  initiated  in  DCs  through  activation  of  the  innate  receptor  Dectin-­1331.  It  is  not  
known   whether   AIRE   is   involved   in   this   process   even   though   the   pattern  
recognition   receptors,   that   are   important   in   initiating   the   innate   immunity  
response   towards  Candida,   are  unaffected   in  APECED  patients209.   There   is  
some  experimental  evidence  supporting  defective  DC  functions  in  response  to  
Candida   challenge   in   APECED   patients54,   209.   Monocytes   from   APECED  
patients   showed   a   delayed   receptor-­mediated   endocytosis   of   Candida-­
antigens  that  resulted  in  decreased  and  altered  intracellular  signaling  pathway  
activation   in   comparison  with   healthy   controls54,   209.   Phagocyte   function   has  
been   reported   to   be   normal   in   APECED   patients364.   Thus   AIRE-­related  
defects   in   innate   immunity   signaling   appear   to   be   limited   to  monocytes   and  
more  specifically  to  DCs  which  normally  express  AIRE372.    
3.3.3.5     Aire  and  B  cells  
Autoantibodies  are  an  important  part  of  the  APECED  syndrome  even  though  
their   role   in   the   pathogenesis   is   unclear.   However,   autoantibodies   clearly  
indicate  that  also  B  cells  are  dysregulated  when  AIRE  is  absent.  Interestingly  
there   is   one   study   that   found   AIRE   expression   in   human   B   lymphocytes  
indicating   a   potentially   direct   role   of   AIRE   in   humoral   immunity444.   Two  
different  mouse  studies  have  been  published  on  the   importance  of  B  cells   in  
Aire-­deficient  mice  but  their  results  are  conflicting.   In  DeVoss  model104   the  T  
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cells  were  indispensable  for  the  autoimmune  syndrome  in  Aire-­deficient  mice,  
but  B  cells  had  a  limited  role  in  the  disease  progression.  Gavanescu  et  al.145  
challenged   these   results   and   claimed   that   without   B   cells   the   Aire-­deficient  
mice  remained  healthy.    
   Hässler   et   al.195   reported   a   significant   increase   in   the   incidence   of  
marginal   zone   B-­cell   lymphoma   in   aged   Aire-­deficient   mice.   The   authors  
speculated   that   this   could   be   a   result   of   increased   and   prolonged   B   cell  
activation.  They  also  found  that   the   lymphocyte   infiltrates   in  the   liver  of  Aire-­
deficient  mice  were  mostly  composed  of  B  cells195.  This  was  further  supported  
by  the  finding  of  DeVoss  et  al.  that  the  lacrimal  gland  lymphocyte  infiltration  in  
Aire-­deficient  mice  contained  a  significant  proportion  of  B  cells103.  Increased  B  
cell  activation  has  been  suggested  to  result  from  an  increased  concentration  
of  B  cell  activating  factor  of  the  TNF  family  (BAFF)  in  both  APECED  patients  
and  Aire-­deficient  mice277.   Increased  B  cell  activation  appears   to  be  partly  T  
cell   independent,   even   though   a   T   cell   dependent   mechanism   has   been  
reported59.  
The  relative  importance  of  B  cell-­mediated  immune  mechanisms  in  the  
pathogenesis   of   APECED   has   not   been   established.   Considering   the   direct  
immuno-­suppressive  role  of  the  Th17  cytokine-­targeted  autoantibodies,  the  B  
cell  selective  immunosuppressive  mAb  rituximab  could  be  paradoxically  used  
to   treat   chronic   Candida   infection   in   APECED   patients.   As   rituximab   has  
proven   effective   in   the   treatment   of   some   autoimmune   diseases,   especially  
those   with   a   relatively   strong   B   cell-­mediated   pathology,   it   has   been  
suggested   as   a   therapeutical   agent   for   APECED145   together   with   other  
immunosuppressive   agents241.   However,   without   proper   clinical   trials,   its  
effect  is  purely  speculative.  
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Table   8:   The   many   roles   of   Aire.   This   table   summarizes   yet   published   Aire-­
associated  or  Aire-­controlled  immunological  phenomena.  
THE  THYMUS   SECONDARY  LYMPHOID  ORGANS  
The  thymus  tissue  organization113   DC  maturation373,  421  
mTEC  development154,  297,  311,  336,  487   DC  -­  driven  deletional  tolerance143  
Ectopic  TSA  expression    
in  mTECs20,  102,  103,  447   Chemokine  production
383  
Deletion  of  autoreactive  thymocytes280,  281  
Expression  of  homing  receptors    
on  APCs421  
MHC  expression  on  mTECs20,  456   Increased  B  cell  activation59,  195  
Thymocyte  migration262     
Increased  apoptosis  of  mTECs124,  167     
Migration  of  DCs  to  the  thymus  medulla272     
Antigen  transfer  to  thymic  DCs219     
Proportion  of  single-­positive  thymocytes274     
Development  of  thymus    
originating  nTregs22,  272     
Development  of  INKT-­cells276,  369     
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AIMS  OF  THE  STUDY  
  
AIRE  is  an  important  transcription  factor  controlling  the  negative  selection  of  T  
cells.  The  aim  of   this  study  was   to   study   the   role  of  AIRE   in   the  generation  
and  maintenance   of   peripheral   tolerance.   More   specifically   the   aims   of   the  
present  study  were:  
  
  
I   To   study   the   functions   of   regulatory   T   cells   in  APECED  patients   that  
lack  AIRE  expression.    
  
II   To   establish   an   experimental   model   where   Aire   expression   in   the  
thymus  and  peripheral  immune  system  could  be  separated.  
  
III   To  study  the  relative  importance  of  defective  central  or  peripheral  Aire  
expression   in  an  experimental   system   that   is   strongly  biased   towards  
autoreactivity  and  autoimmunity.    
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SUMMARY  OF  THE  MATERIALS  AND  METHODS  
  
The  materials  and  methods  used  are  described   in  more  detail   in  the  original  
publications  I-­IV.    
  
1   Sample  material  
1.1   APECED  Patients  and  Healthy  Controls  (I)  
26  patients  were  analyzed  (14  females).  The  mean  age  of  patients  was  39.8  
years   (range   26-­60).   26   (15   females)   healthy   volunteers   were   used   as  
controls   and   their   mean   age   was   40.2   years   (range   23-­65).   The   disease  
components   of   the   patients   are   summarized   in   Table   9.   All   patients   had  
APECED   diagnosis   that   was   verified   by   sequencing   the   14   exons   and   the  
exon-­intron  boundaries  of   the  AIRE   gene.  The  majority   (21   /   26)  of   patients  
were   homozygous   for   the   Finn   major   mutation   R257X   in   AIRE.   The   HLA  
typing  of   the   patients  has  been   carried   out  previously183.   The  HLA-­matched  
control   subject   used   in   the   TCR   repertoire   analysis   was   identified   among  
donors   studied   in   1996   for   acute   viral   infection327.   The   control   subject   was  
healthy  at  the  time  of  the  sampling  for  the  current  study.    
Table   9:   Summary   of   the   most   common   disease   components   of   the   APECED  
patients  studied.  
Disease  component     No.  of  patients  affected   %  of  patients  affected  
Mucocutaneous  candidiasias   26  of  26   100%  
Addison’s  disease   22  of  26   85%  
Hypoparathyroidism   19  of  26   73%  
Hypogodanism   13  of  26   50%  
Hypothyroidism   9  of  26   35%  
Diabetes   6  of  26   23%  
  
None  of  the  patients  or  controls  received  systemic  immunosuppressive  
treatment  at  the  time  of  the  sampling,  were  pregnant,  suffered  from  infections,  
or  had  any  vaccinations  at  the  time  of  sampling.  Patients  received  appropriate  
hormone   replacement   therapy   for   endocrine   deficiencies   at   physiological  
doses,  and  dihydrotachysterol  and  calcium  treatment  for  hypoparathyroidism.  
These  treatments  should  not  have  any  significant  immunomodulatory  effects.    
1.2   Mice  (II-­IV)  
NOD   and   NOD/Scid   mice   were   maintained   in   the   specific   pathogen   free  
environment   in   the   animal   facilities   of   the   National   Institute   for   Health   and  
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Welfare   (THL),   Turku.   Aire-­KO,   Rag1-­KO,   and   AireRag1-­KO   breeding   was  
done   in   barrier   environment   of   the   THL   animal   facility   in   Helsinki.   Cell  
transfers  were  carried  out   in   the  specific-­pathogen   free  animal   facility  of   the  
same  institute.    
Aire-­/-­C57BL/6  mice  were   produced  as   described  by  Ramsey  et  al.384  
and  maintained  by  heterozygous  sibling  breeding  with  standard  backcrossing  
into   the   C57BL/6   background.   NOD,   NOD/Scid   and   Rag1-­/-­   C57BL/6   mice  
were   originally   purchased   from   the   Jackson   Laboratory   (Bar   Harbor,   ME,  
USA)  and  maintained  by  homozygous  sibling  breeding.  
In   order   to   generate   lymphopenic   Aire-­deficient   mice,   Aire-­/-­C57BL/6  
mice   were   crossed   with   lymphopenic   Rag1-­/-­   mice   in   the   C57BL/6  
background.  The  progeny  was   tested   for   the  Aire  mutation  as   described  by  
Ramsey  et   al.384  and  heterozygotes  were   selected   for   further  breeding.  The  
Rag1-­/-­  phenotype  was  tested  from  F2  generation  onwards  by  flow  cytometry  
with   staining   for   CD3?   +   cells   from   PBMCs.   After   identifying   Rag-­/-­Aire+/-­  
animals  the  strain  was  maintained  by  heterozygous  sibling  breeding,  together  
with  genotypic  and  phenotypic  analysis  as  described  above.  
In   all   experiments   using   Aire-­/-­   mice   the   controls   were   parental,  
syngeneic  wild-­type  mice.  Littermates  were  used  as  often  as  possible.  
1.3   Sample  Collection  and  Cell  Isolation  (I-­IV)  
Animals   were   terminated   by   CO2   suffocation   and   cervical   dislocation   at  
selected   time   points   and   ages.      Selected   organs   were   dissected   and  
examined   macroscopically.   Organs   were   frozen   fresh   in   liquid   nitrogen   for  
RNA   extraction.   For   histological   analysis   the   tissues   were   fixed   in   10%  
formalin.   Spleens   and   lymph   nodes   were   collected   in   phosphate   buffered  
saline  and  mechanically  homogenized  under  sterile  conditions.  Released  cells  
were  collected  and  used  for  future  analysis.  
   In   live  animal  experiments,  blood  samples  were  collected  from  the  tail  
vein   using   heparinized   BD   Mictotainer   tubes   (Becton   Dickinson,   Franklin  
Lakes,   NJ,   USA).   At   termination,   blood   was   collected   into   heparinized  
syringes   by   heart   puncture.   Blood   samples   were   centrifuged   and   plasma  
collected.  Leukocytes  were  isolated  by  lysing  erythrocytes  with  sterile  water  or  
by   Ficoll-­Paque   gradient   centrifugation   (GE   Healthcare   Bio-­Sciences,  
Uppsala,  Sweden).    
   From   human   patients,   blood   samples   were   obtained   with   a   vacuum  
venous   sample   collection   system   into   heparinized   tubes.   PBMCs   were  
isolated  by  Ficoll-­Hypaque  gradient  centrifugation  and  cryopreserved   in  90%  
fetal   calf   serum   and   10%   dimethyl   sulfoxide,   if   not   used   directly   for  
experiments.   For   in   vitro   suppression   assays   cells   were   isolated   from   buffy  
coats  obtained  from  healthy  blood  donors  (Finnish  Red  Cross  Blood  Service,  
Helsinki,  Finland).  
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   Thymic  tissue  was  obtained  from  children  undergoing  cardiac  surgery.  
The   removed   tissue   was   immediately   frozen   in   liquid   nitrogen   or   fixed   in  
formalin.    
If   not   analyzed   immediately,   the   tissue   and   plasma   samples   were  
stored   before   analysis   at   -­70°C.   Frozen   PBMC   samples   from   APECED  
patients  were  stored  before  analysis  in  -­154°C.    
  
2   Magnetic   Bead   Cell   Separation   and   In   Vitro  
Suppression  Assay  (I)  
Anti-­CD25   mAb-­coated   Dynabeads   (Dynal,   Oslo,   Norway)   were   used   to  
isolate  CD25hi  cells  for  in  vitro  suppression  assays.  The  cells  attached  to  the  
beads  were  detached  by  an  overnight   incubation  at  +37°C.  The  purity  of   the  
CD4+CD25hi   cells   was   determined   by   flow   cytometry   and   it   typically   ranged  
between  70  to  90%  (I).    
Human  PBMC  were  cultured  in  duplicate  in  a  96-­well  plate  for  5  days  at  
2   x   105   cells   per   200  ?l   RPMI  medium   (Life   Technologies,   Paisley,   United  
Kingdom),   supplemented   with   10%   heat-­inactivated   human   AB   serum  
(Finnish  Red  Cross  Blood  Service),  20  mM  HEPES,  2  mM  L-­glutamine,  50  ?M  
2-­mercaptoethanol,   100   ?g/ml   streptomycin,   and   100   U/ml   penicillin  
(supplements   from   Sigma   Aldrich,   St.   Louis,   MO,   USA).   The   culture   was  
pulsed  for   the   last  6  hours  with  3H-­thymidine  (1  ?Ci  per  well;;  GE  Healthcare  
Bio-­Sciences),   harvested   with   a   Skatron   harvester   (Newington,   NH,   USA),  
and  analyzed  with  a   liquid  scintillation  counter   (Wallac,  Turku,  Finland).  The  
background   in   non-­stimulated   wells   was   reduced   from   the   results.  
Immobilized  anti-­CD3  mAb,  heat-­killed  Candida  albicans,  phytohemagglutinin  
(Sigma   Aldrich),   and   human   insulin   (Orion   Pharma,   Espoo,   Finland)   were  
used  as  mitogens  in  different  concentrations.  
  
3   Adoptive  Cell  Transfers  (II-­IV)  and  Colitis  Clinical  
Score  (III-­IV)  
Donor   mice   for   adoptive   cell   transfer   experiments   were   selected   from   the  
animal  colonies.  For  each  individual  experiment  KO  and  wild-­type  donor  pairs  
were   littermates.   Cervical,   para-­aortic,   and   axillary   lymph   nodes   were  
dissected   aseptically   and   homogenized   mechanically.   Released   cells   were  
collected,  pooled,  washed,  and  counted.  In  NOD  transfer  experiments  (I)   the  
cells  were  stained  with  monoclonal  antibodies  and  the  transferred  population  
was   sorted   using   flow   cytometry.   In   other   transfer   experiments   (II-­III),   non-­
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selected  bulk  lymphocytes  were  transferred.  A  small  representative  fraction  of  
the  transfer  was  stained  and  analyzed  by  flow  cytometry.  
   All   recipients   were   lymphopenic   female   mice.   The   animals   were  
sedated   before   intravenous   injections   with   a   fentanyl-­fluanisone   drug  
combination   (Hypnorm,   VetaPharma,   Sherburn-­in-­Elmet,   UK).   Cell   amounts  
from  104   to  106  were   injected   to   tail  vein   in  sterile  phosphate  buffered  saline  
(PBS).  All   transfer  experiments  were  performed   independently   for   two  times.  
All  donors  and  recipients  were  housed  in  the  same  animal  facility  in  the  same  
rooms  in  order  to  maintain  a  comparable  environment  during  the  experiment.  
After   the   cell   transfer   the   mice   were   monitored   daily   and   weighed  
weekly.   For  NOD  mice,   the   blood   glucose   level   was  monitored  weekly.   For  
cell  transfers  in  Aire-­deficient  animals  (III-­IV)  clinical  scores  for  monitoring  the  
symptoms  were  adopted  from  Cooper  et  al.82  and  Simpson  et  al.423  with  some  
modifications.   The   following   symptoms   or   signs   at   the   time   of   termination  
were  scored  according  to  their  severity:  wasting  (weight  loss  over  10%,  score  
0-­1),   hunching   (score   0-­1),   thickening   of   the   intestinal   wall   (score   0-­1)   and  
stool  consistency  (score  0-­2,  2  =  grossly  bloody  diarrhea).      
  
4   Polymerase   Chain   Reaction   (PCR)   and  
Sequencing  
4.1   RNA   and  DNA   Isolation,   cDNA  Synthesis,   and  Real-­time  
PCR  (I-­IV)  
Frozen   tissues   were   homogenized   in   Tripure   reagent   (Roche   Applied  
Science,   Indianapolis,   IN,   USA)   using   the   Ultra-­Turrax   apparatus  
(Janke&Kunkel,   Staufen,   Germany)   or   VWR   Pellet   Mixer   (VWR,   West  
Chester,  PA,  USA).  Total  cellular  RNA  was  extracted  using  chloroform  phase  
separation   and   the   RNeasy   mini   kit   (Qiagen,   Crawley,   UK).   If   the   down-­
stream   real-­time   PCR   assay   detected   genomic   DNA,   it   was   removed   with  
DNase   I   (Sigma-­Aldrich)   treatment   if   needed,   and   decontamination   was  
verified  using  real-­time  PCR.  First-­strand  cDNA  was  synthesized  using  AMV  
Reverse  Transcriptase  (Finnzymes,  Helsinki,  Finland)  and  an  oligo-­dT  primer  
(Sigma-­Aldrich).  DNA  was   isolated   using   the  QIAamp  Blood   kit   (Qiagen)   or  
DNA  isolation  was  continued  from  the  Tripure  phenol  phase  as  instructed  by  
the  manufacturer  (Roche).  
   Real-­time   PCR   was   done   using   Taqman   Universal   Master   Mix   and  
Gene  Expression  Master  Mix  (Applied  Biosystems,  Carlsbad,  CA,  USA).  The  
ABI  7900HT  instrument  (Applied  Biosystems)  and  iCycler  iQ  instrument  (Bio-­
Rad,   Hercules,   CA,   USA)   were   used   for   the   real-­time   reaction.   Custom  
primer-­probe   sets   for   mouse   TCR   C?   and   T   cell   receptor   excision   circles  
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(TRECs)   were   synthesized   by   Applied   Biosystems.   For   other   genes,  
commercially  available  TaqMan  assays  were  used  (Applied  Biosystems)  and  
all   assays   were   intron   spanning.   mRNA   expression   data   were   normalized  
against  expression   levels  of  TCR  C?  or  house-­keeping  genes  Hypoxanthine  
phosphoribosyl-­transferase   (Hprt,   mouse),   Glyceraldehyde-­3-­phosphate  
dehydrogenase   (mouse),   and   ?-­actin   (human).   All   samples   were   run   in  
duplicate.   All   real-­time   PCR   analyses   included   a   non-­template   control   to  
exclude  non-­specific  amplification  due  to  contamination.  
4.2   TCR  Repertoire  Analysis  (I-­II)  
The  TCR  repertoire  analysis  was  performed  with  a  method  that  is  called  both  
immunoscope  and  spectratyping89.  Selected  V?-­  or  V?-­specific  primers  were  
used   with   a   C?   or   C?-­specific   primer   to   amplify   the   CDR3   region.   The  
amplified  V  gene  product  was  labelled  in  a  run-­off  reaction  with  a  fluorochome  
FAM-­labeled   internal   C?   ?or   ?C?   primer.   Primer   sequences   used   have   been  
published   by   Pannetier   et   al.359   and   Casanova   et   al.62.   All   primers   were  
synthesized   by   Sigma-­Aldrich   and   the   Amplitaq  Gold   enzyme  was   used   for  
the   PCR   reactions   (Applied   Biosystems).   The   amplification   products   were  
separated   and   visualized   on   a   5%   acrylamide   gel   by   using   an   ABI377  
sequencer   or   ABI3730   Automatic   DNA   Sequencer   instrument   (Applied  
Biosystems).   Fluorescence   data   was   analyzed   with   AbiPRISM   or  
GeneMapper  (Applied  Biosystems)  softwares  respectively.      
The   quantitative   analysis   of   changes   in   the   TCR   repertoire   has   been  
described   previously159.   Areas   of   individual   peaks   in   a   CDR3   length   profile  
were  expressed  as  a  percentage  of  the  combined  areas  of  all  the  peaks  in  the  
profile.  Comparison  of   two  profiles  was  done  by  extracting   the   relative  peak  
areas  of  one  profile   from  the  other.  The  absolute  values  of  differences  were  
summed  and,  because  the  differences  were  counted  as  both  increases  at  one  
place   and   decreases   elsewhere,   the   sum   was   divided   by   two,   putting   the  
values   within   the   range   of   0   –   100   %.   For   human   samples,   cord   blood  
(samples   acquired   from   Finnish   Red   Cross   Blood   Service)   TCR   repertoire  
was   used   as   a   reference   for   naïve   TCR   repertoire.   For   establishment   of  
mouse  naïve  repertoires,  cDNA  extracted  from  neonatal  mice   thymuses  was  
used.  
4.3   Sequencing  (II)  
Recipient  mouse  splenocyte  cDNA  was  amplified  with  the  selected  V?  and  C?  
primers  used  for  TCR  repertoire  analysis.  If  the  original  CDR3  region  was  not  
oligoclonal  enough,  the  amplification  products  were  further  separated  on  a  9%  
acrylamide   gel   with   electrophoresis.   The   gel   was   stained   using   the   Silver  
Sequence   DNA   Sequencing   system   (Promega,   Madison,   WI,   USA).   The  
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chosen  bands  were  excised  and  used  as  a   template   for   further  40  cycles  of  
PCR  with  the  same  primers  as  in  the  original  amplification.  The  PCR  products  
were  cloned  using  TOPO  TA  Cloning  Kit  and  One  Shot?  TOP10  chemically  
competent   E.   coli   cells   (Invitrogen,   Carlsbad,   CA,   USA).   The   inserts   were  
amplified   with   an   insert   spanning   plasmid   specific   primer-­set.   The   PCR  
product   was   purified   with   exonuclease   I   and   shrimp   alkaline   phosphatase  
(both   from  USB,   Cleveland,   OH,   USA),   and   sequenced   using   the   BigDye?  
Terminator   v3.1   Kit   and   ABI3730   Automatic   DNA   Sequencer   (Applied  
Biosystems).  
  
5   Flow   Cytometry   and   Cell   Sorting   with   Flow  
Cytometry  (I-­IV)  
Cells   isolated   from   peripheral   venous   blood,   spleen,   lymph   nodes,   and  
mesenteric  lymph  nodes  (MLNs)  were  stained  with  mAbs  directly  conjugated  
to   a   fluorochrome   (see   Table   10).   mAbs   were   purchased   from   BD  
Biosciences,   eBioscience   (San  Diego,   CA,  USA),   Sigma-­Aldrich,   and   Santa  
Cruz  Biotechnology  (Santa  Cruz,  CA,  USA).  mAbs  used  in  these  studies  are  
summarised   in  Table  10.   Intracellular   detection   of   FoxP3  and  Ki67   required  
cell  fixation  and  permeabilizaton  that  was  done  using  the  FoxP3  Fix&Perm  kit  
(eBioscience),   according   to   the   manufacturer's   instructions.   Flow   cytometry  
was   performed   using   the   FACScan   and   FACSAria   instruments   (BD  
Biosciences)   and   the   data   were   analyzed   using   the   CellQuest   and   Diva  
softwares  (BD  Biosciences).  
NOD  donor  cells  for  adoptive  cell  transfer  (II)  were  sorted  after  staining  
with  mAbs  against  CD44,  CD3,  TCR  V?2  and  CD34  (purchased  from  Becton  
Dickinson   and   Sigma   Aldrich).   Sorting   of   cells   was   done   using   a   FACS  
Ventage  instrument  (Becton  Dickinson).  Human  CD4+CD25hi  Treg  sorting  for  
mRNA   extraction   (I)   was   done   using   a   FACStar   instrument   (Becton  
Dickinson).  
  
6   Histological  Analysis  (II-­IV)  
Tissue  samples   fixed   in  10%  formalin  were  embedded   in  paraffin,  cut   into  5  
?m   sections,   and   placed   on   glass   slides.   The   tissue   sections   were   stained  
with   the   standard   hematoxylin   &   eosin   protocol.   The   stained   slides   were  
randomized   and   examined   independently   by   two   examiners   in   a   blinded  
fashion.   Inflammation   of   solid   organs   was   evaluated   on   the   basis   of  
mononuclear   cell   infiltration   and   changes   to   the   tissue   morphology.  
Inflammation  was  scored  according   to   the   reported  severity  of   inflammation.  
For  example  insulitis  scoring  was  done  as  follows:  intact:  no  mononuclear  cell  
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infiltration;;  mild  to  moderate  insulitis:  infiltration  in  islet  periphery  (peri-­insulitis)  
or   intra-­islet   infiltration   in   less   than   half   of   the   islet   area;;   severe   insulitis:  
infiltrating  cells  covering  in  more  than  half  of  the  islet  areas.  
Table  10:  Summary  of  the  mAbs  used  in  these  studies.  
   Specificity   Manufacturer  
Original  
publication  
human   CD3   BD  Biosciences   I  
human   CD4   BD  Biosciences   I  
human   CD25   BD  Biosciences   I  
human   CD62L   BD  Biosciences   I  
human   CD45RO   BD  Biosciences   I  
human   CD45RA   BD  Biosciences   I  
human   HLA-­DR   BD  Biosciences   I  
human   FOXP3  (150D/E4)   a  gift  from  A.  Banham,  Oxford,  UK   I  
human   AIRE   a  gift  from  P.  Petterson,  Tartu,  Estonia   I  
human   AIRE   Santa  Cruz  Biotechnology   I  
human   FOXP3  (236A/E7)   eBioscence   I  
mouse   CD3   BD  Biosciences   II,  III,  IV  
mouse   CD44   BD  Biosciences   II,  III  
mouse   CD34   BD  Biosciences   II  
mouse   TCR  Va2   Sigma-­Aldrich   II  
mouse   CD4   BD  Biosciences  and  eBioscience   III,  IV  
mouse   CD8   BD  Biosciences  and  eBioscience   III,  IV  
mouse   CD19   eBioscience   III  
mouse   FoxP3   eBioscience   III,  IV  
mouse   Ki67   BD  Biosciences   III,  IV  
  
7   Immunohistochemistry  Staining  (I,  III)  
For  immunohistochemistry  of  the  thymus  tissue,  5  ?m  sections  of  the  paraffin  
embedded   formalin-­fixed   tissues   were   used.   The   slides   were   dewaxed   and  
heated  in  a  microwave  oven  for  10  minutes  in  a  buffer  containing  1  mM  EDTA  
in  10  mM  Tris-­HCl,  pH  9.0  for  antigen  retrieval.  Then  slides  were  stained  with  
the  monoclonal  anti-­AIRE  antibodies  and  a  secondary  horseradish  peroxidase  
conjugated  antibody.  The  reaction  was  developed  with  the  EnVision+  protocol  
(DAKO,  Glostrup,  Denmark).    
   Frozen   sections   (5   ?m)   of   organs   dissected   from   Rag1-­/-­   mice   or  
human  thymus  tissue  were  used  for   immunofluorescence   (IF)  stainings.  The  
tissues  used  were  freshly  frozen  in  liquid  nitrogen  before  cutting  into  sections.  
Thymic   sections   were   stained   with   an   anti-­AIRE   mAb   and   an   appropriate  
fluorochrome-­conjugated   secondary   antibody.   In   order   to   screen   mouse  
recipients  of   the  adoptive  cells   transfers   for  autoantibodies,  plasma  samples  
were  diluted  1:5  and  incubated  on  the  frozen  sections  from  selected  organs.  
Autoantibodies   bound   to   the   sections   were   detected   using   fluorescein  
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isothiocyanate-­conjugated   polyclonal   rabbit   anti-­mouse   IgG+IgM   antibody  
(DAKO)  diluted  in  1:50.    
The  sections  were  analyzed  independently  by  two  examiners  using  the  
fluorescence   microscope   Olympus   BX51   (Olympus,   Hamburg,   Germany)  
equipped   with   an   Orca   IIIm   CCD-­camera   (Hamamatsu   Photonics,  
Hamamatsu,   Japan).   For   positive   samples,   the   quantification   of   the  
autoantibody  amount  was  done  by  analyzing  serial  plasma  dilutions.    
  
8   Enzyme-­linked   Immunosorbent   Assay   (ELISA)    
(I,  III-­IV)  
The   acute   phase   protein   serum   amyloid   P   component   (SAP)   and   BAFF  
concentrations   were   measured   using   commercial   ELISA   kits   (SAP:  
Immunology  Consultants  Laboratory  Inc.,  Newberg,  OR,  USA;;  BAFF:  Axxora,  
San  Diego,  CA,  USA),   according   to   the  manufacturer's   instructions.  Plasma  
samples   were   diluted   1:2000   (SAP)   or   1:5   (BAFF),   analyzed   in   duplicates,  
and  absolute  concentrations  were  calculated  from  a  control  dilution  curve  with  
GraphPad   Prism   software   (GraphPad   Software,   La   Jolla,   CA,   USA).  
Absorbances   were   measured   with   the   Labsystems   iEMS   Reader   MF  
instrument  (Thermo  Fisher  Scientific  Inc.,  Loughborough,  UK).    
For  total  immunoglobulin  G  measurement,  a  commercial  ELISA  kit  was  
used   (Bethyl   Laboratories   Inc.,   Montgomery,   TX,   USA)   according   to   the  
manufacturer's   instructions,   with   the   following   dilutions:   coating   antibody  
1:100,  samples  1:2000  (run  in  duplicates)  and  conjugated  secondary  antibody  
1:70  000.  
For  bacterial   antibody  measurement  an   in-­house  ELISA  protocol  was  
used.  Bacterial  strains  of  E.  coli  and  E.  faecalis  were   isolated  from  AireRAG  
mouse  feces  and  grown  in  LB  broth  on  a  shaker  at  +37°C  until  mid-­log  phase.  
Bacteria   were   then   washed   twice   with   PBS   and   the   concentration   was  
adjusted   to   optical   density   of   0.6   at   600   nm   in   PBS.   This   suspension   was  
used  60  ?l/well  for  coating  of  a  MaxiSorp  microtitre  plate  (Nunc  Thermo  Fisher  
Scientific,  Roskilde,  Denmark),  which  was  let  to  dry  over  night  at  +37°C  before  
use.   Heat-­inactivated   serum   samples   were   diluted   1:30.   Mouse   serum   IgG  
and   IgA   specific   for   E.   coli   and   E.   faecalis   were   detected   by   subsequent  
incubation  with  HRP-­conjugated  anti-­mouse   IgG   (Jackson   ImmunoResearch  
laboratories,   West   Grove,   PA,   USA)   or   biotinylated   rabbit   anti-­mouse   IgA  
(Zymed,  San  Francisco,  CA,  USA)   followed  by  HRP-­conjugated   streptavidin  
(Jackson  ImmunoResearch  laboratories)  (all  diluted  1:10  000).  OPD  substrate  
was  purchased  from  Dako.  The  amount  of  bound  antibody  was  measured  as  
optical  density  at  492  nm.  
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   Human   peripheral   blood   TREC   concentration   was   estimated   by   a  
quantitative  PCR-­ELISA  assay,  as  described  by  Al-­Harthi  et  al.11.  
  
9   Statistical  Analysis  (I-­IV)  
Statistical   significances  of   the  differences  or   for   the  change  were  calculated  
with   two-­tailed   Student’s   t-­test   with   P   <   0.05   as   the   limit   for   statistical  
significance.   Correlations   were   calculated   with   Pearson's   correlation  
coefficient,  with  a  limit  of  P  <  0.05  for  significance.  For  P  values  of  AIRE+  cell  
densities  in  the  different  areas  of  the  thymus  Mann-­Whitney  U  test  was  used.    
  
10   Ethical  Considerations  (I-­IV)  
The   animal   work   was   approved   by   the   Animal   Care   Committee   of   the  
University  of  Turku  (II),  Animal  Care  Committee  of   the  University  of  Helsinki,  
and  State  Provincial  Offices  of  Southern  Finland  (III-­IV).  All  work  with  animals  
was  executed   following  guidelines  provided   in   the  EU  directive  86/609/EEC.  
All   human   patients   and   controls   gave   written   informed   consent   before  
sampling.   The   human   studies   were   reviewed   and   approved   by   the   ethical  
committee  of  the  Helsinki  University  Central  Hospital.    
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RESULTS  AND  DISCUSSION  
  
1   Defective  Regulatory  T  Cells  in  APECED  Patients  (I)  
1.1   AIRE  Expression   in   the  Human  Thymus   Is  Concentrated  
around  Hassall’s  Corpuscles  
The  involvement  of  the  thymus  in  the  generation  of  T  cell  central  tolerance  is  
indisputable,   and   the   role   of   Aire   role   in   negative   selection   has   been  
established   in  mouse  models20,   280,   281.  Human  AIRE   is  assumed   to   function  
similarly  as  its  murine  counterpart,  even  though  formal  experimental  evidence  
is   mostly   missing295.   APECED   patients   are   rare   and   samples   from   their  
thymus  are   practically   inaccessible.  By   analyzing   the   expression  of  AIRE   in  
healthy  individuals  and  human  cell  lines  it  is  possible  to  study  AIRE’s  function  
in  the  human  thymus  and  immune  system258,  444.  In  mice,  different  thymic  cell  
populations   have   been   shown   to   have   distinctive   roles   in   the   generation   of  
tolerance,   especially   when   it   comes   to   nTreg   differentiation187,   189,   482.  
Therefore,  we  wanted   to  study   the  spatial  distribution  of  AIRE  expression   in  
the  normal  human  thymus  in  detail.    
The  thymus  tissue  was  obtained  from  immunologically  healthy  children  
undergoing  cardiac  corrective  surgery.   In   immunohistochemical  staining  with  
an   AIRE   specific   mAb   I   could   show   that   AIRE-­expressing   cells   are  
concentrated   around   Hassall’s   corpuscles.   The   median   concentration   of  
AIRE+   cells   was   68.4   cells/mm2   (range   19.5–146.5   cells/mm2)   around  
Hassall’s  corpuscles.  In  comparison,  the  median  concentration  of  AIRE+  cells  
in   the   medulla   areas   devoid   of   Hassall’s   corpuscles   was   26.1   cells/mm2  
(range,   13.0–78.1   cells/mm2).   This   difference   was   statistically   significant  
(P=0.003).  The  corpuscles  themselves  were  mainly  negative  for  AIRE  staining  
(Original  publication  I,  figure  4).  
   Hassall’s  corpuscles  were  originally  considered  to  be  less  prominent  in  
the   mouse   thymus122.   However,   a   recent   study   confirmed   the   existence   of  
Hassall’s  corpuscles  as  keratinized  swirled  structures  in  the  mouse  thymus  by  
using   a   specific   marker   for   human   Hassall’s   corpuscle181   that   also   stained  
similar   structures   in   the   mouse   thymus486.   The   authors   of   this   study   also  
confirmed  our  findings  and  showed  preferential  localization  of  AIRE+  epithelial  
cells  near  Hassall’s  corpuscles  in  human  paediatric  thymuses486.  Three  other  
groups   have   reported   similar   findings   from   adult   samples342,   407,   438.   The  
preferential   localization   of   Aire+   mTECs   around   the   Hassall’s   corpuscle-­like  
structures  has  also  been  found  in  the  mouse  thymus336.  
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Yano  et   al.500   used   transgenic   green   fluorescent   protein   as   a  marker  
linked  to  the  Aire  loci  expression.  Using  this  construct,  they  were  able  to  show  
that  Hassall’s  corpuscle-­like  structures  were  almost  completely  absent   in   the  
Aire-­deficient   murine   thymus,   together   with   various   other   morphological  
changes.  Thymus  morphology  of  APECED  patients  has  not  been  studied,  so  
we  do  not  know  what  kind  of  changes  primary  AIRE  deficiency  causes  in  the  
human  thymus.  From  the  mouse  data  it  is,  however,  possible  to  speculate  that  
primary  AIRE  deficiency  distorts  the  morphology  of  the  human  thymus  as  well,  
possibly  resulting  in  a  loss  of  Hassall’s  corpuscles.    
There   are   some   clinical   conditions   where   thymic   AIRE   expression   is  
lost  secondary  to  some  other  processes.  Thymus  morphology  can  be  studied  
in  detail  in  these  diseases.  For  example  a  secondary  loss  of  AIRE  is  reported  
in   Omenn’s   syndrome63.   In   this   syndrome   the   thymic   histology   is   largely  
distorted  most  likely  due  to  a  mutation  in  the  RAG  gene  that  is  responsible  for  
the   syndrome63,   430.   Also   the   majority   of   human   thymomas   fail   to   express  
AIRE   as   discussed   previously407,   445.   However,   results   obtained   from  
thymomas  must  be  analyzed  with  caution  since  the  malignant  process  itself  is  
capable   of   changing   the  morphology   of   the   thymus.   Interestingly,   Hassall’s  
corpuscles  are  generally   rare   in   thymomas,  but   they  are  more  often  seen   in  
the   AIRE-­expressing   tumors407.   This   can   be   interpreted   so   that   AIRE  
expression  and  Hassall’s   corpuscles   in   thymomas  are  associated  with  more  
differentiated  tumors,  and  only  tumors  of  undifferentiated  origin  fail  to  express  
AIRE  and  lack  Hassall’s  corpuscles.  It  should  be  noted  that  the  loss  of  AIRE  
expression  in  thymoma  can  result  in  an  APECED-­like  syndrome  even  though  
this   is  extremely   rare73,   438.  Therefore,   it   can  be  concluded   that  a  secondary  
loss  of  AIRE  expression  is  associated  with  changes  in  the  thymic  morphology.  
At   present   there   is   not   enough   data   from   human   patients   to   draw   any  
conclusions  of   the  possible  morphological  changes   in   thymuses  of  APECED  
patients.    
In   summary,   AIRE   expressing   cells   are   spatially   linked   to   Hassall’s  
corpuscles   both   in  mice   and  humans.  The  preferential   localization   of   AIRE+  
cells  around  these  structures  is  likely  not  a  coincidence,  but  the  reason  for  this  
connection   is   not   clear.   AIRE+   mTECs   are   considered   to   be   terminally  
differentiated,   and   thus   their   co-­localization   with   Hassall’s   corpuscles   could  
indicate   that   these   keratinized   structures   somehow   drive   the   maturation   of  
mTECs.  This  would  mean   that   the  closer   the  mTEC   is   to   the  corpuscle,   the  
more   mature   it   is.   This   is   supported   by   the   hypothesis   that   Hassall’s  
corpuscles  could  also  function  as  a  “graveyard”  for  apoptotic  mTECs114.  When  
the  dying  mTECs  ends  up  in  Hassall’s  corpuscles,  the  corpuscles  can  acquire  
TSAs  and  be  involved  in  the  negative  selection.  Therefore,  the  loss  of  AIRE+  
mTECs  from  the  thymus  can  also  regulate  the  negative  selection  additionally  
through  Hassall’s  corpuscles.    
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1.2   Phenotype   and   TCR   Repertoire   of   Tregs   in   APECED  
Patients  
The   co-­localization   of   AIRE+   mTECs   and   Hassall’s   corpuscles   could   also  
indicate   a   link   in   nTreg   development   and   AIRE   expression.   Thymic   stromal  
lymphopoietin   produced   by   Hassall’s   corpuscles   has   been   shown   to   drive  
nTreg   development187,   285,   482.   Developing   nTregs   have   also   been   found   to  
localize  around  Hassall’s  corpuscles407,   482.  A  pathogenetic   role   for  defective  
Hassall’s   corpuscles   through   for   example   defective   Treg   development   has  
been   proposed   in   rheumatoid   arthritis36.   It   thus   appears   that   Hassall’s  
corpuscles   potentially   create   a   “tolerizing”   environment   around   them   by  
producing  specific  cytokines.  This  effect  is  not  necessarly  limited  only  to  Treg  
development   since   also   thymic   B   cells   have   been   found   to   preferentially  
accumulate  around  Hassall’s  corpuscles432.    
Hassall’s   corpuscles   are   thus   clearly   involved   in   the   development   of  
Tregs  originating  from  the  thymus.  Loss  of  AIRE  expression  could,  therefore,  
also   affect   Treg   development.   In   human   thymomas,   the   loss   of   AIRE  
expression  was  associated  with  a  reduced  number  of  Tregs  and  a  decreased  
expression   of   FOXP3   in   the   tumor   tissue342,   407.  Murine  Aire   has   also   been  
linked   to   thymic   nTreg   development   through   Aire-­dependent   antigen  
expression   in   mTECs25   and   chemokine   production   that   drives   the  
accumulation   of  medullary  DCs272.  However,   these   studies   did   not   examine  
the   role  of  AIRE   in   the  development  of  human  nTregs.  This  motivated  us   to  
study  Tregs  in  APECED  patients.    
1.2.1   Reduced   Expression   of   FOXP3   in   Tregs   from   APECED  
Patients  
We  analyzed  the  phenotype  of  Tregs  in  APECED  patients  and  compared  that  
with  healthy  controls.  As  measured  by  flow  cytometry,  there  was  no  difference  
in   the   expression   of   T   cell   activation   and  memory  markers  CD25,  HLA-­DR,  
CD62L,   CD45RA   and   CD45RO   between   patients   and   controls   (Original  
publication  I,  table  I).  When  the  FOXP3+  population  was  analyzed,  there  was  
a   marked   decrease   in   the   frequency   of   FOXP3+   cells   in   APECED   patients  
(Original  publication  I,  figure  2C).  In  a  more  detailed  analysis,  the  numbers  of  
CD4+CD25highFOXP3+   cells   were   comparable   between   the   patients   and  
controls,   but   the   mean   fluorescence   intensity   of   FOXP3-­positive   cells   was  
significantly   lower   in   the   patients’  CD4+CD25high   cells   (Original   publication   I,  
figure   2D-­F).   The   lower   protein   expression   level   of   FOXP3   in   APECED  
patients’  Tregs  was  confirmed  at  a  mRNA   level  also  by   real-­time  PCR.  This  
was   done   by   analyzing   the   expression   of   FOXP3   mRNA   in   sorted  
CD4+CD25high   cells   in   both   patients   and   controls,   and   the   patients   had   a  
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significantly  decreased  expression  level  of  FOXP3  mRNA  (Original  publication  
I,  figure  2A-­B).    
1.2.2   Tregs  of  APECED  Patients  Have  a  Naïve-­like  TCR  Repertoire    
The  TCR   repertoire   reflects   changes  on  a   clonal   level   in   peripheral   T   cells.  
Next  we  analyzed  the  TCR  V?  repertoire  in  50  000  sorted  CD25high  cells  from  
an  APECED  patient   and   a  HLA   class   II-­   and   sex-­  matched   healthy   control.  
The  TCR   repertoire  analysis  was  carried  out  with   the  spectratyping  method,  
where  the  lenghts  of  CDR3  regions  of  a  given  TCR  V-­C  gene  combination  are  
visualized  on  a  polyacrylamide  gel89.  The  fluorescence  intensity  of  the  bands  
in  the  gel  is  measured,  and  the  analysis  gives  the  CDR3  length  profile  of  the  
gene   studied.   It   has   been   shown   that   the   relative   areas   of   two   peaks   in   a  
CDR3   length   distribution   profile   correlate   with   the   difference   in   sequence  
diversity   within   them23.   This  method   gives   a  more   accurate   estimate   of   the  
clonality   spectrum   of   a   given   T   cell   population   than   a  mere   analysis   of   the  
TCR   gene   expression.   Clonal   expansion   that   can   be   identified   by   a   biased  
TCR   gene   usage   profile   in   peripheral   blood   must   be   very   large,   and   such  
expansions   are   rarely   seen   except   in   acute   infections   or   hematological  
malignancies166.   By   spectratyping   it   is   possible   to   identify   expanded   T   cell  
clones  within  the  same  TCR  V  gene.  It  is  also  possible  to  estimate  the  poly-­  or  
oligoclonality   of   the   total   TCR   repertoire370.   Thus   spectratyping   was   well-­
suited  for  the  detailed  analysis  of  Tregs  in  APECED.    
The   CD25high   cells   from   a   healthy   control   expressed   a   biased   but  
polyclonal  TCR  repertoire;;  a  finding  that  is  well  in  line  with  published  results  of  
Treg  TCR  repertoires354.  The  patient  TCR  repertoire  was,  however,  markedly  
different.  Clonal  expansions  of  single  CDR3  lengths  were  fewer  in  the  patient  
repertoire  (Original  publication  I,  figure  3A).  Also  the  overall  number  of  CDR3  
length  differencies  was  higher   indicating   that  no  significant   loss  of   individual  
TCR   clones   had   taken   place   in   peripheral   competition   between   lymphocyte  
clones  (Original  publication  I,  figure  3B).  Generally,  the  Treg  TCR  repertoire  of  
the  patient  resembled  more  a  naïve  TCR  repertoire  than  the  TCR  repertoire  of  
the  control  subject.  The  observatio  was  further  verified  by  comparing  the  TCR  
repertoires  of   the  control  and  the  patient   to  a  mean  TCR  repertoire  acquired  
from  cord  blood  samples  (Original  publication  I,  figure  3C).  Cord  blood  T  cells  
posses  the  most  naïve  TCR  repertoire  that  can  be  obtained  from  humans  as  
the   T   lymphocytes   isolated   from   the   cord   blood   have   encountered   only  
antigens  that  are  present   in  utero.  The  TCR  repertoire   in  CD25high  cells  from  
APECED  patients  was  more  similar   to  the  mean  naïve  TCR  V?   repertoire  of  
11   cord   blood   samples   (Original   publication   I,   figure   3D).   In   summary,   the  
TCR   repertoire   of   the   APECED   patient’s   Tregs   was   naïve-­like   while   the  
repertoire  of  Tregs   from  a  healthy   individual  had  signs  of   clonal  expansions  
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indicating   past   activation   and   proliferation   of   certain   clones.   Similar   results  
were  obtained  from  four  non-­HLA  matched  patient-­control  pairs.      
   The  data  presented  in  publication  I  indicate  several  abnormalities  in  the  
Treg  population  of  APECED  patients.  The  most  prominent  defect  is  the  lower  
expression   level   of   FOXP3.   Constitutively   high   expression   of   FOXP3   is  
indispensable   for   the   stable   Treg   phenotype   and   suppressive   function   in  
humans399.   Our   data   suggest   that   Tregs   are   dysfunctional   in   APECED  
because   they   fail   to   express   high   levels   of   FOXP3.   The   naïve-­like   TCR  
repertoire   of   Tregs   in   APECED   patients   also   supports   this   conclusion.   In  
APECED  patients  Tregs  have  not  undergone  as  many  clonal  expansions  as  
healthy  controls  do.  A  clonal  expansion  in  the  TCR  repertoire  requires  that  the  
particular  clone  has  proliferated  considerably.  It  is  thus  possible  that  APECED  
patient  Tregs   fail   to  proliferate  as  efficiently  as   they  should   in   the  peripheral  
immune  system.  Even  though  Tregs  were  originally  described  to  be  anergic  in  
vitro,  the  current  view  is  that  TCR-­mediated  Treg  activation  results  in  a  rapid  
proliferation   and   effector   maturation   in   vivo316.   Treg   activation,   which  
precedes  the  proliferation,  is  required  for  suppressive  functions  of  Tregs.  Our  
results  show  that  the  prominent  clonal  expansions  indicating  strong  activation  
and  proliferation  are  missing   from   the  Treg   repertoire   that  has  developed   in  
the  absence  of  AIRE.  
   However,  our   results  do  not  show  at  which   level   this  AIRE-­dependent  
defect   in   Treg   activation   takes   place.   AIRE   is   expressed   also   in   secondary  
lymphoid  organs,  so  it  is  possible  that  extra-­thymic  AIRE-­expressing  cells  are  
involved   in  peripheral  Treg  activation.  Our  group  has  studied   the  phenotypic  
defects  in  APECED  patients’  Tregs  further.  Laakso  et  al.261  were  able  to  show  
that  the  decreased  FOXP3  expression  was  less  pronounced  in  Tregs  with  the  
recent   thymic   emigrant   phenotype.   On   the   contrary,   activated   Tregs   in  
APECED   patients   showed   a   significantly   lower   expression   level   of   FOXP3  
when   compared   to   healthy   controls.   This   indicates   a   failure   in   FOXP3  
expression   upon   peripheral   activation   in   APECED,   which   is   essential   for  
proper   Treg   functions316.   Thus,   taken   together,   our   data   and   the   reported  
dysfunction  of  the  activated  Tregs  in  APECED  patients261  suggest  that  extra-­
thymic   AIRE   expression   could   be   involved   in   the   peripheral   Treg   activation  
and  clonal  expansion.  
1.3   Defective   Suppressive   Functions   of   APECED   Patient  
Tregs  
To   ascertain   a   functional   defect   in   APECED   patient   Tregs   implied   by   the  
findings   of   altered   phenotype   and   TCR   repertoire,   CD4+CD25high   cells   were  
isolated  from  APECED  patients  and  an  in  vitro  suppression  assay  was  carried  
out.  Tregs   isolated   from  patients  used   in  a  1:3   ratio   to  CD25-­   cells   failed   to  
suppress   T   cell   proliferation   in   response   to   a   polyclonal   stimulus   (Original  
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publication   I,   figure   1).   Immobilized   mAbs   against   human   CD3   and  
phytohaemagglutinin  were  used  as  polyclonal  mitogens.  A  failure  to  suppress  
proliferation  was  evident  in  the  patient  Tregs  even  using  a  1:1  CD4+CD25high  
to  CD25-­  cell  ratio.    
Effector   cell   resistance   to   Treg-­mediated   suppression   has   been  
proposed   to   be   an   important   mechanism   in   some   human   autoimmune  
diseases55.   Thus,   we   wanted   to   test   whether   the   effector   cell   resistance   in  
APECED   patients   would   explain   the   failed   Treg   suppression   in   the   in   vitro  
suppression   assay.  CD4+CD25high   cells   isolated   from  a   healthy   blood   donor  
were  were  able  to  suppress  anti-­CD3  mAb-­driven  proliferation  equally  well  in  
patients  and   controls.  Therefore,   the   effector  T   cells   isolated   from  APECED  
patients  are  not  resistant  to  normally  functional  Treg-­mediated  suppression.  
When  heat-­inactivated  Candida  albicans  was  used  as  a  mitogen  in  the  
in   vitro   suppression   assay,   the   patient-­derived   Tregs   suppressed   the  
proliferation  as  well  as  the  controls  did  (Original  publication  I,  figure  1).    This  
could  have  resulted  from  the  increased  amount  of  Candida-­specific  activated  
effector   Tregs   in   the   CD25high   population,   since   the   patients   have   chronic  
Candida  infections.  Thus  the  pre-­existing  numerous  Candida-­specific  Tregs  in  
APECED  patients  could  compensate  for  the  otherwise  defective   in  vitro  Treg  
activation   and   suppression,   and   no   overt   difference   with   healthy   controls  
could  be  seen.  Tregs  isolated  from  the  patients  suppressed  Candida-­specific  
immune   responses   in   vitro   as   efficiently   as   control   subjects   Tregs   even  
though   they   failed   to  suppress   the  proliferation   induced  by  strong  polyclonal  
mitogens.   This   indicates   that   there   is   a   difference   between   polyclonal   and  
antigen-­specific   Treg-­mediated   suppression,   and   these   mechanisms   are  
affected  by  AIRE  differently.  Another  possible  explanation  for  this  difference  is  
that  Tregs  express   also  TLRs  and   can  be  activated   through   them442.   In  our  
experimental   conditions   we   did   not   differentiate   between   TLR-­   or   TCR-­
mediated  activation.  It  is  thus  possible  that  the  heat-­inactivated  Candida  used  
could  have  bypassed   the  TCR  and  activated  Tregs   indirectly   through  TLRs.  
Murine  Aire  has  been  associated  with  TLR  expression  in  a  monocyte  cell-­line  
in   vitro514,   but   in   human  APECED  patients   the  TLR  expression  ex   vivo   has  
been  reported  to  be  normal209.  
   Our   data   confirm   that   Tregs   in   APECED   patients   fail   to   suppress  
polyclonal   lymphocyte   proliferation   in   vitro.   Similar   Treg   defects   have   been  
reported   for   other   human   autoimmune   diseases   as   well55.   Treg   defects   in  
human   autoimmune   diseases   can   be   divided   into   three   main   categories:  
inadequate  number  of   Treg   cells,   defect   in  Treg-­mediated   suppression,   and  
effector   cell   resistance   to   Treg-­mediated   suppression55.   APECED   patients  
have   normal   numbers   of   Tregs   cells   and   their   effector   T   cells   are   normally  
suppressed   by   Tregs.   Our   data   show   that   the   Tregs   that   have   developed  
without  AIRE  are  functionally  defective.    
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Considering   the   role   of   AIRE   in   the   thymus   driving   ectopic   TSA  
expression,   it   is  possible   that   the  nTreg   repertoire,  which  developed  without  
AIRE,  has  specific  inadequencies  for  certain  self-­antigens  that  are  expressed  
in   the   thymus   in   an  AIRE-­dependent  manner.   This   theory   could   explain   the  
relatively   limited   number   of   tissues   affected   in   APECED.   The   exact  
mechanism  of  how  nTreg  generation   is  affected  without  AIRE  could  also  be  
explained  by  defective  development  or   function  of  Hassall’s  corpuscles.  The  
results   obtained   using   Aire-­deficient   mice   support   this   view500,   but   this  
mechanism   remains   to   be   validated   using   thymic   samples   acquired   from  
APECED  patients.    
Even  though  the  suppression  assay  can  be  criticized,  it  is  currently  the  
method   of   choice   for   testing   human   Treg   functional   activity.   However,   it  
remains  unclear  how  well   the   in   vitro   data   reflect   the  suppressive  activity   in  
vivo399.   In   mice   studies   where   Aire-­deficient   animals   were   crossed   with  
FoxP3-­deficient  Scurfy  mice,  the  offspring  developed  a  more  severe  disease  
that  either  one  of   the  parental  strains  alone71.  This   finding   indicates   that   the  
normal  function  of  Tregs  is  important  in  maintaining  at  least  some  level  of  self-­
tolerance   in   the   murine   autoimmune   syndrome   evoked   by   Aire   deficiency.  
Thus,   it   is   possible   that   the   dysfunctionality   in   Tregs   caused   by   the   loss   of  
AIRE  has  a  role  in  the  pathophysiology  of  human  APECED.    
1.4   FoxP3  Expression  in  Aire-­/-­  Mice  
APECED   patients   consistently   express   lower   levels   of   FOXP3   than   healthy  
controls.  We  wanted  to  analyze  whether  the  same  finding  would  also  apply  to  
Aire-­deficient  mice  as  well.  mRNA  expression   levels  of  FoxP3   in   the  spleen  
and   thymus   lysates   of   six   Aire-­/-­  mice   and   6  wild-­type  mice   in   the  C576/BL  
background   were   quantitated   by   real-­time   PCR.   There   was   no   significant  
difference  between  Aire-­deficient  and  control  mice.  When  the  salivary  glands  
of   the  same  mice  were  analyzed,   the  expression   level  of   the  TCR  gene  C?  
was  used  to  normalize  the  FoxP3  expression  level   to  the  total   level  of  T  cell  
infiltration.  Since  each  mature  ??  T  cell  also  expresses  this  gene  segment,  it  
is  a  reliable  way  to  normalize  the  specific  gene  expression  to  the  total  amount  
of  T  cells  in  the  sample.  The  salivary  gland  is  a  common  target  of  lymphocyte  
infiltration  in  the  different  Aire-­deficient  mouse  strains  (Table  4).  We  were  able  
to  detect  clearly  more  TCR  C?  mRNA  expression  in  the  knockout  animals  as  
an  indication  of  an  increased  amount  of  T  cells  infiltrating  the  tissue  compared  
with   the   wildtype   controls.   Also   FoxP3   expression   was   increased   in   the  
salivary   glands   and   it   correlated   significantly   (P=0.0005)   with   the   TCR   C?  
expression  (Original  publication  I,  figure  5).  This  finding  clearly  shows  that  in  
Aire-­/-­  mice   the   lymphocyte   infiltration   to  a   target  organ   is  accompanied  with  
increased  Treg  accumulation  as  well.    
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These  data   indicate  an  active  ongoing   local  suppression  of   inflammation  
in   the   Aire-­deficient   mice.   However,   the   analysis   was   done   using   relatively  
young  animals,  which  could  affect  the  interpretation.  Indeed,  Hässler  et  al.195  
found   that   when   Aire-­deficient   mice   were   aged   from   15   to   24   months,   the  
autoimmune  manifestations  were  more   pronounced.   Aricha  et   al.22   reported  
that   the   number   of   peripheral   FoxP3+   Tregs  was   normal   in   animals   aged   2  
months  but  it  was  reduced  in  6-­month-­olds  (when  analysed  by  flowcytometry).  
It   is,   therefore,  possible   that  also   in  Aire-­/-­  mice   the  Treg  defect   is  not   in   the  
amount  of  Tregs,  but   instead   it   is  a  question  of  a   functional   impairment   that  
becomes  pronounced  only  when  the  animals  get  older,  or  when  their  immune  
system  is  put  under  extensive  stress.  Aire-­/-­  mice  used  in  this  experiment  were  
kept  under  barrier  circumstances   in  a  specific  pathogen-­free  –  facility  so   the  
external  antigen  load  in  these  animals  was  minimal.    
  
2   Lymphopenia-­induced   Proliferation   as   a   Model  
for   Studying   Polyclonal   T   Cell   Responses   in  
Autoreactivity-­prone  Experimental  Conditions  (II)  
  
Our   initial   work   with   the   APECED   patients   and   Aire-­deficient   mice   showed  
conflicting   results   regarding   the   Tregs   function   and   FoxP3   expression.   The  
Peltonen’s  Aire-­/-­C57BL/6  mice  used  in  our  experiments  were  actually  overtly  
healthy,   even   though   autoantibodies   and   lymphocyte   infiltration   in   solid  
organs   found   in   the   mice   can   be   cinsidered   a   sign   of   autoimmunity236.   In  
addition   to  genetic  differences  between  humans  and  mice,   this  difference   in  
phenotypes  could   result   from  different  environmental   factors.  The  only  study  
so   far   focused   on   the   general   environmental   factors   affecting   the   Aire-­
deficient  mice  phenotype  has  been  conducted  by  Gray  et  al.168.  They  reported  
that   germ-­free  Aire-­deficient  mice,   i.e.  mice   that   have   lived   in   strictly   sterile  
environment,  had  similar  disease  progression  as   their  specific  pathogen-­free  
kept  counterparts.  They  also  tested  whether  TLR-­stimulation  would  affect  the  
disease   progression,   however,   no   difference  was   found168.   The   reliability   of  
this  study  can  be  criticised,  since  the  study  groups  were  very  small;;   in  some  
treatment  groups  only  2  or  3  mice  were  used.    
Treatment   or   cells   and   animals   with   TLR-­ligands   can   mimic   certain  
aspects   of   microbial   infection   but   it   will   not   fully   reproduce   e.g.   real   viral  
infection.  One  hallmark  of  some  viral  infections  is  transient  lymphopenia27  that  
has  been  associated  with  the  onset  of  autoimmunity  in  humans94.  We  wanted  
to  study  the  phenomenon  of  LIP  in  more  detail  since  it  has  been  proposed  to  
increase   the   risk   of   autoimmunity   in   both   mouse   models   and   in   clinical  
cases254.  Also  Tregs  have  been   reported   to  have  a  major   role   in   controlling  
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the   lymphopenia-­initiated  proliferation.  Therefore  LIP  appeared   to  be  a  good  
model   for   studying   T   cell   autoreactivity   in   a   polyclonal,   non-­transgenic  
experimental  system.    
2.1   Lymphopenia-­induced  Proliferation  as  a  Model   to  Enrich  
Self-­   or   Normal   Flora-­   Reactive   Clones   from   Polyclonal  
Population  
T  cells  that  express  two  different  TCRs  with  separate  antigen  specificities  are  
consistently   found   in  peripheral  blood  both   in  mice  and  humans199,   357.  Their  
true   significance   in   the   function   of   the   adaptive   immune   system   is   still  
unknown.   The   dual   antigen   specificity   of   T   cells   has   been   suggested   to  
increase   the   risk   for   autoimmunity   through   faulty   negative   selection504,   but  
dual-­specific  TCRs  are  also  preferentially  expressed  among  human  Tregs462.  
Dual  antigen  specificity  has  also  been  proposed  to  be  beneficial  by  expanding  
the   foreign   antigen   recognition   capacity   of   a   single   cell198.   We   wanted   to  
elucidate   these   conflicting   findings   of   dual-­specific   TCRs   by   using   LIP   as   a  
model   to   enrich   autoreactive   TCR   clones   from   a   polyclonal   repertoire.  We  
selected   the   NOD   mouse   strain   for   this   experiment   since   it   is   a   well-­
established  mouse  model  for  autoimmunity18.    
   NOD   mice   were   generated   in   1974   from   inbreeding   cataract-­model  
mice   that   developed   autoimmune   diabetes286.   NOD  mice,   especially   female  
mice,   spontaneously   develop   autoimmune   diabetes   with   a   high   frequency.  
Over  20  gene   loci  have  been  associated  with  predisposition  or  protection  of  
diabetes   in   NOD   animals18.   When   NOD   mice   are   crossed   to   lymphopenic  
backgrounds   such   as   nude,   i.e.   athymic   or   Scid  mice,   they   are   saved   from  
insulitis   and   diabetes.   This   strongly   suggests   that   diabetes   in   NOD  mice   is  
caused  by  the  adaptive  immune  system418.  The  diabetes  in  NOD  animals  is  a  
multifactorial   disease   similarly   to   autoimmune   diabetes   in   humans153.   In  
addition   to   diabetes,   the   mice   often   acquire   also   other   autoimmune  
manifestations,  which  indicate  a  severe  multilayered  immune  dysregulation56,  
151,   431,   465.   NOD   is   widely   used   as   a   model   for   human   tissue-­specific  
autoimmune  diseases115.    
In  order  to  study  how  the  T  cell  clones  that  express  two  different  TCR  
V?   chains   behave   in   LIP,   we   sorted   50   000   lymphocytes   isolated   from   the  
lymph  nodes  of  a  NOD  donor  according  to  the  surface  expression  of  TCR  V?2  
gene,  and  transferred  them  to  lymphopenic  NOD/Scid  recipients  using  an  i.v.  
injection.  As  it  has  been  estimated  that  15%  of  peripheral  T  cells  express  two  
V?   chains199,   approximately   7   500   of   the   transferred   cells   also   expressed  
another   V?   chain.   In   this   experimental   system   we   were   able   to   follow   the  
changes   in   both   single-­   and   dual-­specific   TCR   repertoires   during   LIP   in  
exactly  the  same  circumstances.    
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2.2   Dual-­specific  TCR  Repertoire  Grows  more  Oligoclonal   in  
Lymphopenia-­induced   Proliferation   than   Single-­specific  
TCR  Repertoire    
TRECs  are   loops  of  un-­translated  genomic  DNAs  that  are  spliced  out  during  
the   TCR   recombination   process   in   the   thymus197.   After   the   TCR  
recombination   during   each   cell   division,   the   TREC   concentration   is   halved  
because   extra-­chromosomal   DNA   is   not   replicated387.   Thus   the   TREC  
concentration   can   be   used   to   estimate   the   overall   proliferation   history   in   a  
given  T  cell  population.  We  confirmed   the  vigorous  T  cell  proliferation   in   the  
recipients   that   received   the   sorted   T   cell   transfer   by   measuring   the   TREC  
concentration   from   recipients   spleen   samples   after   their   termination.  The  all  
NOD/Scid  recipients  were  terminated  2  months  after  the  sorted  T  cell  transfer.  
During   the   transfer   experiment   no   clinical   symptoms   of   autoimmunity   were  
noticed  and  at  the  time  of  termination  the  proliferation  had  most  likely  reached  
a   plateau   phase   since   all   tested   recipient   cells   were   positive   for   memory  
surface  markers  as  analyzed  by  flowcytometry  (data  not  shown).    
All   NOD/Scid   recipients   that   received   the   sorted   T   cell   transfer   were  
negative  for  TRECs  at  the  time  of  termination.  In  order  to  estimate  how  many  
times   the   transferred   cells   had  divided,   the  TREC   level  was  measured   in   a  
donor   sample   that   represented   the   TREC   level   of   the   transferred   cells   pre-­
proliferation.  Serial  dilutions  from  a  thymic  DNA  sample  was  done  in  order  to  
estimate  how  many  cell  divisions  are  required  to  reach  a  negative  TREC  level  
in   our   assay.   Then   we   compared   the   TREC   level   in   the   pre-­transfer   donor  
sample  with  the  dilution  curve  (Figure  6).  This  comparison  put  the  number  of  
cell   divisions   in   the   transferred   cells   to   a  minimum   of   eight   divisions.   Most  
proliferating  cells  probably  divided  more  than  eight  times.    
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Figure  6:  A  schematic  representation  of  the  TREC  based  estimation  of  cell  divisions  
in  the  transferred  cells.  
  
In  order  to  study  the  changes  in  the  dual-­specific  TRC  repertoire  during  
lymphopenia-­induced  proliferation,  we  decided  to  analyze  the  V?1  and  V?17  
genes   to   represent   dual-­specific   repertoires   in   transferred   cells.   As   roughly  
estimated   from   the  number  of   the  different  V?  genes   in  a  normal   repertoire,  
approximately  4%  of  dual-­specific  TCRs  utilised  either  one  of  the  selected  two  
V?   genes.   The   expression   level   of   these   two   genes   were   measured   in  
recipient  samples  by  real-­time  PCR,  and  there  was  no  difference  in  the  overall  
expression   levels   of   these   dual-­specific   TCRs   after   T   cell   proliferation  
(Original  publication  II,  figure  1).    
For  a  more  detailed  analysis,  we  carried  out  a  TCR  repertoire  analysis  
from  the  recipients’  splenocytes  on  single-­specific  TCRs,  represented  by  V?2,  
and  dual-­specific  TCRs,  represented  by  V?1  and  V?17,  before  and  after   the  
proliferation.   By   using   the   same   model   for   estimating   changes   in   the   TCR  
repertoire   as   in   APECED   patients   (see   pages   87-­88),   the   single-­   and   dual-­
specific   repertoires   were   compared   with   both   pre-­transfer   repertoires   and  
naïve  polyclonal  TCR  repertoires   that  were  acquired   from  8  neonatal  mouse  
thymuses.  The  dual-­specific   repertoire  changed  significantly  more  during   the  
proliferation  than  the  single-­specific  repertoire:  the  average  change  compared  
with   the   pre-­transfer   repertoire   was   17%   in   single-­specific   V?2   repertoire,  
while  in  the  dual-­specific  V?1  it  was  58%  and  in  V?17  75%.  The  difference  in  
the   repertoire   change   remained   significant   when   the   repertoires   were  
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compared  with   the   naïve   polyclonal   repertoire   (Original   publication   II,   figure  
3).  
This   comparison,   however,   did   not   reveal   us   how   the   repertoire  
changed.  Therefore,  we  compared  the  total  number  of  different  CDR3  lengths  
in   the  single-­  and  dual-­specific   repertoire.  The  dual-­specific  TCR   repertoires  
became   more   oligoclonal   during   LIP   (Original   publication   II,   figure   2).   The  
duration  of  proliferation  had  no  effect  on  the  change  in  the  repertoire  in  similar  
experiments   with   different   durations   of   the   proliferation   phase,   up   to   12  
months.    
Our  data  here  show  that  the  transferred  lymphocytes  proliferate  in  LIP,  
but  all  clones  do  not  proliferate  equally  well.  The  repertoire  of  the  non-­sorted  
TCRs   changed   significantly   more   often   during   the   proliferation,   and   the  
resulting   repertoire   was   markedly   more   skewed   than   the   sorted,   and   thus  
mostly  single-­specific  TCR  repertoire.  It  can  be  argued  that  the  small  number  
of  transferred  non-­sorted  TCRs  would  impact  the  skewing  of  the  repertoire.  To  
exclude   this   possibility,   another   series   of   transfer   experiments   were  
conducted.  We  transferred  a  small  number  of  non-­selected  T  lymphocytes  to  
RAG1-­knockout   recipients   and   compared   the   pre-­   and   post-­transfer  
repertoires  of   selected  V?   genes.   In   this   setting   the   repertoire   per  V?   gene  
changed.  The  change,  however,  was  not  so  pronounced  as  it  was  in  the  non-­
V?2  TCRs  in  the  original  transfer,  even  though  the  proportions  of  the  V  genes  
in  the  non-­selected  transfer  were  a  minority  of  the  total  repertoire.  Also,  in  the  
original  sorted  transfer,  the  non-­V?2  TCRs  were  a  minority  but  their  repertoire  
became   significantly   more   skewed   during   proliferation   than   in   this   second  
non-­selected   transfer.  Therefore,  we  can  conclude   that   the  narrowing  of   the  
dual-­specific  TCR   repertoire  did  not   result   from   the  original  small  number  of  
transferred   TCRs,   but   it   is   a   phenomenon   associated   with   the   special  
characteristics  of  dual-­specific  TCRs.  
2.3   Lymphopenia-­induced   Proliferation   Can   Be   Used   to  
Enrich  Autoreactive  Clones  from  a  Polyclonal  Repertoire  
Nest   we   characterized   the   effects   of   LIP   on   dual-­specific   V?2   and   V?1  
expressing   cells.   First   we   estimated   how   many   non-­V?2   TCRs   were  
transferred   to   the   recipients.   This   was   done   by   choosing   a   single  
spectratyping  band  representing  a  single  CDR3  length  of  the  V?1  gene  from  a  
pre-­transfer  donor  sample.  It  has  previously  been  shown  that  the  relative  area  
of   a   peak   in   the   spectratyping   profile   correlates  with   the   sequency   diversity  
within  it23.  When  we  sequenced  the  different  CDR3  sequences  in  the  chosen  
band,   21   different   CDR3   sequences   were   found.   Based   on   the   estimated  
frequency   of   V?1   genes   in   the   total   TCR   repertoire   the   21   different   CDR3  
sequences   found   represented   12.8%   of   the   total   transferred   V?   repertoire  
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(see  figure  7  for  illustration  how  the  estimation  was  done).  This  confirmed  that  
the   original   literature-­based   estimation   of   15%   dual-­specific   TCRs   in   the  





Figure   7:   An   illustration   of   how   the   frequency   of   non-­V?2   TCRs,   i.e.   dual-­specific  
TCRs,  in  the  transferred  cells  was  calculated.  
  
The  V?1  CDR3  bands,  that  were  of  the  same  length  as  in  the  donor  sample,  
were   also   analyzed   from   the   post-­transfer   samples   of   three   recipients.   The  
recipient  samples  each  had  one  or  two  different  CDR3  sequences,  indicating  
that  the  dual-­specific  V?1  repertoire  had  contracted  to  5%,  on  average,  of  the  
original  (Original  publication  II,  figure  4).    
One  CDR3  sequence  was  identical  both   in  nucleotide  and  amino  acid  
sequence   in   two   out   of   the   three   recipient   mice   analyzed.   This   finding  
indicates   that   this  particular  sequence   is   targeted   to  some  common  self-­,  or  
commensal  antigen  driving  LIP,  and  this  antigen  and  the  TCR  clone  specific  
to  it  were  shared  with  different  recipients.  It  highlights  how  effective  the  LIP  is  
in   enriching   autoreactive   clones   from   a   polyclonal   repertoire.   Quiel   et  
al.381used  TG-­TCR  T  cells  diluted  with  non-­specific  T   cell   clones   in  order   to  
study   how   the   frequency  of   an  antigen-­specific  TCR  affects   the  proliferative  
response   of   T   cells.   They   found   that   after   immunization   with   the   model  
antigen,  the  more  infrequent  the  antigen  specific  clones  were  in  the  original  T  
cell   repertoire,   the  more   they   proliferated381.   Considering   our   data   with   the  
dual-­specific  TCRs,   it   appears   that   the  dual-­specific   repertoire   contains   rare  
autoreactive   or   commensal   flora   reactive   clones   that   efficiently   proliferate   in  
response   to   self-­antigen-­derived   activation   signals   and   finally   dominate   the  
dual-­specific  TCR  repertoire.    
   We   did   not   notice   any   clinical   signs   of   autoimmunity,   for   example  
hyperglycemia,  in  our  recipient  mice.  In  histological  analysis  we  found  that  all  
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recipients  had  a  mild  insulitis  at  the  time  of  termination  (Original  publication  II,  
figure   5A).   TCR   repertoire   analysis   from   pancreas   draining   lymph   nodes  
showed  a  similar  contraction  of  the  dual-­specific  V?1  repertoire  as  the  one  we  
had  seen   in   the  splenocytes.  The  small  number  of   the   transferred  cells  may  
explain  why  insulitis  did  not  progress  to  diabetes  in  the  recipients.  It  was  also  
possible   that   the   transfer   period   was   too   short   for   the   development   of  
diabetes269,  or  that  the  sorting  affected  the  CD4  /  CD8  ratio  of  the  transfer,  as  
both   of   the   main   T   cell   populations   are   needed   for   the   development   of  
diabetes  in  NOD  mice18.      
  One   further   intriguing   possibility   is   that   the   sorted   transfer   would  
contain   a   population   of   Tregs   that   could   have   suppressed   the   disease  
progression.   Indeed,   it  has  been  reported  that  an  unusually  high  percentage  
of  human  Tregs  have  two  functional  V?-­chains462.  It  has  to  be  pointed  out  that  
our   experimental   sysmtem   was   not   originally   designed   to   study   Tregs   as  
such,  and  thus  we  could  only  measure  the  expression  level  of  FoxP3  in  pre-­  
and   post-­transfer   splenocytes.   The   expression   level   increased   significantly,  
indicating  that  Tregs  in  our  transfer  expanded  during  LIP  (Original  publication  
II,  figure  5B).    
   These   data   obtained   from   the   NOD  model   clearly   indicate   that   dual-­
specific   TCRs   behave   differently   in   LIP   than   the   single-­specific   TCRs.   This  
indicates   that   dual-­specific   TCRs   contain   autoreactive   clones   that   dominate  
the   repertoire   after   proliferation.   The   autoreactivity   of   the   dual-­specific  
repertoire   could   be   a   result   of   faulty   negative   selection,   or   an   increased  
proportion   of   Tregs  within   the   dual-­specific   population.   The  Treg   population  
has  been  suggested  to  contain  highly  autoreactive  clones  more  often  than  the  
normal  effector  cells  even  though  the  Treg  repertoire  contains  also  TCRs  that  
are  specific  for  foreign  antigens354.  If  Tregs  would  have  a  dual-­specific  TCR,  it  
could   explain   some   discrepancies   seen   in   the   Treg   TCR   repertoires   in  
different  studies354.  Tregs  proliferate  effectively  during  LIP  and  are   important  
in   controlling   the   autoreactivity   as   discussed   previously49,   269,   492,   so   in   our  
experimental  LIP  system  Treg  proliferation  may  be  favored.    
   Even   though   our   results   are   not   complete   to   answer   the   question   of  
whether   or   not   dual-­specific   TCRs   are   harmful   or   beneficial   to   the   immune  
system,  this  study  confirms  that  dual-­specific  TCRs  contain  functional  clones.  
If  all  dual-­specific  TCRs  would  be  dysfunctional,   there  would  not  have  been  
any   detectable   non-­V?2   TCRs   in   the   recipients   after   the   proliferation.      The  
different  outcome  of  LIP  for  single-­  and  dual-­specific  TCRs  indicates  that  dual-­
specific  TCRs  form  a  separate  biological  niche  in  the  total  TCR  repertoire.    
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3   Loss  of  Aire  Expression  in  the  Thymus  Is  not  
Sufficient  to  Cause  Autoimmunity  in  
Lymphopenia-­induced  Proliferation  (III)  
  
APECED  patients  show  a  clear  functional  defect  in  Tregs  but  the  analysis  of  
the  machanism   of   this   defect   was   not   possible   to   be   carried   out   in   human  
patients.   Emerging   evidence   supports   a   role   for   AIRE   also   outside   the  
thymus119,  308.  Our  data  indicated  that  the  Treg  defect  in  APECED  could  be  an  
extra-­thymic   AIRE-­dependent   phenomenon.   Next   we   wanted   to   study   the  
impact  of  AIRE  on  Tregs  separately  in  the  thymus  and  in  secondary  lymphoid  
organs.   The   overall   functional   defect   seen   in   in   the   Tregs   isolated   from  
APECED   patients   could   result   from   defects   at   various   stages   of   the   Treg  
lifecycle:  1)  qualitatively  defective  nTreg  development  in  the  thymus,  2)  errors  
in  Treg  homing  to  the  target  tissues  followed  by  inadequate  activation  signals,  
3)   failure   in   the   induction   of   the   Treg   phenotype   in   naïve   cells   (iTregs),   4)  
defects   in  Treg  activation,  proliferation,  and  maintenance  of   the  suppressive  
phenotype,  and  5)  defective  cell-­to-­cell  suppression,  for  example  by  inefficient  
production   of   suppressive   cytokines.  We   reasoned   that   AIRE   expression   in  
the  thymus  has  an  impact  on  stage  1,  but  peripherally  expressed  AIRE  could  
be   important   in   the   remaining  stages.   In  order   to  pinpoint   the   level   in  which  
the   loss  of  AIRE  causes  Treg  defects,   it  was  necessary   to   separate  AIRE’s  
expression  in  the  thymus  and  in  the  peripheral  immune  system.    
Our  data  in  the  NOD  model  showed  that  LIP  enriches  rare  autoreactive  
T  cell  clones  so  that   they  can  eventually  dominate  the  repertoire.  We  further  
analyzed   whether   Aire   expression   in   the   thymus   during   T   cell   development  
and   in   the   peripheral   immune   system  have  different   effects   on   lymphocytes  
undergoing  LIP.  Our  findings  in  the  NOD  transfer  model  confirmed  that  LIP  is  
a  good  model  for  studying  general  autoreactivity  of  the  transferred  population  
and  Tregs  controlling  the  proliferation269.  
We   chose   to   use   Aire-­deficient   mouse   model   in   the   C57BL/6  
background   that   is   relatively   resistant   for   the   development   of   autoimmunity.  
The   autoimmune   syndrome   in   this   background   is   spontaneously   mild,   so   it  
would   be   relatively   easy   to   see   the   impact   that   LIP   has   on   Aire-­dependent  
autoimmune  manifestations.  The  C57BL/6  background  also  provided  a  good  
control   group   since   no   autoimmunity   has   been   reported   in   adoptive   cell  
transfers  using  un-­selected  cells  from  C57BL/6  mice269,  491.  
3.1   Lymphopenia  and  Aire  –  Possible  Synergistic  Factors  in  
the  Breakdown  of  Tolerance?  
We  considered  that  lymphopenia  could  also  be  important  in  the  context  of  Aire  
as  some  autoimmune  components  reported  in  Aire-­deficient  mice  are  shared  
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with   other   lymphopenia-­associated   autoimmune   mouse   models.   A   good  
example   of   this   is   gastritis   that   is   a   common   autoimmune   manifestation   in  
Aire-­deficient   mice   in   the   BALB/c   background232.   BALB/c   animals   also  
develop  autoimmune  gastritis  with   high   prevalence  after   thymectomy   that   is  
carried   out   on   the   third   post-­natal   day.   The   post-­thymectomy   gastritis   in  
BALB/c   mice   is   strongly   associated   with   the   expression   level   of   gastric  
autoantigens  in  the  thymus10,  318  but  overt  autoimmunity  also  requires  LIP303.  It  
should  be  noted  that  the  recognized  gastric  autoantigens  in  post-­thymectomy  
and   in   Aire   deficiency   associated   autoimmune   gastritis   are   different;;   gastric  
H/K   ATPase   and   Mucin   6   respectively.   The   clinical   pictures   are   otherwise  
similar:   lymphocyte   infiltration   to   the   gastric   mucosa   and   production   of  
autoantibodies.    
In  mice,  neonatal   thymectomy   results   in  a  severe  T  cell   lymphopenia  
and  a  high  rate  of  LIP314,  which  can  cause  autoimmunity   in  selected  genetic  
backgrounds138.   Results   in   the   conditional   Aire-­expressing   mouse   model  
indicate   that  Aire  expression   in   the  perinatal  period   is  more   important   in   the  
maintenance  of   tolerance   than   later   in   life171.   It  appears   that  Aire-­dependent  
autoimmunity   shares   a   strong   resemblance   with   the   third   post-­natal   day  
thymectomy  model171.  In  the  conditional  Aire  expression  model,  autoimmunity  
following   the  perinatal   loss  of  Aire  expression  can  be  prevented  by  blocking  
LIP   indicating   that   the   proliferation   has   an   impact   on   the   Aire-­related  
autoimmunity171.    
Aire   deficiency   results   in   a   severe   autoimmunity   in   Scurfy   and   NOD  
backgrounds71,   232.  NOD  mice  have  been   reported   to  have  defective   central  
tolerance   and   thus   the   synergistic   effects   on   the   central   tolerance   following  
the   loss   of  Aire   are   believed   to   explain   the   severe   phenotype  of  Aire-­/-­NOD  
mice520.   Accelerated   autoimmunity   due   to   the   loss   of   Aire   in   the   Scurfy  
background  has  been  suggested   to   reflect   the   importance  of   fully   functional  
peripheral   tolerance   in   other  Aire-­deficient  mice  models71.   Interestingly   both  
NOD240,   269   and   Scurfy67   mice   have   also   been   suggested   to   be   partially  
lymphopenic.  In  both  strains,  dysregulated  LIP  is  believed  to  be  a  co-­factor  in  
the  generation  of  autoimmunity67,  254.    
Scurfy  mice  spontaneously  develop  an  autoimmune  syndrome   that   is  
relatively   limited   in   terms   of   affected   organs414.   This   is   somewhat   strange  
because  the  FoxP3  mutation  prevents  virtually  all  Tregs’  functions.  However,  
when  cells  isolated  from  Scurfy  mice  were  adoptively  transferred  to  RAG-­KO  
mice,  the  recipient  mice  developed  a  strickingly  similar  autoimmune  syndrome  
to   that   is   seen   in   the   Aire-­/-­FoxP3sf   mice414.   The   autoimmune   syndrome   of  
Aire-­/-­FoxP3sf  mice  and   the  disease   that  developed  after  adoptive   transfer  of  
Scurfy   cells   to   lymphopenic   recipients,   is   different   from   both   original   strains  
with   single   defects,   namely   Aire-­/-­   and   Scurfy.   The   syndrome   following  
adoptive   transfer   of   Scurfy   cells   to   lymphopenic   recipients   has   peculiar  
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components  such  as  inflammation  of  the  skeletal  muscles71,  414.  Therefore  it  is  
possible   that   the   severe   autoimmunity   in   Aire-­/-­FoxP3sf   mice   results   from  
combined  effects  of  the  loss  of  Aire  and  FoxP3  expression  together  with  LIP.  
In   many   models   of   LIP-­associated   autoimmunity,   the   disease   is  
believed  to  result  from  a  reduced  Treg/Teffector  ratio138,  269,  318.  It  appears  that  
in  selected  genetic  backgrounds  Tregs   fail   to  act  or  proliferate  as  effectively  
as   autoreactive   effector   T   cells   do   during   LIP,   and   autoimmunity   develops.  
Therefore   LIP   is   a   good  model   for   studying   Treg   function   in   the   context   of  
Aire.  Motivated  by   the  Treg   findings   in  APECED  patients,  we  wanted   to   test  
whether  LIP  would  be  sufficient   to  break  the  tolerance  in  Aire-­deficient  mice,  
with   special   focus   on   Treg   functions   during   the   proliferation.   Lymphopenic  
mice   also   enabled   dissecting   the   peripheral   Aire   expression   from   the   Aire  
expression  in  the  thymus  as  described  in  detail  below.  
3.2   Lymphocytes  Adoptively  Transferred  from  Aire-­/-­  Donors  
to  Normal  Lymphopenic  Hosts  Show  Signs  of  Immune  
Dysregulation  
We  took  advantage  of  LIP  in  order  to  analyze  whether  the  proliferation  would  
enrich   autoreactive   clones   from   the   T   cell   repertoire   that   had   developed  
without  the  presence  of  Aire.  A  similar  approach  has  been  used  for  example  
in  NOD  mice269.  We   reasoned   that   this   process   could  worsen   the   relatively  
mild   spontaneous   autoimmunity   in   Aire-­deficient   mice   without   any   other  
genetic  defects.  One  million  non-­selected  peripheral  mature  lymphocytes  from  
an   Aire-­deficient   donor   were   transferred   to   lymphopenic   recipients   in   the  
same  background  strain.  In  order  to  avoid  the  leakiness  of  some  lymphopenic  
strains1,  264  RAG1  KO  mice  were  chosen  as  the  recipients.  In  the  control  group  
we   transferred   the  same  amount  of  unselected   lymphocytes   from  a  wildtype  
littermate  to  lymphopenic  recipients  (Figure  8).    
The  donor  mice  were  born  and  maintained   in  a  barrier  animal   facility  
before   the  cell   transfer   in  order   to  minimize   the  external  antigen   load  on   the  
animals.  The  transferred  lymphocytes  were  isolated  and  pooled  from  cervical,  
para-­aortic,   and   axillary   lymph   nodes   aseptically   and   injected   into   the   tail-­
veins   of   the   recipient   animals.   The   transfer   experiment   was   done   twice  
independently  so  that  the  total  number  of  donor  animals  was  4  (Aire-­deficient  
donor   n=2,   wildtype   donor   n=2).   We   analyzed   the   transferred   cells   pre-­
transfer   by   flow   cytometry   and   saw   no   significant   difference   between   Aire-­
deficient  and  wildtype  donors  in  the  major  T  cell  populations.  Also  the  amount  
of  B  cells,  the  proportion  of  cells  in  the  cell  cycle  (analyzed  by  expression  of  
the  cell  cycle  marker  Ki67),  and  the  proportion  of  FoxP3+  Tregs  were  equal  in  
the  donors.  All  donors  and  recipients  were  females.  
The  cells  transferred  from  Aire-­deficient  donors  to  RAG1-­KO  recipients  
underwent   LIP   in   an   Aire-­sufficient   environment   (hereafter   named   the   Aire-­
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group).  However,  the  cells  had  developed  without  Aire.  Considering  the  role  of  
Aire   in   the   negative   selection   of   developing   T   cells,   the   transferred   T   cells  
should  have  contained  more  autoreactive  clones  than  the  cells  transferred  to  




Figure   8:   The   transfer   rationale.   By   transferring  mature   lymphocytes   from   an  Aire-­
deficient  donor  to  lymphopenic  recipients  that  have  normal  expression  of  Aire,  I  could  
isolate   the   impact   of   Aire   in   the   thymus   during   T   cell   development   from   Aire’s  
peripheral  expression.  The  control  group  was  otherwise  similar,  but  the  transferred  T  
cells  had  developed  in  a  normal  Aire-­expressing  thymus.    
  
The   recipients   were   terminated   two   months   after   the   transfer,   and  
peripheral  blood  lymphocytes  and  various  tissues  were  collected  for  analysis.  
As   proof   of   the   immune   dysregulation   in   the   Aire-­group,   we   observed   a  
significant  hyperproliferation  of  CD3+  T  cells   in   the  Aire-­group  at   the   time  of  
termination  (Table  10).  Hyperproliferation  was  evident  both  in  circulating  blood  
cells  and  in  the  spleen  samples  measured  by  the  increased  expression  of  the  
cell-­cycle  marker  Ki67.  The  frequency  of  CD3+  cells  in  the  spleen  was  higher  
in   the   Aire-­group   as   compared   with   the   control   group.  When   we   compared  
Ki67  expression  between   the  major  T  cell  populations,   the  CD8+  cytotoxic  T  
cells   originating   in   the   Aire-­deficient  mouse  were   significantly  more   often   in  
tha   active   cell   cycle   and   thus   mostly   accounting   for   the   general   T   cell  
hyperproliferation  (Original  publication  III,  figure  1).  
In  the  LIP  of  T  cells,  the  naïve  CD8+  have  been  reported  to  proliferate  
more  actively   than  naïve  CD4+  cells441.  As   the  proliferation   is  driven  by  self-­
antigen-­MHC   complexes   or   antigens   derived   from   commensal   flora315   we  
concluded  that  this  hyperproliferation  of  CD8+  T  cells  in  the  Aire-­group  reflects  
an  increased  autoreactivity  of  the  naïve  T  cell  repertoire  in  Aire-­deficient  mice.  
Ramsey  et  al.  also  found  T  cell  hyperproliferation   in  Aire-­deficient  mice  after  
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immunization384.  Antigen-­specific  T  cell  proliferation  has  been  reported   to  be  
significantly  higher  in  those  antigen  specific  clones  that  were  infrequent  in  the  
original   T   cell   repertoire381.   Therefore   the   global   hyperproliferation   of   CD8+  
cells  could  actually  be  a   result  of  hyperproliferation  of  several  originally   rare  
autoreactive   clones   in   the   original   T   cell   repertoire.   Aire   regulates   the  
expression  of  a  set  of  TSAs  in  the  thymus295,  so  it  is  indeed  feasible  that  the  T  
cell  repertoire  from  an  Aire-­deficient  host  contains  many  different  autoreactive  
TCRs.  LIP   liberates   these  clones   from  homeostatic  control  mechanisms  and  
they  proliferate  en  masse.  The   loss  of   thymic  Aire   is,   therefore,   sufficient   to  
cause  a  significant  dysregulation  in  the  T  cell  proliferative  responses.  
  
Table  11:  T  cell  hyperproliferation  in  the  Aire-­group  
     Aire-­group  %(±  SD)   Control  group  %  (±  SD)   P-­value  
CD3+  of  PBMC  (1  mo  
after  the  cell  transfer)  
27.9  (±  10.8)   23.0  (±  6.4)   0.235  
CD3+  of  PBMC     25.6  (±  12.0)   21.9  (±  21.5)   0.652  
CD3+  of  splenocytes     43.6  (±  7.0)   31.8  (±  9.6)   0.0068  
Ki67+  of  CD3+  
splenocytes    
17.6  (±  3.1)   12.1  (±  2.9)   0.033  
CD8+  of  CD3+  
splenocytes  
38.5  (±  10.8)   29.0  (±  6.1)   0.026  
Ki67+  of  CD3+CD8+  
splenocytes  
5.5  (±  0.9)   3.0  (±  0.6)   0.0020  
  
   Next,   we   analyzed   the   existence   of   autoantibodies   in   the   recipients,  
another   reported   common   feature   of   the   Aire-­deficient   mice   models.   Both  
study   groups   had   low   levels   of   circulating   CD19+   cells,   consistent   with   the  
reported   lower   LIP   of   B   cells46.   Total   plasma   IgG   and   BAFF   levels   were  
comparable  between  the  groups  indicating  no  significant  B  cell  dysregulation  
in  the  Aire-­group  on  a  systemic  level  (Original  publication  III,  figure  3A).    
One   donor   plasma   sample   stained   positive   for   smooth   muscle   and  
retinal   antibodies,   and   this   autoantibody   production   was   transferred   to   all  
recipients   receiving   cells   from   this   donor.   De   novo   antibody   production  
targeted  against  smooth  muscle  was  found  also  in  the  recipients  that  received  
cells  from  the  donors  that  stained  negative  for  smooth  muscle  autoantibodies  
(Figure  9).  No  other  types  of  autoantibodies  were  seen  even  though  we  used  
a  wide  array  of  tissues  (kidney,  ovary,  liver,  salivary  gland,  stomach,  intestine,  
pancreas,  adrenal  gland)  to  screen  autoantibody  production  in  our  recipients.  
In   total,   all   recipients   in   the  Aire-­group   had   either   retinal   or   smooth  muscle  
autoantibodies.   36%   of   the   control   group   recipients   stained   positive   for  
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smooth  muscle  antibodies  even  though  all  control  donors  were  negative  for  all  
autoantibodies  tested.  This  could  indicate  that  smooth  muscle  autoantibodies  
are   a   result   of   the   general   proliferation   process   in   LIP.   The   Aire-­group   had  
autoantibodies  significantly  more  often  (Original  publication  III,  figure  3B).    
   Smooth  muscle   autoantibodies   are   common   in   autoimmune   hepatitis  
that   is  not  associated  with  APECED341.  Smooth  muscle  autoantibodies  have  
not   previously   been   found   in   Aire-­deficient   mice.   In   the   Finnish   APECED  
patient   cohort   7.1%   of   patients   devoid   of   hepatitis   and   0%   of   patients   with  
autoimmune  hepatitis  were  positive  for  smooth  muscle  autoantibodies340.  Our  
recipient  mice  did  not  show  signs  of  increased  hepatitis,  so  our  results  are  in  
line   with   the   ones   obtained   from   the   APECED   patients.   Retinal  
autoantibodies,  however,  are  common  in  Aire-­deficient  animals  (Table  4).  We  
were  able  to  adoptively  transfer  the  autoreactivity  against  the  eye  but  not  the  
other  components  of  autoimmunity  seen  in  Aire-­deficient  mice.    
Smooth  muscle   autoantibodies   were   generated   in   both   study   groups  
indicating   that   this   kind   of   autoreactivity   is   common   in   general   in   LIP.  
However,  the  Aire-­group  had  these  autoantibodies  more  often  than  the  control  
group,   suggesting   increased   B   cell-­mediated   autoreactivity.   The   IF   assay  
used   did   not   differentiate   between   T   cell-­dependent   and   -­independent  
antibody  production.  Aire-­deficient  mice  have  higher  levels  of  BAFF  indicating  
T   cell-­independent   B-­cell   dysregulation277.   The   study   groups   did   not   have  
significant   differences   in   the   plasma   concentration   of   BAFF,   so   it   is   safe   to  
assume   that   the  autoantibody  production   in   this   transfer  setting   followed   the  
dysregulated  T  cell  immune  response  in  LIP.    During  LIP  T  cells  home  to  the  
T  cell  areas  in  secondary  lymphoid  organs  and  proliferate  there  irrespective  of  
the  presence  of  B  cells46,  117.  Thus  the  importance  of  B  cells  in  LIP-­associated  
autoimmunity   is   insignificant.  The  significance  of  B  cells   in   the  generation  of  
autoimmunity  in  Aire-­deficient  mice  has  been  suggested  to  be  limited,  and  the  
Th1   type   T   cell   response   has   been   concluded   to   be   the   major   effector  
population  driving  the  autoimmunity104.    
We  conclude  that  the  autoantibodies  found  in  the  Aire-­group  reflect  the  
increased  T  cell  autoreactivity,  and  do  not  cause  autoimmunity  per  se  since  all  
animals  stayed  clinically  healthy  during  the  follow-­up  period.  However,  it  was  
evident   that   the   transfer   contained   B   cells   with   the   capacity   to   produce  
autoantibodies  and  these  cells  remained  functional  in  lymphopenic  recipients.  
LIP   did   not   amplify   humoral   autoreactivity   as   no   organ-­specific   de   novo  
autoantibody  production  was  found.  
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Figure   9:   Immunofluorescence   staining   of   a   section   of   mouse   small   intestine.   A  
plasma   sample   from   an   Aire-­group   recipient   was   used   for   staining.   The   outer  
muscular   layer   of   the   intestine,   that   is   composed   of   smooth   muscle,   is   stained  
positive,  but  the  intestinal  epithelium  is  negative.    
3.3   Aire-­group  Show  a  Th1-­biased  T  Cell  Response  
A   significant   proportion   of   antigens   driving   the   fast   lymphocyte   proliferation  
after   adoptive   cell   transfer   to   RAG1-­KO   recipients   originates   from   the   gut  
commensal   flora441.   The   rapid   burst   of   proliferation   is   reduced   in   animals  
maintained   in   a   germ-­free   environment237.   Adoptive   cell   transfer   of   naïve   T  
cells   to   a   lymphopenic   recipient   often   results   in   colitis375.   Considering   this  
background,  we  decided  to  carry  out  a  detailed  analysis  of  T  cells   in  the  gut  
and  gut  draining  lymphoid  tissue  of  the  recipients.    
T   cell   hyperproliferation,   which   was   apparent   also   systemically,   was  
more   pronounced   in   the   MLNs   in   the   Aire-­groups   (original   publication   III,  
figure  4A),  but  no  clinical  colitis  was  evident   in  the  histological  sections  from  
colon.   Real-­time   PCR   from   colon   homogenates   showed   no   significant  
difference  in  the  TCR  C?  mRNA  expression  level  in  the  Aire-­group  compared  
with   the   control   group.   Thus   there   was   no   difference   between   the   study  
groups   in   T   cell   infiltration   into   the   colon   tissue.   When   we   measured   the  
expression   of   different   Th   subtype-­associated   master   regulator   genes  
normalized  to  TCR  C?  expression  level,  we  noted  a  significant  increase  in  the  
expression   of   Tbet   in   the   colons   isolated   from   the   Aire-­group   (Original  
publication  III,  figure  4B).  Tbet  is  an  important  regulatory  gene  of  the  Th1  type  
cells  that  are  important  in  cell-­mediated  immune  responses.  In  the  Aire-­group  
the  colonic  T  cell  infiltrates  were  dominated  by  the  Th1  type  cells,  which  was  
not  the  case  in  the  control  group.  DeVoss  et  al.  found  a  similar  Th1-­dominated  
lymphocyte   infiltration   to   solid   target   organs   in   lymphoreplete   Aire-­deficient  
mice104.    
It   has   been   shown   that   CD8+   cell   do   not   proliferate   in   LIP   efficiently  
without   the   help   from   CD4+   T   cells,   nor   are   they   alone   sufficient   to   cause  
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autoimmune  pathology186,   270.   In  order   to  cause   tissue  destruction,   the  CD8+  
cells   need   additional   help   from   Th1   type   CD4+   cells.   Also   in   Aire-­deficient  
mice,  CD8+   cells   failed   to   cause  autoimmunity   without  CD4+   cells104.   In   our  
model,  the  CD8+  T  cells  hyperproliferated  in  the  peripheral  blood  of  the  Aire-­
group.  It  is  possible  that  the  Th1  dominance  in  the  colon  reflects  some  kind  of  
Aire-­dependent  dysregulation   in   the   initiation  of  Th   immune   responses.  This  
could   cause   bias   in   the   downstream   immune   responses.   For   example,   the  
DCs   from   APECED   patients   have   been   shown   to   produce   more   Th1   type  
cytokines   in  response  to  endotoxin  stimulation   in  vitro  396.  This  dysregulation  
was,  however,  not  sufficient  to  cause  autoimmunity  in  our  lymphocyte  transfer  
model.  
In  APECED  patients,  neutralizing  autoantibodies  against  Th17  effector  
cytokines   are   common241.   It   has   been   speculated   that   these   autoantibodies  
could  be  a  secondary  event  caused  by  a  chronic  Candida  infection  resulting  in  
an   increased   production   of   these   cytokines   followed   by   autoantibody  
formation   against   them.   Supporting   this   view   an   enhanced   Th17   type  
response  towards  Candida  has  been  found  in  APECED  patients4.  In  mice,  no  
cytokine  autoantibodies  have  been  published  so  far,  but  it  is  possible  that  the  
aseptic  environment  of  mice  facilities  and  the  absence  of  chronic  candidiasis  
explains   this   difference.   Only   one   group   has   been   able   to   show   that   when  
Aire-­/-­   mice   were   exposed   to   Candida,   the   mice   showed   increased  
susceptibility   to   the   pathogen4.   The   effector   T   cells   isolated   from   the   gut  
draining   lymph   nodes   of   the   intragastrically   infected   Aire-­/-­   mice   showed   a  
more  pronounced  Th1  and  Th17  type  cytokine  response  to  Candida  antigens  
in   vitro   when   compared   with   infected   Aire+/+   controls4.   This   finding   could  
indicate   that   the   biased   Th   response   in   the   absence   of   Aire   could   have   a  
pathogenetic   role   in   the   failure   to   clear  Candida   infection.   Our   results   also  
suggest  that  Aire  deficiency  causes  a  bias  in  Th  response.  This  Th  response  
dysregulation   is   also   evident   in   responses   to   both   self   and   commensal  
antigens.  
3.4   Hyperproliferation  of  Aire-­/-­  Donor  Originating  Tregs  in  
Gut-­draining  Lymphoid  Tissue  
The  recipients   in  the  Aire-­groups  stayed  clinically  healthy  even  though  signs  
of   immune  dysregulation   and  hyperproliferation   of   autoreactive  T  cells  were  
evident.  We  wanted  to  study  whether  the  suppressive  functions  of  peripheral  
tolerance  would  prevent  the  hyperproliferating  autoreactive  T  cell  clones  from  
causing  tissue  damage.  During  proliferation  Tregs  are  important  in  controlling  
the  fast  LIP492,  but  under  a  steady-­state  environment  they  appear  to  function  
and   develop   relatively   independently   of   the   presence   of   gut   microbiota312.  
iTregs,  however,  are  generated  especially   in   the   intestine,  and  gut  microbial  
antigens   are   important   in   the   process165.   The   importance   of   Tregs   in  
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controlling  LIP  is  highlighted  by  T  cell  transfer  colitis,  which  can  be  prevented  
by  the  co-­transfer  of  Tregs227.    
Initially  one  month  after  the  transfer,  the  proportion  of  FoxP3+  Tregs  in  
the   circulation   was   comparable   between   the   study   groups.   At   the   time   of  
termination,  CD4+  cells  in  the  Aire-­group  did  not  hyperproliferate  systemically,  
but   when   we   analyzed   the   subpopulation   of   FoxP3+   expressing   Tregs,   a  
significant  difference  between  the  groups  was  found.  The  proportion  of  Tregs  
in  the  cell  cycle  was  higher  in  the  Aire-­group  both  in  the  circulation  and  in  the  
gut  draining  lymphoid  tissue  than  in  the  Control  group  (Original  publication  III,  
figure  5B).   In  MLNs,   the   frequency  of  Tregs  was  also  significantly  elevated,  
indicating  an  accumulation  of  Tregs  to  the  site  of  active  proliferation  (Original  
publication   III,   figure   5C-­D).   Also   in   the   colon   tissue   the   amount   of   FoxP3  
mRNA  normalized  to  the  expression  level  of  TCR  C?  was  significantly  higher  
in  the  Aire-­group  (Original  publication  III,  figure  5E).    
An   increased   proportion   of   FoxP3+   cells   does   not   fully   reflect   the  
suppressive   function   of   the   Tregs.   For   a   more   detailed   analysis   of   the  
increased  Tregs  in  the  Aire  group,  we  measured  the  relative  expression  of  a  
suppressive   cytokine   TGF-­?   in   MLNs.   TGF-­?   mRNA   expression   was  
significantly  higher  in  the  Aire-­group  than  in  the  control  group  (Figure  10).  The  
increase   was   evident   when   the   TGF-­?   mRNA   level   was   normalized   to   C?  
mRNA   expression.   Thus,   there   were   significantly   more   TGF-­?   producing   T  
cells  in  the  MLNs  of  the  Aire-­group.  This  increase  in  TGF-­?  production  is  most  
likely   due   to   the   increased   amount   of   Tregs   in   the   MLNs.   In   contrast   to  
humans,   in   mice   the   transient   non-­suppressive   FoxP3   up-­regulation   in  
activated  T  effector  cells  has  not  been  reported517.  Thus  it  is  unlikely  that  the  
increased   proportion   of   FoxP3+   cells   would   be   non-­suppressive   cells.   The  
increase   in   the  production  of   the  suppressive  cytokine  TGF-­?  also   indicates  
that   FoxP3+   Tregs,   which   accumulated   in   MLNs,   were   indeed   true  






Figure   10:   Relative   TGF-­?   mRNA  
expression   normalized   to   C?  
expression   in   total   lymphocytes  
isolated   from   mesenterial   lymph  
nodes.  
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Taken   together,   we   can   conclude   that   the   dysregulated   lymphocyte  
proliferation   in   the   Aire-­group   did   not   result   in   autoimmunity   because   of  
increased  Treg-­mediated  suppression  at  the  sites  of  active  T  cell  proliferation.  
Correct   homing   and   accumulation   of   Tregs   to   the   site   of   inflammation   has  
been  shown  to  be  indispensable  for  their  suppressive  activity420.  Our  findings  
indicate   that   the   loss  of  Aire  during  T  cell  development  does  not  affect  Treg  
functions  during  LIP,  or  the  accumulation  of  Tregs  to  the  site  of  inflammation.    
One  interesting  explanation  for  the  increase  in  Treg  frequency  could  be  
that  the  high  affinity  autoreactive  clones  that  had  escaped  negative  selection  
in   the   Aire-­deficient   thymus,   would   have   acquired   a   Treg   phenotype   in   the  
periphery   during   LIP   in   an   Aire-­sufficient   environment.   Peripheral   iTreg  
conversion   has   been   reported   to   take   place   especially   in   the   gut   draining  
lymphoid  tissue  and  during  LIP  87,  88,  165.  TCR  signaling  and  TGF-­?  are  needed  
for   the   conversion69.   Originally   it   was   believed   that   low-­affinity   TCR  
engagement  up-­regulates  FoxP3  in  the  periphery,  but  recent  evidence  shows  
that   high-­affinity   peptide-­TCR   interactions   are   needed   for   a   stable   iTreg  
phenotype162.   iTreg   conversion   appears   to   be   antigen-­specific   in   the  
generation   of   oral   tolerance   and   under   lymphopenic   conditions88.   The   iTreg  
and  nTreg  repertoires  have  been  reported  to  be  overlapping  and,  therefore,  it  
is   hypothesized   that   the   peripheral   conversion   to   the  Treg   phenotype   could  
give  certain  TCR  specificities  “a  second  chance”  to  become  Tregs  after  thymic  
selections267.    
Our   model   could   not   distinguish   between   iTreg   conversion   and   the  
expansion   of   nTregs   from   the   original   transfer.   The   elevated   TGF-­?  
expression  level  could  result  from  an  increased  amount  of  active  Tregs  in  the  
mesentery.   However,   these   two   explanations   need   not   be   exclusionary.  
Haribhai  et  al.192  reported  that  the  collaboration  between  iTregs  and  nTregs  is  
needed  for  effective  protection  from  T  cell  transfer  colitis.  nTregs  can  enhance  
iTreg   conversion   via   TGF-­?   production.   Thus,   the   increased   proportion   of  
Tregs   in   the  Aire-­group  MLNs  could   result   from  both   increased  homing  and  
proliferation  of  nTregs,  and  increased  iTreg  conversion  in  a  TGF-­?-­dependent  
fashion.  The  loss  of  thymic  Aire  did  not  affect  this  process.  
  
4   Loss  of  Aire  Expression  in  the  Peripheral  Immune  
System  Causes  Symptomatic  Autoimmunity  (IV)    
4.1   Generation  of  Lymphopenic  Aire-­deficient  Mice  
(AireRAG1)  
In  order   to  study  whether  Aire  expression  outside  the  thymus  has  an   impact  
on   peripheral   tolerance,   we   crossed   Aire-­/-­  mice  with  RAG1-­KO  mice   in   the  
C57BL/6  background.  The  resulting  double-­KO  mice  were  completely  devoid  
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of   autoimmune   manifestations   and   also   produced   litters   in   a   comparable  
amount   compared   to   wildtype  mice.   This   finding   proves   that   the   subfertility  
often  seen  in  Aire-­deficient  males220  is  of  autoimmune  origin  and  mediated  by  
cells  of  adaptive   immune  system.  The  RAG1-­KO  genetic   construct  prevents  
all  B  or  T  cell  receptor  recombinations,  and  accordingly  no  mature  B  or  T  cells  
were  found  in  the  periphery  of  AireRAG1  double-­KO  mice.    
4.2   Adoptive  Transfer  of  Unselected  Lymphocytes  from  a  
Normal  Donor  Generates  Colitis  in  AireRAG1  Mice  
A  similar   transfer  as   in   the  Aire-­group  experiment  was  carried  out  using   the  
AireRAG1  double-­KO  mice  as  recipients.  Donors  were  wildtype  mice  from  the  
Aire   breeding   colony.   This   study   group   is   hereafter   called   the   AireRAG1-­
group.   In   the   control   group   recipients   were   Aire-­sufficient   RAG1-­KO   mice  
(Figure  11).  In  this  setting  we  ere  able  to  follow  how  the  loss  of  Aire  from  the  
peripheral   immune   system   affected   the   outcome   of   LIP.   Donor   cells   were  
chosen   to   be   isolated   from   wildtype   donors,   since   in   this   experiment   we  
wanted  to  exclude  the  role  of  Aire  in  the  thymus  and  in  negative  selection.      
  
  
Figure   11:   The   transfer   rationale.   By   transferring   mature   lymphocytes   from   Aire-­
sufficient  donors  to  Aire-­deficient  lymphopenic  recipients,  that  express  no  Aire  in  the  
secondary   lymphoid  organs,  we  could  follow  the  role  of  peripherally  expressed  Aire  
during  LIP.  
We   followed   the   wellbeing   of   the   AireRAG1   and   control   recipients  
weekly.  The  majority  of   the   recipients   (11  out  of   12)   in   the  AireRAG1-­group  
developed  diarrhoea   from   the   second  week   after   transfer   onwards   (Original  
publication   IV,   figure   1A).   No   recipients   in   the   control   group   were  
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symptomatic.  Three  out  of  12  AireRAG1   recipients   lost  weight  or  developed  
general   signs   of   wasting   disease   (bad   fur,   hunching)   together   with   the  
diarrhoea.   The   disease   was   so   severe   in   one   mouse   to   necessitate  
termination  before  the  end  of  the  experiment.  The  mouse  was  terminated  on  
the  fourth  week  after  the  transfer  since  it  had  lost  over  20%  of  its  body  weight.  
The  rest  of  the  recipients  were  terminated  2  months  after  the  transfer.    
   At   the   time   of   termination   a  macroscopical   analysis   of   the  AireRAG1  
recipients   showed   that   the   animals   were   suffering   from   colitis   that   was  
characterized   by   a   grossly   enlarged   colon   (7/11),   fibrotic   mesentery,  
mesenterial   lymphadenopathy   (6/11),  and  splenomegaly   (6/11).  These  signs  
of   intestinal   inflammation   were   also   found   in   the   only   mouse   that   did   not  
develop  clinical   diarrhoea.   In   the  control   group   two  mice  out  of  11   lost  over  
10%  of   their  body  weight  during   the   two-­month   transfer  experiment  and  one  
had  mesenterial  lymphadenopathy.  A  clinical  score  was  used  to  compare  the  
disease   in   the   AireRAG1-­   and   control   groups   (modified   from   Simpson   et  
al.423).  In  the  clinical  score  animals  are  given  points  according  to  the  following  
symptoms   found   at   autopsy:   wasting   (weight   loss   in   excess   of   10%),  
hunching,  and  colon  enlargement  each  gave  a  maximum  of  one  point.  Stool  
consistency  was  evaluated  on  a   scale   from  0   to   2,  watery   stools   giving   the  
maximum  of  2  points.  The  clinical  scores  were  thus  evaluated  on  a  scale  of  0-­
5.  The  mean  clinical  score  in  the  AireRAG1-­group  was  1.8  (SD  ±  0.9)  while  in  
the   control   group   it   was   0.2   (SD   ±   0.4).   The   difference   was   statistically  
significant  (P  <  0.0001).  
Colitis  was  confirmed  by  a  histological  analysis  of  colon  sections.  The  
colon  wall  was  thickened  and  mononuclear  basal  layer  lymphocyte  infiltration  
was   evident   (Original   publication   IV,   figure   1B).   However,   epithelial  
ulcerations  were  not  seen,  so  the  colitis  was  graded  histologically  as  mild.  A  
more  thorough  histological  analysis  was  done  in  one  of   the  two  independent  
transfer   experiments.   Histological   staining   revealed   gastritis   in   4/6   and  
exocrine   pancreatitis   in   2/6   of   the   AireRAG1  mice   tested.   In   other   reported  
target   organs   in  Aire-­deficient  mice,   histological   analysis   did   not   reveal   any  
significant  difference  between  the  groups.    
We  used  the  systemic  inflammation  marker  SAP  to  measure  the  overall  
inflammation   in   the   recipients.   One   month   after   the   transfer,   both   recipient  
groups  had  elevated  serum  SAP  levels:  AireRAG1-­group,  mean  173  mg/l  (SD  
±   90),   and   control   group,   mean   133  mg/ml   (SD   ±   69,   P=0.27).   In   the   four  
weeks   previous   to   the   termination,   the   SAP   concentration   increased   in   the  
AireRAG1-­group   significantly   more   than   in   the   control   group.   The   mean  
concentration   at   the   time   of   termination   was   389   mg/l   (SD   ±   306)   in   the  
AireRAG1-­group  and  224  mg/l   (SD  ±  188)   in   the  control  group   (significance  
for  change;;  AireRAG1  P=0.020,  control  P=0.14)  (Original  publication  IV,  figure  
1C).   It   should   be   noted   that   both   groups   showed   high   variation   in   the  SAP  
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concentrations   and   that   explains   why,   even   though   the   average  
concentrations  were  clearly  different,   the  differences  did  not   reach  statistical  
significance.  
The  loss  of  Aire  could  affect   the  barrier  function  of   the  gut  epithelium,  
as   its   expression   has   been   associated   with   tight   junction  molecules185   and  
Aire   has   been   suggested   to   control   the   expression   of   many   intestine-­
associated  genes172.  Increased  epithelial  leakage  due  to  the  loss  of  Aire  could  
explain  the  colitis  in  the  AireRAG1-­group  irrespective  of  LIP,  even  though  this  
should   then   be   evident   in   immunocompetent   Aire-­deficient   mice   as   well.  
Increased  epithelial  leakage  should  manifest  as  a  systemic  immune  response  
towards   gut   flora   antigens.   Therefore,   we   analyzed   recipients   for   the  
production  of  antibodies  targeted  against  the  commensal  flora  bacteria  E.coli  
or   Enterococcus   spp.   but   found   no   difference   between   the   groups.   In  
conclusion,   the   colitis   in   the   AireRAG1   recipients   did   not   result   from   a  
significantly  increased  systemic  leakage  of  intestinal  flora  antigens.  
Next  we   tested   the   recipients   for   autoantibodies   targeted   to   intestinal  
tissue,   since   we   reasoned   that   these   autoantibodies   could   reflect   an  
autoimmune   inflammation   targeted   to   the   gut   tissue   itself.      The   loss   of  Aire  
could,  in  theory,  for  example  reveal  new  antigenic  structures  in  the  gut.  If  this  
kind   of   scenario   would   be   true,   the   colitis   seen   in   our   AireRAG1   recipients  
would   actually   be   the   result   of   the   reactivity   of   a  normal  T   cell   repertoire   to  
new   antigenic   structures.   Naturally,   this   would   mean   that   Aire-­deficient  
animals  would  spontaneously  develop  autoimmunity  towards  intestinal  tissue,  
which   is   not   the   case.   In   IF   staining   using   frozen   gut   sections,   40%   of   the  
control   and   50%   of   AireRAG1-­group   recipients   stained   positive   for   smooth  
muscle  antibodies  similarly  to  the  first  Aire  transfer  experiment  (III).  This  time  
the   difference   between   the   groups   was   not   statistically   significant,   and   the  
staining   intensity   was   generally   weak   in   both   groups.   No   autoantibodies  
targeted  to  the  intestinal  epithelium  were  found.    
In  summary,   in  the  AireRAG1-­group  the   intestinal  barrier  function  was  
overtly  normal.  A  comparable  proportion  of  the  recipient  mice   in  both  groups  
had   low   levels  of  autoantibodies   targeted   to   the  smooth  muscle   layer  of   the  
intestinal  wall.  Most  likely,  the  smooth  muscle  autoantibodies  reflect  common  
immune   processes   during   LIP   and   were   not   associated   with   the   loss   of  
peripherally  expressed  Aire,  since  they  were  as  common  in  the  control  group.  
The   inflammation   marker   SAP   increased   more   in   the   AireRAG1-­group  
indicating   that   the   systemic   inflammation  was   present   in   both   groups,   but   it  
was   more   pronounced   when   peripheral   Aire   was   missing.   Considering   the  
evidence   that   LIP   is   strongly   dependent   on   the   gut   commensal   flora  
antigens123,   237,   we   suggest   that   the   loss   of   Aire   expression   from   the  
secondary   lymphoid   organs   caused   a   local   dysregulated   inflammatory  
response   to   gut   microbial   antigens.   This   dysregulation   resulted   in   a   mild  
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colitis.  No  systemic  antibodies   targeted   to   the  gut  microbiota  were   found,  so  
the   dysregulation   appeared   to   be   weak   and   anatomically   restriced   to   the  
intestine  or,  limited  only  to  cellular  immune  responses.    
4.3   Adoptively  Transferred  Normal  Tregs  Proliferate  Slower  
in  Aire-­deficient  Lymphopenic  Mice  
The  AireRAG1-­group  did  not  show  significant  systemic  hyperproliferation  of  T  
cells   one  month   after   the   transfer,   or   at   the   time   of   termination.   The   CD3+  
frequencies  and  CD4  /  CD8  proportions  were  comparable  between  the  study  
groups  both  in  the  circulation  and  the  spleen  (Figure  12).  Therefore,  the  colitis  
in   the   AireRAG1-­group   was   not   caused   by   systemic   uncontrolled  
lymphoproliferation   like   it   is   in   for   example   the   IL-­2  KO  mice288.  Ramsey  et  
al.383  found  that  Aire-­/-­  DCs  drive  T  cell  hyperproliferation   in  vitro.  Our  results  
in  vivo  do  not  support  this  view,  at  least  not  systemically.  On  the  contrary,  the  
AireRAG1-­group   had   lower   numbers   of   circulating   T   cells   compared   to   the  
control  group,  even  though  the  difference  did  not  reach  statistical  significance.    
  
  
Figure   12:   Analysis   of   T   cell  
populations   in   the   AireRAG1-­
group.   No   significant  
hyperproliferation   at   the   time   of  
termination   of   A)   T   cells   in  
general  or  B)   in   the  CD4+  T  cell  
subset   in   the   AireRAG1group.  
The  cells  analyzed  were  isolated  
from  the  spleen.  The  differences  
are   not   statistically   significant.
  
Consistent  with  the  inflammation  in  the  colon  tissue,  we  noted  an  increase  
in   the   proportion   of   CD3+   cells   in   MLNs   in   the   AireRAG1-­group.   In   the  
AireRAG1-­group  on  average  63%  (SD  ±17)  of  lymphocytes  isolated  from  the  
MLNs   were   CD3   positive   as   compared   with   the   control   group   where   the  
proportion   of   T   cells   was   28%   (SD   ±18,   P=0.015).   The   proportion   of   CD3+  
cells   in  active  cell  cycle  was  comparable   in  both  groups.  This  could   indicate  
that   the  accumulation  or  proliferation  of  T  cells   in   the  AireRAG1-­group  mice  
mesenterium   had   already   taken   place   before   termination.   The   CD4   /   CD8  
ratio   was   comparable   in   both   groups.   Thus,   both   of   the   main   T   cell  
populations  accounted  equally   to   the   increased  amount  of  T  cells   in   the  gut  
draining   lymph  nodes.  The  accumulation   of  CD3+   cells   into   the   gut   draining  
lymph  nodes  could  explain  the  lower  proportion  of  T  cells  in  the  spleen  (Figure  
12A).  This  finding,  together  with  the  lack  of  intestinal  autoantibodies,  strongly  
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indicates  that  the  colitis  found  in  the  AireRAG1  recipients  was  mediated  by  T  
cells.  
The  AireRAG1-­group  showed  a  significant  accumulation  of  T  cells  into  gut  
draining   lymph   nodes   and   had   symptomatic   colitis.   Taken   together,   these  
findings   indicate   that   during   LIP,   the   T   cell   responses   were   locally  
dysregulated   when   peripherally   expressed   Aire   was   missing,   and   the   local  
dysregulation   resulted   in   symptomatic   autoimmune   disease.   As   discussed  
previously,  Tregs  are  important  in  controlling  LIP.  Therefore,  the  symptomatic  
autoimmune   colitis   in   AireRAG1   animals   could   have   been   caused   by  
peripheral  Aire-­dependent  defects  in  Treg  functions.    
We  measured   the   amount   of   FoxP3+  Tregs   in   the   circulation   one  month  
after   the   transfer.   The   frequency   of   FoxP3+   positive   cells   in   the   total   CD4+  
population  was  lower  in  the  AireRAG1-­group,  but  the  difference  did  not  reach  
statistical   significance.   In   the  AireRAG1-­group  4.2%   (SD  ±  0.98)  CD4+   cells  
expressed  FoxP3  while   in   the   control   group   5.8%   (SD   ±   1.6)   of  CD4+   cells  
were  positive   for  FoxP3   (P=0.0944).  However,  when  we  analyzed   the  Ki67+  
subpopulation  of  Tregs  one  month  after  the  transfer  it  was  evident  that  in  the  
AireRAG1-­group  a  significantly  lower  proportion  of  Tregs  was  in  an  active  cell  
cycle.  The  proportion  of  FoxP3+Ki67+  cells  of  total  CD4+  cells  was  1.8%  (SD  ±  
0.7)  in  the  AireRAG1-­group,  while  it  was  3.4%  in  the  control  group  (SD  ±  0.9,  
P=0.012,  original  publication  IV,  figure  2A).  The  difference  was  still  evident  in  
the  spleen  at   the   time  of   termination  (AireRAG  1.6%  SD  ±  0.8,  control  3.3%  










Figure  13:  Percentage  of  Tregs   in   the  
cell  cycle  during  the  2-­month  transfer.  
  
   It   appeared   that   the   loss   of   Aire   from   the   peripheral   immune   system  
caused  a  decreased  systemic  proliferation  of  Tregs  during  LIP.  This  resulted  
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in  a  decreased  frequency  of  Tregs  in  the  spleen  at  the  time  of  termination:  the  
percentage  of  the  FoxP3+  cells  in  the  total  CD4+  population  in  the  AireRAG1-­
group  was  10.5%  (SD  ±  6.0),  when   in   the  control  group   it  was  18.9%  (SD  ±  
2.1,   P=0.0174,   original   publication   IV,   figure   2C).   It   is   known   that   defective  
Treg  activation  may  cause  delayed  Treg  proliferation.  Our  data  suggest   that  
the  peripheral  expression  of  Aire   is   required  for  correctly   timed  and  effective  
Treg  activation  during  LIP.  This  is  illustrated  when  the  data  of  Tregs  in  active  









Figure   14:   The   kinetics   of   the  
proportion  of  Tregs  in  the  cell  cycle   in  
the   circulating   blood   (FoxP3+Ki67+   of  
the  total  CD4+  population).  Time-­point  
“transfer”   is   the   proportion   of   Ki67+  
Tregs  in  the  transferred  cells  analyzed  
pre-­transfer.   At   the   time-­point   of   one  
month  P=0.039  for  difference  between  
groups,  at  two  months  P=0.46.  
  
If   Tregs   are   not   fully   activated,   it   may   result   in   a   decreased   Treg   /   T  
effector  cell  ratio  that  has  been  associated  with  autoimmunity  in  mice246,  318.  It  
is  thus  possible  that  the  delayed  proliferation  of  Tregs  in  the  AireRAG1-­group  
explains   the   locally   dysregulated   immune   response   in   the   colon  during   LIP.  
Intestinal   lymph   nodes   have   been   shown   to   express   intestinal   self-­antigens  
together  with  Aire271.  It  is  possible  that  an  Aire-­dependent  antigen  expression  
in   the   gut-­associated   lymphoid   tissue   would   be   associated   with   Treg  
activation,  or  even  conversion  of  iTregs  from  naïve  T  cells.    
  
5   Summary  of  the  Results  (III-­IV)  
The   findings   from   these   two   separate   transfer   experiments   (Publications   III  
and   IV)   indicate   that   the   loss   of   Aire   from   the   peripheral   immune   system  
results   in   delayed   proliferation   of   Tregs,   but   that   the   thymic   loss   of   Aire  
expression   does   not   affect   Treg   function   in   the   peripheral   immune   system  
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(Figure   15).   LIP   in   chronically   lymphopenic   animals   is   largely   driven   by   gut  
commensal   antigens,   and   shares   many   features   of   a   normal   microbial  
antigen-­specific  immune  response123,  441.  Our  experimental  model  of  adoptive  
cell   transfer   to   RAG1-­deficient   recipients   thus   mimics   a   normal   immune  
response   to   foreign   antigens.   We   have   shown   here   that   peripherally  
expressed  Aire   is   involved   in  Treg  activation  and  proliferation  during  such  a  
response.   The   loss   of   Aire   from   the   secondary   lymphoid   organs   can   cause  
autoimmune   disease   resulting   from   a   defective   systemic   Treg   proliferation.  
This   resulted   in   a   reduced   Treg   frequency   and   dysregulated   effector   T   cell  
response   to   commensal   antigens.   In   contrast,   Tregs   that   had   developed  
without   Aire   hyperproliferated   in   an   Aire-­sufficient   lymphopenic   environment  
and  protected  the  animals  from  autoimmune  pathology,  even  though  signs  of  
immune  dysregulation  were  evident.    
FoxP3+  Tregs  are  generated  in  vivo  through  multiple  pathways.  nTregs  
originate  from  the  thymus,  but  iTregs  are  also  generated  from  the  memory  T  
cell  population,  or   through  peripheral   iTreg  conversion88.  There   is   increasing  
evidence   showing   that   Tregs   are   important   in   controlling   the   immune  
responses  to  infectious  agents  as  well,  possibly  guiding  the  immune  response  
to  the  most  effective  mechanism  of  fighting  the  external  microbes34.  Antigen-­
specific  Tregs  expand  very  early  during  the   immune  response,  so  it  appears  
that   the   fast   proliferation   of   Tregs   is   essential   for   controlling   the   immune  
response.   In   the   light   of   the   results   gained   from   our   mouse   model,   it   is  
possible   to  speculate   that  extra-­thymic  Aire-­expressing  cells  are   important   in  
the  activation,  or  conversion  of  Tregs  during  immune  responses.    
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Figure   15:   Summary   of   the   results   of   the   two   independent   adoptive   cell   transfers,  
isolating   Aire’s   thymic   and   peripheral   expression.   Teff   =   effector   T   cell,   i.e.   non-­
suppressive  T  cell.  
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Concluding  remarks  and  future  directions  
  
Originally  AIRE  was  believed  to  function  solely  as  a  transcription  factor  driving  
the   promiscuous   antigen   expression   in   the   thymic   medulla.   By   utilizing   the  
Aire-­deficient   mouse   models,   the   functions   and   expression   of   Aire   during  
thymic   organogenesis   and   in   peripheral   lymphoid   organs   has   been  
established.   Furthermore,   recent   data   also   provide   evidence   for   Aire   in  
complex   immunological  processes,  such  as   lymphocyte  trafficking.  AIRE  has  
thus   evolved   from   a   transcription   factor   enabling   negative   selection   to   a  
significant   controller   of   T   cell   development   and   functions,   with   the   main  
emphasis   still   on   the  development  of  T   cell   tolerance.  The   complete   role  of  
AIRE  in  the  immune  system  as  a  whole  remains  to  be  revealed.      
When   we   published   the   Treg   defects   in   APECED   patients,   the   article  
received  critical  attention;;  for  example  it  was  claimed  that  there  is  no  evidence  
that  AIRE  has  an  effect  on  Tregs  at  a  global   level296.   It  was  also  suggested  
that  the  decrease  in  FOXP3  expression  in  APECED  patients  could  result  from  
a  dilution  effect,  caused  by  the  increased  amount  of  activated  effector  T  cells  
due  to  an  ongoing   immune  response  against   for  example  Candida296.   In  our  
work,   there   were   no   significant   differences   between   patients   and   healthy  
controls  in  the  number  of  activated  CD25+  cells,  nor  in  the  expression  of  other  
activation-­associated   markers.   None   of   the   patients   were   suffering   from  
systemic   infections   during   sampling.   Considering   the   fact   that   activated  
human   lymphocytes   up-­regulate   FOXP3   without   suppressive   function,   the  
non-­suppressive  FOXP3  expressing  effector  cells  would  have  been  seen  as  a  
pronounced  CD25highFOXP3low  population.  This  was,  however,  not   the  case.  
We  can  thus  conclude  that  the  increased  effector  cells  in  APECED  patients  do  
not  explain  the  decrease  in  FOXP3  expression.    
The  observation   that  Tregs   from  APECED  patients  express   low   levels  of  
FOXP3   has   been   replicated   in   a   Norwegian   APECED-­patient   cohort,   even  
though   the   authors   only   did   phenotypical   analysis   and   carried   out   no  
functional  analyses494.  Also,  our  own  group  has  further  substantiated  that  the  
defective  Treg  population  in  APECED  patients  is  actually  the  activated  Tregs  
that  fail  to  express  high  levels  of  FOXP3  261.    
The  main  argument  against  an  AIRE-­related  Treg  defect  has  been  that  our  
findings   in  APECED  have  not  been  replicated   in  Aire-­deficient  mice.   Indeed,  
originally   Aire-­deficient   mice   had   an   overtly   normal   Treg   function19.   Recent  
more   detailed   analyses   have,   however,   shown   that   murine   Tregs   are   not  
normal   when   Aire   is   missing.   Aschenbrenner25   and   Lei272   have   shown   that  
Aire-­expressing  mTECs  are  required  for  murine  nTreg  development.  Hubert220  
analyzed  the  published  Treg  frequencies  in  different  Aire-­deficient  animals  in  
detail  and  suggested  that  there  is  a  trend  towards  a  decreased  proportion  of  
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peripheral   Tregs,   even   though   the   differences   in   single   studies   were   not  
statistically   significant.      Aricha22   analyzed   the   proportion   of   Tregs   in   Aire-­
deficient  mice  and  found  that  Aire-­deficient  mice  have  significantly  less  Tregs  
in  the  thymus,  but  that  the  peripheral  proportion  of  Tregs  is  decreased  only  in  
older   animals.   In   subsequent   more   detailed   analyses,   the   peripheral   Tregs  
and  thymic  Treg  development  were  found  to  be  impaired  in  the  Aire-­deficient  
mice.    
In   the   two  transfer  experiments  we  showed  that   the   loss  of  Aire  from  the  
periphery   during   lymphopenia-­induced   proliferation   resulted   in   autoimmune  
colitis,   while   the   loss   of   Aire   during   lymphocyte   maturation   did   not   cause  
symptomatic   autoimmunity   in   a   similar   setting.   This   finding   provides  
experimental   support   for   the   role  of   extra-­thymic  Aire   in   the  maintenance  of  
peripheral   tolerance.  Aire-­deficient   recipient  mice  suffering   from  colitis  had  a  
lower  proportion  of  Tregs   in   the  cell  cycle,  and   this  slower  Treg  proliferation  
resulted  in  a  decreased  systemic  amount  of  FoxP3.  This  indicates  that  extra-­
thymic  Aire  is  involved  either  in  Treg  activation,  iTreg  conversion,  or  efficient  
FoxP3   expression.   An   intrinsic   defect   in   Tregs   is   excluded,   since   the  
transferred   Tregs   originated   from   wildtype   donors   with   unaffected   Treg  
development.  In  comparison,  Tregs  that  had  developed  in  the  absence  of  Aire  
hyperproliferated   in   Aire-­sufficient   recipients.   This   difference   indicates   that  
Tregs  that  developed  without  Aire  are  functional  and  capable  of  suppressing  
autoreactive  proliferation  if  Aire  is  present  in  the  secondary  lymphoid  organs.    
Teh  et  al.449  studied  different  molecules  associated  with  the  maintenance  
of   peripheral   tolerance   together   with   Aire   deficiency   (as   discussed   on   page  
58).  They  found  that  Aire-­deficient  mice  crossed  with  the  Cbl-­b  deficient  mice  
developed   a   more   severe   autoimmune   syndrome   than   either   one   of   the  
parental   strains.   However,   when   Aire-­deficient   mice   were   crossed   with  
Card11   deficient   animals,   the   disease   severity   was   not   affected449.   The  
authors  concluded  that   the  reduced  need  for  co-­stimulation  caused  by  Cbl-­b  
deficiency   would   be   the   causative   agent   for   accelerated   disease,   but   the  
results  can  be  also  interpreted  differently.  Cbl-­b  signaling  has  been  shown  to  
mediate   FoxP3   up-­regulation   and   iTreg   conversion158,   191   in   the   periphery,  
while   Card11   signaling   has   been   shown   to   be   required   for   thymic  
development   of   nTregs317   but   it   not   essential   in   the   periphery31.   It   is   thus  
possible  that   the  severe  autoimmune  disease   in  Aire-­/-­Cbl-­b-­/-­  mice   is  caused  
by   additive   defects   in   the   peripheral   up-­regulation   of   FoxP3,   or   the   iTreg  
phenotype  conversion  
The   APECED   patient   Tregs   failed   to   suppress   T   cell   proliferation   in  
response   to   polyclonal   stimulus   in   vitro.   Also,   in   Aire-­deficient   lymphopenic  
mice,   Tregs   failed   to   suppress   T   cell   hyperproliferation   in   MLNs   during   an  
immune  response  driven  by  polyclonal  microbial  antigens123.   It   thus  appears  
that  the  Treg  defect  following  the  loss  of  AIRE  is  not  universal  but,  instead,  it  
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appears  only  in  a  situation  where  several  clones  of  lymphocytes  proliferate.  If  
this  would  be  the  case,  the  failures   in  Treg  activation  and  suppression  could  
explain  the  episodic  disease  progression  in  APECED  that  is  one  of  the  special  
features  of  the  disease.  Without  prompt  Treg  action  in  the  very  early  phases  
of   the   immune   response,   lymphocyte   proliferation   and   activation   is  
dysregulated   and   can   cause  autoimmune   tissue   damage.   In   patients,   these  
attacks   could   follow   for   example   dysregulated   immune   responses   towards  
viral  or  bacterial  infections.    
It   has   been   speculated   that   iTregs   would   be   more   important   in   the  
maintenance  of  tolerance  in  humans  than  in  mice,  because  a  longer  lifespan  
results   in   thymic   involution   that   reduces   the   thymic   output   of   nTregs.   This  
could   explain   the   original   differences   in   the   disease   severity   between   Aire-­
deficient  mice  and  APECED  patients;;  the  peripheral  loss  of  AIRE  reduces  the  
amount  of  peripheral   functional  Tregs  and  the  effect   is  cumulative  with   time.  
Also  in  Aire-­deficient  mice  the  autoimmune  syndrome  is  more  severe  in  aged  
animals   that   also   have   reduced   numbers   of   Tregs22.   This   is   consistent  with  
our   theory  of  serial  dysregulated   immune  responses   to   foreign  antigens   that  
lead  to  autoimmune  episodes.    
Future   studies   should   be   aimed   at   identifying   the   peripheral   AIRE-­
expressing  cells  that  are   involved  in  Treg  activation.  The  mechanisms  of   the  
defect   in  Treg   function  should  be  dissected   in  more  detail;;   our  data  are  not  
sufficient   to   differentiate   between   defective   activation,   proliferation,   or   iTreg  
conversion.  If  an  AIRE-­dependent  peripheral  pathway  for  Treg  function  would  
be   identified,   it   could  be  utilized   for   example   in   antigen-­specific   induction  of  
Tregs   ex   vivo.   The   knowledge   of   how   to   manipulate   Treg   responses   is  
important   for   the   development   of   new   therapy   options   for   autoimmune  
diseases  and  chronic  infections.    
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